id	sid	tid	token	lemma	pos
dpc-2863	1	1	dermatology	dermatology	NOUN
dpc-2863	1	2	:	:	PUNCT
dpc-2863	1	3	practical	practical	ADJ
dpc-2863	1	4	and	and	CCONJ
dpc-2863	1	5	conceptual	conceptual	ADJ
dpc-2863	1	6	original	original	ADJ
dpc-2863	1	7	article	article	NOUN
dpc-2863	1	8	|	|	ADV
dpc-2863	1	9	dermatol	dermatol	ADJ
dpc-2863	1	10	pract	pract	NOUN
dpc-2863	1	11	concept	concept	NOUN
dpc-2863	1	12	.	.	PUNCT
dpc-2863	2	1	2023;13(2):e2023134	2023;13(2):e2023134	NUM
dpc-2863	2	2	1	1	NUM
dpc-2863	2	3	investigation	investigation	NOUN
dpc-2863	2	4	of	of	ADP
dpc-2863	2	5	the	the	DET
dpc-2863	2	6	pd-1	pd-1	NOUN
dpc-2863	2	7	/	/	SYM
dpc-2863	2	8	pd	pd	ADJ
dpc-2863	2	9	-	-	PUNCT
dpc-2863	2	10	l1	l1	PROPN
dpc-2863	2	11	expression	expression	NOUN
dpc-2863	2	12	in	in	ADP
dpc-2863	2	13	the	the	DET
dpc-2863	2	14	lesional	lesional	ADJ
dpc-2863	2	15	skins	skin	NOUN
dpc-2863	2	16	of	of	ADP
dpc-2863	2	17	patients	patient	NOUN
dpc-2863	2	18	with	with	ADP
dpc-2863	2	19	psoriasis	psoriasis	NOUN
dpc-2863	2	20	selma	selma	PROPN
dpc-2863	2	21	emre1	emre1	PROPN
dpc-2863	2	22	,	,	PUNCT
dpc-2863	2	23	nuran	nuran	ADJ
dpc-2863	2	24	süngü2	süngü2	PROPN
dpc-2863	2	25	,	,	PUNCT
dpc-2863	2	26	yıldız	yıldız	PROPN
dpc-2863	2	27	hayran3	hayran3	PROPN
dpc-2863	2	28	,	,	PUNCT
dpc-2863	2	29	d	d	PROPN
dpc-2863	2	30	deniz	deniz	PROPN
dpc-2863	2	31	demirseren4	demirseren4	PROPN
dpc-2863	2	32	,	,	PUNCT
dpc-2863	2	33	akın	akın	PROPN
dpc-2863	2	34	aktas1	aktas1	NOUN
dpc-2863	2	35	,	,	PUNCT
dpc-2863	2	36	tuce	tuce	ADJ
dpc-2863	2	37	özkara	özkara	ADJ
dpc-2863	2	38	duman1	duman1	NOUN
dpc-2863	2	39	1	1	NUM
dpc-2863	2	40	yildirim	yildirim	PROPN
dpc-2863	2	41	beyazit	beyazit	PROPN
dpc-2863	2	42	university	university	PROPN
dpc-2863	2	43	,	,	PUNCT
dpc-2863	2	44	medical	medical	ADJ
dpc-2863	2	45	school	school	NOUN
dpc-2863	2	46	,	,	PUNCT
dpc-2863	2	47	department	department	NOUN
dpc-2863	2	48	of	of	ADP
dpc-2863	2	49	dermatology	dermatology	NOUN
dpc-2863	2	50	,	,	PUNCT
dpc-2863	2	51	ankara	ankara	PROPN
dpc-2863	2	52	,	,	PUNCT
dpc-2863	2	53	turkey	turkey	PROPN
dpc-2863	2	54	2	2	NUM
dpc-2863	2	55	yildirim	yildirim	PROPN
dpc-2863	2	56	beyazit	beyazit	PROPN
dpc-2863	2	57	university	university	PROPN
dpc-2863	2	58	,	,	PUNCT
dpc-2863	2	59	medical	medical	ADJ
dpc-2863	2	60	school	school	NOUN
dpc-2863	2	61	,	,	PUNCT
dpc-2863	2	62	department	department	NOUN
dpc-2863	2	63	of	of	ADP
dpc-2863	2	64	pathology	pathology	PROPN
dpc-2863	2	65	,	,	PUNCT
dpc-2863	2	66	ankara	ankara	PROPN
dpc-2863	2	67	,	,	PUNCT
dpc-2863	2	68	turkey	turkey	PROPN
dpc-2863	2	69	3	3	NUM
dpc-2863	2	70	ministry	ministry	PROPN
dpc-2863	2	71	of	of	ADP
dpc-2863	2	72	health	health	PROPN
dpc-2863	2	73	,	,	PUNCT
dpc-2863	2	74	ankara	ankara	PROPN
dpc-2863	2	75	city	city	PROPN
dpc-2863	2	76	hospital	hospital	PROPN
dpc-2863	2	77	,	,	PUNCT
dpc-2863	2	78	department	department	NOUN
dpc-2863	2	79	of	of	ADP
dpc-2863	2	80	dermatology	dermatology	NOUN
dpc-2863	2	81	,	,	PUNCT
dpc-2863	2	82	ankara	ankara	PROPN
dpc-2863	2	83	,	,	PUNCT
dpc-2863	2	84	turkey	turkey	PROPN
dpc-2863	2	85	4	4	NUM
dpc-2863	2	86	university	university	PROPN
dpc-2863	2	87	of	of	ADP
dpc-2863	2	88	health	health	NOUN
dpc-2863	2	89	science	science	NOUN
dpc-2863	2	90	,	,	PUNCT
dpc-2863	2	91	ankara	ankara	PROPN
dpc-2863	2	92	city	city	PROPN
dpc-2863	2	93	hospital	hospital	PROPN
dpc-2863	2	94	,	,	PUNCT
dpc-2863	2	95	department	department	NOUN
dpc-2863	2	96	of	of	ADP
dpc-2863	2	97	dermatology	dermatology	NOUN
dpc-2863	2	98	,	,	PUNCT
dpc-2863	2	99	ankara	ankara	PROPN
dpc-2863	2	100	,	,	PUNCT
dpc-2863	2	101	turkey	turkey	PROPN
dpc-2863	2	102	key	key	ADJ
dpc-2863	2	103	words	word	NOUN
dpc-2863	2	104	:	:	PUNCT
dpc-2863	2	105	autoimmunity	autoimmunity	NOUN
dpc-2863	2	106	,	,	PUNCT
dpc-2863	2	107	immunohistochemistry	immunohistochemistry	NOUN
dpc-2863	2	108	,	,	PUNCT
dpc-2863	2	109	pd1	pd1	NOUN
dpc-2863	2	110	,	,	PUNCT
dpc-2863	2	111	pdl-1	pdl-1	X
dpc-2863	2	112	,	,	PUNCT
dpc-2863	2	113	psoriasis	psoriasis	NOUN
dpc-2863	2	114	citation	citation	NOUN
dpc-2863	2	115	:	:	PUNCT
dpc-2863	2	116	emre	emre	PROPN
dpc-2863	2	117	s	s	PROPN
dpc-2863	2	118	,	,	PUNCT
dpc-2863	2	119	süngü	süngü	ADJ
dpc-2863	2	120	n	n	CCONJ
dpc-2863	2	121	,	,	PUNCT
dpc-2863	2	122	hayran	hayran	NOUN
dpc-2863	2	123	y	y	PROPN
dpc-2863	2	124	,	,	PUNCT
dpc-2863	2	125	demirseren	demirseren	PROPN
dpc-2863	2	126	dd	dd	PROPN
dpc-2863	2	127	,	,	PUNCT
dpc-2863	2	128	aktas	aktas	PROPN
dpc-2863	2	129	a	a	NOUN
dpc-2863	2	130	,	,	PUNCT
dpc-2863	2	131	duman	duman	PROPN
dpc-2863	2	132	tö	tö	PROPN
dpc-2863	2	133	.	.	PUNCT
dpc-2863	3	1	investigation	investigation	NOUN
dpc-2863	3	2	of	of	ADP
dpc-2863	3	3	the	the	DET
dpc-2863	3	4	pd-1	pd-1	NOUN
dpc-2863	3	5	/	/	SYM
dpc-2863	3	6	pd	pd	ADJ
dpc-2863	3	7	-	-	PUNCT
dpc-2863	3	8	l1	l1	PROPN
dpc-2863	3	9	expression	expression	NOUN
dpc-2863	3	10	in	in	ADP
dpc-2863	3	11	the	the	DET
dpc-2863	3	12	lesional	lesional	ADJ
dpc-2863	3	13	skins	skin	NOUN
dpc-2863	3	14	of	of	ADP
dpc-2863	3	15	patients	patient	NOUN
dpc-2863	3	16	with	with	ADP
dpc-2863	3	17	psoriasis	psoriasis	NOUN
dpc-2863	3	18	.	.	PUNCT
dpc-2863	4	1	dermatol	dermatol	NOUN
dpc-2863	4	2	pract	pract	PROPN
dpc-2863	4	3	concept	concept	NOUN
dpc-2863	4	4	.	.	PUNCT
dpc-2863	5	1	2023;13(2):e2023134	2023;13(2):e2023134	X
dpc-2863	5	2	.	.	X
dpc-2863	5	3	doi	doi	NOUN
dpc-2863	5	4	:	:	PUNCT
dpc-2863	5	5	https://doi.org/10.5826/dpc.1302a134	https://doi.org/10.5826/dpc.1302a134	PROPN
dpc-2863	5	6	accepted	accept	VERB
dpc-2863	5	7	:	:	PUNCT
dpc-2863	5	8	november	november	PROPN
dpc-2863	5	9	17	17	NUM
dpc-2863	5	10	,	,	PUNCT
dpc-2863	5	11	2022	2022	NUM
dpc-2863	5	12	;	;	PUNCT
dpc-2863	5	13	published	publish	VERB
dpc-2863	5	14	:	:	PUNCT
dpc-2863	6	1	april	april	PROPN
dpc-2863	6	2	2023	2023	NUM
dpc-2863	6	3	copyright	copyright	NOUN
dpc-2863	6	4	:	:	PUNCT
dpc-2863	6	5	©	©	PROPN
dpc-2863	6	6	2023	2023	NUM
dpc-2863	6	7	emre	emre	PROPN
dpc-2863	6	8	et	et	PROPN
dpc-2863	6	9	al	al	PROPN
dpc-2863	6	10	.	.	PUNCT
dpc-2863	7	1	this	this	PRON
dpc-2863	7	2	is	be	AUX
dpc-2863	7	3	an	an	DET
dpc-2863	7	4	open	open	ADJ
dpc-2863	7	5	-	-	PUNCT
dpc-2863	7	6	access	access	NOUN
dpc-2863	7	7	article	article	NOUN
dpc-2863	7	8	distributed	distribute	VERB
dpc-2863	7	9	under	under	ADP
dpc-2863	7	10	the	the	DET
dpc-2863	7	11	terms	term	NOUN
dpc-2863	7	12	of	of	ADP
dpc-2863	7	13	the	the	DET
dpc-2863	7	14	creative	creative	ADJ
dpc-2863	7	15	commons	common	NOUN
dpc-2863	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2863	7	17	license	license	NOUN
dpc-2863	7	18	(	(	PUNCT
dpc-2863	7	19	by	by	ADP
dpc-2863	7	20	-	-	PUNCT
dpc-2863	7	21	nc-4.0	nc-4.0	NOUN
dpc-2863	7	22	)	)	PUNCT
dpc-2863	7	23	,	,	PUNCT
dpc-2863	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2863	7	25	,	,	PUNCT
dpc-2863	7	26	which	which	PRON
dpc-2863	7	27	permits	permit	VERB
dpc-2863	7	28	unrestricted	unrestricted	ADJ
dpc-2863	7	29	noncommercial	noncommercial	ADJ
dpc-2863	7	30	use	use	NOUN
dpc-2863	7	31	,	,	PUNCT
dpc-2863	7	32	distribution	distribution	NOUN
dpc-2863	7	33	,	,	PUNCT
dpc-2863	7	34	and	and	CCONJ
dpc-2863	7	35	reproduction	reproduction	NOUN
dpc-2863	7	36	in	in	ADP
dpc-2863	7	37	any	any	DET
dpc-2863	7	38	medium	medium	NOUN
dpc-2863	7	39	,	,	PUNCT
dpc-2863	7	40	provided	provide	VERB
dpc-2863	7	41	the	the	DET
dpc-2863	7	42	original	original	ADJ
dpc-2863	7	43	authors	author	NOUN
dpc-2863	7	44	and	and	CCONJ
dpc-2863	7	45	source	source	NOUN
dpc-2863	7	46	are	be	AUX
dpc-2863	7	47	credited	credit	VERB
dpc-2863	7	48	.	.	PUNCT
dpc-2863	8	1	funding	funding	NOUN
dpc-2863	8	2	:	:	PUNCT
dpc-2863	8	3	none	none	NOUN
dpc-2863	8	4	.	.	PUNCT
dpc-2863	9	1	competing	compete	VERB
dpc-2863	9	2	interests	interest	NOUN
dpc-2863	9	3	:	:	PUNCT
dpc-2863	9	4	none	none	NOUN
dpc-2863	9	5	.	.	PUNCT
dpc-2863	10	1	authorship	authorship	NOUN
dpc-2863	10	2	:	:	PUNCT
dpc-2863	10	3	all	all	DET
dpc-2863	10	4	authors	author	NOUN
dpc-2863	10	5	have	have	AUX
dpc-2863	10	6	contributed	contribute	VERB
dpc-2863	10	7	significantly	significantly	ADV
dpc-2863	10	8	to	to	ADP
dpc-2863	10	9	this	this	DET
dpc-2863	10	10	publication	publication	NOUN
dpc-2863	10	11	.	.	PUNCT
dpc-2863	11	1	corresponding	correspond	VERB
dpc-2863	11	2	author	author	NOUN
dpc-2863	11	3	:	:	PUNCT
dpc-2863	11	4	selma	selma	PROPN
dpc-2863	11	5	emre	emre	PROPN
dpc-2863	11	6	,	,	PUNCT
dpc-2863	11	7	yildirim	yildirim	PROPN
dpc-2863	11	8	beyazit	beyazit	PROPN
dpc-2863	11	9	university	university	PROPN
dpc-2863	11	10	,	,	PUNCT
dpc-2863	11	11	medical	medical	ADJ
dpc-2863	11	12	school	school	NOUN
dpc-2863	11	13	,	,	PUNCT
dpc-2863	11	14	department	department	NOUN
dpc-2863	11	15	of	of	ADP
dpc-2863	11	16	dermatology	dermatology	NOUN
dpc-2863	11	17	,	,	PUNCT
dpc-2863	11	18	ankara	ankara	PROPN
dpc-2863	11	19	city	city	NOUN
dpc-2863	11	20	hospitals	hospital	NOUN
dpc-2863	11	21	,	,	PUNCT
dpc-2863	11	22	orthopedics	orthopedic	NOUN
dpc-2863	11	23	and	and	CCONJ
dpc-2863	11	24	neurology	neurology	NOUN
dpc-2863	11	25	hospital	hospital	NOUN
dpc-2863	11	26	,	,	PUNCT
dpc-2863	11	27	cankaya	cankaya	NOUN
dpc-2863	11	28	,	,	PUNCT
dpc-2863	11	29	ankara	ankara	PROPN
dpc-2863	11	30	,	,	PUNCT
dpc-2863	11	31	turkey	turkey	PROPN
dpc-2863	11	32	.	.	PUNCT
dpc-2863	12	1	orcid	orcid	NOUN
dpc-2863	12	2	number	number	NOUN
dpc-2863	12	3	:	:	PUNCT
dpc-2863	12	4	0000	0000	NUM
dpc-2863	12	5	-	-	PUNCT
dpc-2863	12	6	0001	0001	NUM
dpc-2863	12	7	-	-	PUNCT
dpc-2863	12	8	5963	5963	NUM
dpc-2863	12	9	-	-	PUNCT
dpc-2863	12	10	8939	8939	NUM
dpc-2863	12	11	e	e	NOUN
dpc-2863	12	12	-	-	NOUN
dpc-2863	12	13	mail	mail	NOUN
dpc-2863	12	14	:	:	PUNCT
dpc-2863	12	15	dr_semre@yahoo.com	dr_semre@yahoo.com	X
dpc-2863	12	16	introduction	introduction	NOUN
dpc-2863	12	17	:	:	PUNCT
dpc-2863	12	18	psoriasis	psoriasis	NOUN
dpc-2863	12	19	is	be	AUX
dpc-2863	12	20	an	an	DET
dpc-2863	12	21	immune	immune	NOUN
dpc-2863	12	22	-	-	PUNCT
dpc-2863	12	23	mediated	mediate	VERB
dpc-2863	12	24	,	,	PUNCT
dpc-2863	12	25	chronic	chronic	ADJ
dpc-2863	12	26	and	and	CCONJ
dpc-2863	12	27	inflammatory	inflammatory	ADJ
dpc-2863	12	28	disease	disease	NOUN
dpc-2863	12	29	whose	whose	DET
dpc-2863	12	30	pathogenesis	pathogenesis	NOUN
dpc-2863	12	31	is	be	AUX
dpc-2863	12	32	affected	affect	VERB
dpc-2863	12	33	by	by	ADP
dpc-2863	12	34	the	the	DET
dpc-2863	12	35	interactions	interaction	NOUN
dpc-2863	12	36	of	of	ADP
dpc-2863	12	37	several	several	ADJ
dpc-2863	12	38	immune	immune	ADJ
dpc-2863	12	39	cells	cell	NOUN
dpc-2863	12	40	and	and	CCONJ
dpc-2863	12	41	cytokines	cytokine	NOUN
dpc-2863	12	42	.	.	PUNCT
dpc-2863	13	1	pd-1	pd-1	ADJ
dpc-2863	13	2	is	be	AUX
dpc-2863	13	3	an	an	DET
dpc-2863	13	4	inhibitor	inhibitor	NOUN
dpc-2863	13	5	receptor	receptor	NOUN
dpc-2863	13	6	that	that	PRON
dpc-2863	13	7	is	be	AUX
dpc-2863	13	8	expressed	express	VERB
dpc-2863	13	9	to	to	ADP
dpc-2863	13	10	a	a	DET
dpc-2863	13	11	large	large	ADJ
dpc-2863	13	12	extent	extent	NOUN
dpc-2863	13	13	in	in	ADP
dpc-2863	13	14	t	t	PROPN
dpc-2863	13	15	lymphocytes	lymphocyte	NOUN
dpc-2863	13	16	and	and	CCONJ
dpc-2863	13	17	responsible	responsible	ADJ
dpc-2863	13	18	for	for	ADP
dpc-2863	13	19	regulating	regulate	VERB
dpc-2863	13	20	autoimmunity	autoimmunity	NOUN
dpc-2863	13	21	and	and	CCONJ
dpc-2863	13	22	self	self	NOUN
dpc-2863	13	23	-	-	PUNCT
dpc-2863	13	24	tolerance	tolerance	NOUN
dpc-2863	13	25	.	.	PUNCT
dpc-2863	14	1	objectives	objective	NOUN
dpc-2863	14	2	:	:	PUNCT
dpc-2863	14	3	in	in	ADP
dpc-2863	14	4	this	this	DET
dpc-2863	14	5	study	study	NOUN
dpc-2863	14	6	,	,	PUNCT
dpc-2863	14	7	we	we	PRON
dpc-2863	14	8	aimed	aim	VERB
dpc-2863	14	9	to	to	PART
dpc-2863	14	10	investigate	investigate	VERB
dpc-2863	14	11	the	the	DET
dpc-2863	14	12	expression	expression	NOUN
dpc-2863	14	13	of	of	ADP
dpc-2863	14	14	pd-1	pd-1	NOUN
dpc-2863	14	15	/	/	SYM
dpc-2863	14	16	pd	pd	ADJ
dpc-2863	14	17	-	-	ADJ
dpc-2863	14	18	l	l	NOUN
dpc-2863	14	19	molecules	molecule	NOUN
dpc-2863	14	20	in	in	ADP
dpc-2863	14	21	the	the	DET
dpc-2863	14	22	lesioned	lesione	VERB
dpc-2863	14	23	skins	skin	NOUN
dpc-2863	14	24	of	of	ADP
dpc-2863	14	25	psoriasis	psoriasis	NOUN
dpc-2863	14	26	patients	patient	NOUN
dpc-2863	14	27	.	.	PUNCT
dpc-2863	15	1	methods	method	NOUN
dpc-2863	15	2	:	:	PUNCT
dpc-2863	15	3	the	the	DET
dpc-2863	15	4	study	study	NOUN
dpc-2863	15	5	included	include	VERB
dpc-2863	15	6	30	30	NUM
dpc-2863	15	7	psoriasis	psoriasis	NOUN
dpc-2863	15	8	patients	patient	NOUN
dpc-2863	15	9	,	,	PUNCT
dpc-2863	15	10	and	and	CCONJ
dpc-2863	15	11	15	15	NUM
dpc-2863	15	12	healthy	healthy	ADJ
dpc-2863	15	13	volunteers	volunteer	NOUN
dpc-2863	15	14	as	as	ADP
dpc-2863	15	15	the	the	DET
dpc-2863	15	16	control	control	NOUN
dpc-2863	15	17	group	group	NOUN
dpc-2863	15	18	.	.	PUNCT
dpc-2863	16	1	anti	anti	PROPN
dpc-2863	16	2	pd-1	pd-1	ADJ
dpc-2863	16	3	and	and	CCONJ
dpc-2863	16	4	pd	pd	PROPN
dpc-2863	16	5	-	-	PUNCT
dpc-2863	16	6	l1	l1	PROPN
dpc-2863	16	7	antibodies	antibody	NOUN
dpc-2863	16	8	were	be	AUX
dpc-2863	16	9	applied	apply	VERB
dpc-2863	16	10	to	to	ADP
dpc-2863	16	11	the	the	DET
dpc-2863	16	12	skin	skin	NOUN
dpc-2863	16	13	biopsy	biopsy	NOUN
dpc-2863	16	14	samples	sample	NOUN
dpc-2863	16	15	that	that	PRON
dpc-2863	16	16	were	be	AUX
dpc-2863	16	17	collected	collect	VERB
dpc-2863	16	18	from	from	ADP
dpc-2863	16	19	the	the	DET
dpc-2863	16	20	patient	patient	NOUN
dpc-2863	16	21	and	and	CCONJ
dpc-2863	16	22	control	control	NOUN
dpc-2863	16	23	groups	group	NOUN
dpc-2863	16	24	.	.	PUNCT
dpc-2863	17	1	cytoplasmic	cytoplasmic	ADJ
dpc-2863	17	2	and	and	CCONJ
dpc-2863	17	3	membranous	membranous	ADJ
dpc-2863	17	4	staining	staining	NOUN
dpc-2863	17	5	of	of	ADP
dpc-2863	17	6	pd-1	pd-1	ADJ
dpc-2863	17	7	and	and	CCONJ
dpc-2863	17	8	pd	pd	PROPN
dpc-2863	17	9	-	-	PROPN
dpc-2863	17	10	l1	l1	PROPN
dpc-2863	17	11	were	be	AUX
dpc-2863	17	12	considered	consider	VERB
dpc-2863	17	13	positive	positive	ADJ
dpc-2863	17	14	.	.	PUNCT
dpc-2863	18	1	the	the	DET
dpc-2863	18	2	number	number	NOUN
dpc-2863	18	3	of	of	ADP
dpc-2863	18	4	stained	stain	VERB
dpc-2863	18	5	immune	immune	ADJ
dpc-2863	18	6	cells	cell	NOUN
dpc-2863	18	7	that	that	PRON
dpc-2863	18	8	was	be	AUX
dpc-2863	18	9	examined	examine	VERB
dpc-2863	18	10	for	for	ADP
dpc-2863	18	11	each	each	DET
dpc-2863	18	12	case	case	NOUN
dpc-2863	18	13	.	.	PUNCT
dpc-2863	19	1	results	result	NOUN
dpc-2863	19	2	:	:	PUNCT
dpc-2863	19	3	the	the	DET
dpc-2863	19	4	percentage	percentage	NOUN
dpc-2863	19	5	of	of	ADP
dpc-2863	19	6	the	the	DET
dpc-2863	19	7	tissues	tissue	NOUN
dpc-2863	19	8	with	with	ADP
dpc-2863	19	9	high	high	ADJ
dpc-2863	19	10	pd-1	pd-1	ADP
dpc-2863	19	11	(	(	PUNCT
dpc-2863	19	12	+	+	NOUN
dpc-2863	19	13	)	)	PUNCT
dpc-2863	19	14	and	and	CCONJ
dpc-2863	19	15	pdl-1	pdl-1	ADV
dpc-2863	19	16	(	(	PUNCT
dpc-2863	19	17	+	+	ADJ
dpc-2863	19	18	)	)	PUNCT
dpc-2863	19	19	immune	immune	ADJ
dpc-2863	19	20	cell	cell	NOUN
dpc-2863	19	21	counts	count	NOUN
dpc-2863	19	22	were	be	AUX
dpc-2863	19	23	significantly	significantly	ADV
dpc-2863	19	24	higher	high	ADJ
dpc-2863	19	25	in	in	ADP
dpc-2863	19	26	the	the	DET
dpc-2863	19	27	psoriasis	psoriasis	NOUN
dpc-2863	19	28	patients	patient	NOUN
dpc-2863	19	29	compared	compare	VERB
dpc-2863	19	30	to	to	ADP
dpc-2863	19	31	healthy	healthy	ADJ
dpc-2863	19	32	controls	control	NOUN
dpc-2863	19	33	(	(	PUNCT
dpc-2863	19	34	p	p	NOUN
dpc-2863	19	35	values	value	NOUN
dpc-2863	19	36	=	=	SYM
dpc-2863	19	37	0.004	0.004	NUM
dpc-2863	19	38	and	and	CCONJ
dpc-2863	19	39	0.002	0.002	NUM
dpc-2863	19	40	,	,	PUNCT
dpc-2863	19	41	respectively	respectively	ADV
dpc-2863	19	42	)	)	PUNCT
dpc-2863	19	43	.	.	PUNCT
dpc-2863	20	1	a	a	DET
dpc-2863	20	2	negative	negative	ADJ
dpc-2863	20	3	and	and	CCONJ
dpc-2863	20	4	statistically	statistically	ADV
dpc-2863	20	5	significant	significant	ADJ
dpc-2863	20	6	correlation	correlation	NOUN
dpc-2863	20	7	was	be	AUX
dpc-2863	20	8	detected	detect	VERB
dpc-2863	20	9	between	between	ADP
dpc-2863	20	10	pdl-1(+	pdl-1(+	PROPN
dpc-2863	20	11	)	)	PUNCT
dpc-2863	20	12	immune	immune	ADJ
dpc-2863	20	13	cell	cell	NOUN
dpc-2863	20	14	numbers	number	NOUN
dpc-2863	20	15	and	and	CCONJ
dpc-2863	20	16	pasi	pasi	NOUN
dpc-2863	20	17	scores	score	NOUN
dpc-2863	20	18	(	(	PUNCT
dpc-2863	20	19	p	p	X
dpc-2863	20	20	=	=	NOUN
dpc-2863	20	21	0.033	0.033	NUM
dpc-2863	20	22	,	,	PUNCT
dpc-2863	20	23	r=-0.57	r=-0.57	NUM
dpc-2863	20	24	)	)	PUNCT
dpc-2863	20	25	.	.	PUNCT
dpc-2863	21	1	conclusions	conclusion	NOUN
dpc-2863	21	2	:	:	PUNCT
dpc-2863	21	3	in	in	ADP
dpc-2863	21	4	the	the	DET
dpc-2863	21	5	lesioned	lesione	VERB
dpc-2863	21	6	skin	skin	NOUN
dpc-2863	21	7	samples	sample	NOUN
dpc-2863	21	8	of	of	ADP
dpc-2863	21	9	psoriasis	psoriasis	NOUN
dpc-2863	21	10	patients	patient	NOUN
dpc-2863	21	11	,	,	PUNCT
dpc-2863	21	12	the	the	DET
dpc-2863	21	13	pd-1	pd-1	ADJ
dpc-2863	21	14	and	and	CCONJ
dpc-2863	21	15	pd	pd	PROPN
dpc-2863	21	16	-	-	PUNCT
dpc-2863	21	17	l1	l1	PROPN
dpc-2863	21	18	expressions	expression	NOUN
dpc-2863	21	19	were	be	AUX
dpc-2863	21	20	significantly	significantly	ADV
dpc-2863	21	21	higher	high	ADJ
dpc-2863	21	22	in	in	ADP
dpc-2863	21	23	immune	immune	ADJ
dpc-2863	21	24	cells	cell	NOUN
dpc-2863	21	25	than	than	ADP
dpc-2863	21	26	that	that	PRON
dpc-2863	21	27	in	in	ADP
dpc-2863	21	28	the	the	DET
dpc-2863	21	29	skin	skin	NOUN
dpc-2863	21	30	samples	sample	NOUN
dpc-2863	21	31	of	of	ADP
dpc-2863	21	32	the	the	DET
dpc-2863	21	33	healthy	healthy	ADJ
dpc-2863	21	34	controls	control	NOUN
dpc-2863	21	35	.	.	PUNCT
dpc-2863	22	1	this	this	DET
dpc-2863	22	2	study	study	NOUN
dpc-2863	22	3	was	be	AUX
dpc-2863	22	4	the	the	DET
dpc-2863	22	5	first	first	ADJ
dpc-2863	22	6	investigation	investigation	NOUN
dpc-2863	22	7	of	of	ADP
dpc-2863	22	8	the	the	DET
dpc-2863	22	9	expression	expression	NOUN
dpc-2863	22	10	of	of	ADP
dpc-2863	22	11	pd-1	pd-1	NOUN
dpc-2863	22	12	/	/	SYM
dpc-2863	22	13	pd	pd	ADJ
dpc-2863	22	14	-	-	ADJ
dpc-2863	22	15	l	l	NOUN
dpc-2863	22	16	molecules	molecule	NOUN
dpc-2863	22	17	in	in	ADP
dpc-2863	22	18	the	the	DET
dpc-2863	22	19	immune	immune	ADJ
dpc-2863	22	20	cells	cell	NOUN
dpc-2863	22	21	in	in	SCONJ
dpc-2863	22	22	found	find	VERB
dpc-2863	22	23	the	the	DET
dpc-2863	22	24	lesioned	lesione	VERB
dpc-2863	22	25	skins	skin	NOUN
dpc-2863	22	26	of	of	ADP
dpc-2863	22	27	psoriasis	psoriasis	NOUN
dpc-2863	22	28	patients	patient	NOUN
dpc-2863	22	29	.	.	PUNCT
dpc-2863	23	1	abstract	abstract	ADJ
dpc-2863	23	2	2	2	NUM
dpc-2863	23	3	original	original	ADJ
dpc-2863	23	4	article	article	NOUN
dpc-2863	23	5	|	|	ADV
dpc-2863	23	6	dermatol	dermatol	ADJ
dpc-2863	23	7	pract	pract	NOUN
dpc-2863	23	8	concept	concept	NOUN
dpc-2863	23	9	.	.	PUNCT
dpc-2863	24	1	2023;13(2):e2023134	2023;13(2):e2023134	NUM
dpc-2863	24	2	introduction	introduction	NOUN
dpc-2863	24	3	psoriasis	psoriasis	NOUN
dpc-2863	24	4	is	be	AUX
dpc-2863	24	5	an	an	DET
dpc-2863	24	6	immune	immune	NOUN
dpc-2863	24	7	-	-	PUNCT
dpc-2863	24	8	mediated	mediate	VERB
dpc-2863	24	9	,	,	PUNCT
dpc-2863	24	10	chronic	chronic	ADJ
dpc-2863	24	11	and	and	CCONJ
dpc-2863	24	12	inflammatory	inflammatory	ADJ
dpc-2863	24	13	disease	disease	NOUN
dpc-2863	24	14	whose	whose	DET
dpc-2863	24	15	pathogenesis	pathogenesis	NOUN
dpc-2863	24	16	is	be	AUX
dpc-2863	24	17	affected	affect	VERB
dpc-2863	24	18	by	by	ADP
dpc-2863	24	19	the	the	DET
dpc-2863	24	20	interactions	interaction	NOUN
dpc-2863	24	21	of	of	ADP
dpc-2863	24	22	several	several	ADJ
dpc-2863	24	23	immune	immune	ADJ
dpc-2863	24	24	cells	cell	NOUN
dpc-2863	24	25	and	and	CCONJ
dpc-2863	24	26	cytokines	cytokine	NOUN
dpc-2863	24	27	.	.	PUNCT
dpc-2863	25	1	over	over	ADP
dpc-2863	25	2	the	the	DET
dpc-2863	25	3	last	last	ADJ
dpc-2863	25	4	two	two	NUM
dpc-2863	25	5	decades	decade	NOUN
dpc-2863	25	6	,	,	PUNCT
dpc-2863	25	7	highly	highly	ADV
dpc-2863	25	8	significant	significant	ADJ
dpc-2863	25	9	advancements	advancement	NOUN
dpc-2863	25	10	have	have	AUX
dpc-2863	25	11	been	be	AUX
dpc-2863	25	12	achieved	achieve	VERB
dpc-2863	25	13	regarding	regard	VERB
dpc-2863	25	14	the	the	DET
dpc-2863	25	15	pathogenetic	pathogenetic	ADJ
dpc-2863	25	16	mechanisms	mechanism	NOUN
dpc-2863	25	17	of	of	ADP
dpc-2863	25	18	psoriasis	psoriasis	NOUN
dpc-2863	25	19	where	where	SCONJ
dpc-2863	25	20	t	t	NOUN
dpc-2863	25	21	helper	helper	NOUN
dpc-2863	25	22	1	1	NUM
dpc-2863	25	23	(	(	PUNCT
dpc-2863	25	24	th1	th1	NOUN
dpc-2863	25	25	)	)	PUNCT
dpc-2863	25	26	and	and	CCONJ
dpc-2863	25	27	th	th	NUM
dpc-2863	25	28	17	17	NUM
dpc-2863	25	29	lymphocytes	lymphocyte	NOUN
dpc-2863	25	30	play	play	VERB
dpc-2863	25	31	a	a	DET
dpc-2863	25	32	major	major	ADJ
dpc-2863	25	33	role	role	NOUN
dpc-2863	25	34	[	[	X
dpc-2863	25	35	1].1	1].1	ADV
dpc-2863	25	36	recently	recently	ADV
dpc-2863	25	37	,	,	PUNCT
dpc-2863	25	38	new	new	ADJ
dpc-2863	25	39	molecules	molecule	NOUN
dpc-2863	25	40	and	and	CCONJ
dpc-2863	25	41	pathways	pathway	NOUN
dpc-2863	25	42	responsible	responsible	ADJ
dpc-2863	25	43	for	for	ADP
dpc-2863	25	44	regulating	regulate	VERB
dpc-2863	25	45	autoimmunity	autoimmunity	NOUN
dpc-2863	25	46	and	and	CCONJ
dpc-2863	25	47	tolerance	tolerance	NOUN
dpc-2863	25	48	have	have	AUX
dpc-2863	25	49	been	be	AUX
dpc-2863	25	50	defined	define	VERB
dpc-2863	25	51	.	.	PUNCT
dpc-2863	26	1	one	one	NUM
dpc-2863	26	2	of	of	ADP
dpc-2863	26	3	these	these	DET
dpc-2863	26	4	molecules	molecule	NOUN
dpc-2863	26	5	,	,	PUNCT
dpc-2863	26	6	programmed	program	VERB
dpc-2863	26	7	death-1	death-1	PROPN
dpc-2863	26	8	(	(	PUNCT
dpc-2863	26	9	pd-1	pd-1	ADV
dpc-2863	26	10	)	)	PUNCT
dpc-2863	26	11	(	(	PUNCT
dpc-2863	26	12	cd279	cd279	PROPN
dpc-2863	26	13	)	)	PUNCT
dpc-2863	26	14	is	be	AUX
dpc-2863	26	15	an	an	DET
dpc-2863	26	16	immune	immune	ADJ
dpc-2863	26	17	check	check	NOUN
dpc-2863	26	18	point	point	NOUN
dpc-2863	26	19	that	that	PRON
dpc-2863	26	20	sends	send	VERB
dpc-2863	26	21	inhibitor	inhibitor	NOUN
dpc-2863	26	22	signals	signal	NOUN
dpc-2863	26	23	to	to	ADP
dpc-2863	26	24	the	the	DET
dpc-2863	26	25	immune	immune	ADJ
dpc-2863	26	26	system	system	NOUN
dpc-2863	26	27	to	to	PART
dpc-2863	26	28	maintain	maintain	VERB
dpc-2863	26	29	a	a	DET
dpc-2863	26	30	balance	balance	NOUN
dpc-2863	26	31	between	between	ADP
dpc-2863	26	32	t	t	NOUN
dpc-2863	26	33	cell	cell	NOUN
dpc-2863	26	34	activation	activation	NOUN
dpc-2863	26	35	and	and	CCONJ
dpc-2863	26	36	self	self	NOUN
dpc-2863	26	37	-	-	PUNCT
dpc-2863	26	38	tolerance	tolerance	NOUN
dpc-2863	26	39	in	in	ADP
dpc-2863	26	40	peripheral	peripheral	ADJ
dpc-2863	26	41	tissues	tissue	NOUN
dpc-2863	26	42	.	.	PUNCT
dpc-2863	27	1	pd-1	pd-1	ADJ
dpc-2863	27	2	is	be	AUX
dpc-2863	27	3	an	an	DET
dpc-2863	27	4	inhibitor	inhibitor	NOUN
dpc-2863	27	5	receptor	receptor	NOUN
dpc-2863	27	6	in	in	ADP
dpc-2863	27	7	the	the	DET
dpc-2863	27	8	form	form	NOUN
dpc-2863	27	9	of	of	ADP
dpc-2863	27	10	a	a	DET
dpc-2863	27	11	transmembrane	transmembrane	ADJ
dpc-2863	27	12	glycoprotein	glycoprotein	NOUN
dpc-2863	27	13	that	that	PRON
dpc-2863	27	14	belongs	belong	VERB
dpc-2863	27	15	to	to	ADP
dpc-2863	27	16	the	the	DET
dpc-2863	27	17	cd28	cd28	PROPN
dpc-2863	27	18	/	/	SYM
dpc-2863	27	19	ctla-4	ctla-4	NOUN
dpc-2863	27	20	family	family	NOUN
dpc-2863	27	21	with	with	ADP
dpc-2863	27	22	the	the	DET
dpc-2863	27	23	weight	weight	NOUN
dpc-2863	27	24	of	of	ADP
dpc-2863	27	25	50	50	NUM
dpc-2863	27	26	-	-	SYM
dpc-2863	27	27	55	55	NUM
dpc-2863	27	28	kda	kda	NOUN
dpc-2863	27	29	.	.	PUNCT
dpc-2863	27	30	pd-1	pd-1	VERB
dpc-2863	27	31	is	be	AUX
dpc-2863	27	32	expressed	express	VERB
dpc-2863	27	33	in	in	ADP
dpc-2863	27	34	active	active	ADJ
dpc-2863	27	35	t	t	NOUN
dpc-2863	27	36	cells	cell	NOUN
dpc-2863	27	37	,	,	PUNCT
dpc-2863	27	38	b	b	NOUN
dpc-2863	27	39	cells	cell	NOUN
dpc-2863	27	40	,	,	PUNCT
dpc-2863	27	41	thymocytes	thymocyte	NOUN
dpc-2863	27	42	,	,	PUNCT
dpc-2863	27	43	natural	natural	ADJ
dpc-2863	27	44	killers	killer	NOUN
dpc-2863	27	45	(	(	PUNCT
dpc-2863	27	46	nk	nk	PROPN
dpc-2863	27	47	)	)	PUNCT
dpc-2863	27	48	and	and	CCONJ
dpc-2863	27	49	double	double	ADJ
dpc-2863	27	50	negative	negative	ADJ
dpc-2863	27	51	thymocytes	thymocyte	NOUN
dpc-2863	27	52	(	(	PUNCT
dpc-2863	27	53	cd4ˉcd8ˉ	cd4ˉcd8ˉ	PROPN
dpc-2863	27	54	)	)	PUNCT
dpc-2863	27	55	.	.	PUNCT
dpc-2863	28	1	pd-1	pd-1	PUNCT
dpc-2863	28	2	has	have	VERB
dpc-2863	28	3	two	two	NUM
dpc-2863	28	4	ligands	ligand	NOUN
dpc-2863	28	5	:	:	PUNCT
dpc-2863	28	6	inhibitor	inhibitor	NOUN
dpc-2863	28	7	signals	signal	NOUN
dpc-2863	28	8	are	be	AUX
dpc-2863	28	9	achieved	achieve	VERB
dpc-2863	28	10	by	by	ADP
dpc-2863	28	11	the	the	DET
dpc-2863	28	12	bonding	bonding	NOUN
dpc-2863	28	13	of	of	ADP
dpc-2863	28	14	pd-1	pd-1	ADP
dpc-2863	28	15	to	to	ADP
dpc-2863	28	16	its	its	PRON
dpc-2863	28	17	ligands	ligand	NOUN
dpc-2863	28	18	–	–	PUNCT
dpc-2863	28	19	pd-1	pd-1	VERB
dpc-2863	28	20	ligand	ligand	ADJ
dpc-2863	28	21	1	1	NUM
dpc-2863	28	22	(	(	PUNCT
dpc-2863	28	23	pd	pd	NOUN
dpc-2863	28	24	-	-	PUNCT
dpc-2863	28	25	l1	l1	NOUN
dpc-2863	28	26	)	)	PUNCT
dpc-2863	28	27	and	and	CCONJ
dpc-2863	28	28	pd-1	pd-1	ADV
dpc-2863	28	29	ligand	ligand	PROPN
dpc-2863	28	30	2	2	NUM
dpc-2863	28	31	(	(	PUNCT
dpc-2863	28	32	pd	pd	NOUN
dpc-2863	28	33	-	-	NOUN
dpc-2863	28	34	l2	l2	NOUN
dpc-2863	28	35	)	)	PUNCT
dpc-2863	28	36	.	.	PUNCT
dpc-2863	29	1	while	while	SCONJ
dpc-2863	29	2	pd	pd	PROPN
dpc-2863	29	3	-	-	PROPN
dpc-2863	29	4	l1	l1	PROPN
dpc-2863	29	5	is	be	AUX
dpc-2863	29	6	widely	widely	ADV
dpc-2863	29	7	expressed	express	VERB
dpc-2863	29	8	in	in	ADP
dpc-2863	29	9	t	t	NOUN
dpc-2863	29	10	cells	cell	NOUN
dpc-2863	29	11	,	,	PUNCT
dpc-2863	29	12	b	b	NOUN
dpc-2863	29	13	cells	cell	NOUN
dpc-2863	29	14	,	,	PUNCT
dpc-2863	29	15	macrophages	macrophage	NOUN
dpc-2863	29	16	and	and	CCONJ
dpc-2863	29	17	dendritic	dendritic	ADJ
dpc-2863	29	18	cells	cell	NOUN
dpc-2863	29	19	,	,	PUNCT
dpc-2863	29	20	pd	pd	NOUN
dpc-2863	29	21	-	-	PUNCT
dpc-2863	29	22	l2	l2	NOUN
dpc-2863	29	23	is	be	AUX
dpc-2863	29	24	expressed	express	VERB
dpc-2863	29	25	in	in	ADP
dpc-2863	29	26	active	active	ADJ
dpc-2863	29	27	macrophages	macrophage	NOUN
dpc-2863	29	28	and	and	CCONJ
dpc-2863	29	29	dendritic	dendritic	ADJ
dpc-2863	29	30	cells	cell	NOUN
dpc-2863	29	31	.	.	PUNCT
dpc-2863	30	1	the	the	DET
dpc-2863	30	2	pd-1	pd-1	NOUN
dpc-2863	30	3	/	/	SYM
dpc-2863	30	4	pd	pd	ADJ
dpc-2863	30	5	-	-	ADJ
dpc-2863	30	6	l	l	NOUN
dpc-2863	30	7	pathway	pathway	NOUN
dpc-2863	30	8	participates	participate	VERB
dpc-2863	30	9	in	in	ADP
dpc-2863	30	10	the	the	DET
dpc-2863	30	11	pathogenesis	pathogenesis	NOUN
dpc-2863	30	12	of	of	ADP
dpc-2863	30	13	autoimmune	autoimmune	ADJ
dpc-2863	30	14	diseases	disease	NOUN
dpc-2863	30	15	.	.	PUNCT
dpc-2863	31	1	signals	signal	NOUN
dpc-2863	31	2	that	that	PRON
dpc-2863	31	3	are	be	AUX
dpc-2863	31	4	generated	generate	VERB
dpc-2863	31	5	by	by	ADP
dpc-2863	31	6	pd-1	pd-1	ADJ
dpc-2863	31	7	and	and	CCONJ
dpc-2863	31	8	its	its	PRON
dpc-2863	31	9	ligands	ligand	NOUN
dpc-2863	31	10	,	,	PUNCT
dpc-2863	31	11	pd	pd	PROPN
dpc-2863	31	12	-	-	PROPN
dpc-2863	31	13	l1	l1	PROPN
dpc-2863	31	14	and	and	CCONJ
dpc-2863	31	15	pd	pd	NOUN
dpc-2863	31	16	-	-	PUNCT
dpc-2863	31	17	l2	l2	NOUN
dpc-2863	31	18	,	,	PUNCT
dpc-2863	31	19	regulate	regulate	VERB
dpc-2863	31	20	central	central	ADJ
dpc-2863	31	21	and	and	CCONJ
dpc-2863	31	22	peripheral	peripheral	ADJ
dpc-2863	31	23	tolerance	tolerance	NOUN
dpc-2863	31	24	by	by	ADP
dpc-2863	31	25	means	mean	NOUN
dpc-2863	31	26	of	of	ADP
dpc-2863	31	27	several	several	ADJ
dpc-2863	31	28	mechanisms	mechanism	NOUN
dpc-2863	31	29	[	[	X
dpc-2863	31	30	2	2	NUM
dpc-2863	31	31	-	-	SYM
dpc-2863	31	32	4	4	NUM
dpc-2863	31	33	]	]	PUNCT
dpc-2863	31	34	.	.	PUNCT
dpc-2863	32	1	in	in	ADP
dpc-2863	32	2	experimental	experimental	ADJ
dpc-2863	32	3	autoimmunity	autoimmunity	NOUN
dpc-2863	32	4	and	and	CCONJ
dpc-2863	32	5	pathogenic	pathogenic	ADJ
dpc-2863	32	6	polymorphism	polymorphism	NOUN
dpc-2863	32	7	models	model	NOUN
dpc-2863	32	8	,	,	PUNCT
dpc-2863	32	9	it	it	PRON
dpc-2863	32	10	was	be	AUX
dpc-2863	32	11	seen	see	VERB
dpc-2863	32	12	that	that	SCONJ
dpc-2863	32	13	a	a	DET
dpc-2863	32	14	decrease	decrease	NOUN
dpc-2863	32	15	in	in	ADP
dpc-2863	32	16	the	the	DET
dpc-2863	32	17	expression	expression	NOUN
dpc-2863	32	18	of	of	ADP
dpc-2863	32	19	pd-1	pd-1	ADJ
dpc-2863	32	20	and	and	CCONJ
dpc-2863	32	21	its	its	PRON
dpc-2863	32	22	ligands	ligand	NOUN
dpc-2863	32	23	is	be	AUX
dpc-2863	32	24	associated	associate	VERB
dpc-2863	32	25	with	with	ADP
dpc-2863	32	26	some	some	DET
dpc-2863	32	27	autoimmune	autoimmune	ADJ
dpc-2863	32	28	disorders	disorder	NOUN
dpc-2863	32	29	such	such	ADJ
dpc-2863	32	30	as	as	ADP
dpc-2863	32	31	type	type	NOUN
dpc-2863	32	32	1	1	NUM
dpc-2863	32	33	diabetes	diabetes	NOUN
dpc-2863	32	34	mellitus	mellitus	NOUN
dpc-2863	32	35	,	,	PUNCT
dpc-2863	32	36	inflammatory	inflammatory	ADJ
dpc-2863	32	37	bowel	bowel	NOUN
dpc-2863	32	38	disease	disease	NOUN
dpc-2863	32	39	,	,	PUNCT
dpc-2863	32	40	rheumatoid	rheumatoid	NOUN
dpc-2863	32	41	arthritis	arthritis	NOUN
dpc-2863	32	42	,	,	PUNCT
dpc-2863	32	43	systemic	systemic	ADJ
dpc-2863	32	44	lupus	lupus	PROPN
dpc-2863	32	45	erythematosus	erythematosus	PROPN
dpc-2863	32	46	,	,	PUNCT
dpc-2863	32	47	ankylosing	ankylose	VERB
dpc-2863	32	48	spondylitis	spondylitis	NOUN
dpc-2863	32	49	,	,	PUNCT
dpc-2863	32	50	and	and	CCONJ
dpc-2863	32	51	encephalomyelitis	encephalomyelitis	X
dpc-2863	33	1	[	[	X
dpc-2863	33	2	2,3	2,3	NUM
dpc-2863	33	3	]	]	PUNCT
dpc-2863	33	4	.	.	PUNCT
dpc-2863	34	1	regulatory	regulatory	PROPN
dpc-2863	34	2	t	t	PROPN
dpc-2863	34	3	-	-	PUNCT
dpc-2863	34	4	cells	cell	NOUN
dpc-2863	34	5	(	(	PUNCT
dpc-2863	34	6	treg	treg	PROPN
dpc-2863	34	7	)	)	PUNCT
dpc-2863	34	8	is	be	AUX
dpc-2863	34	9	a	a	DET
dpc-2863	34	10	t	t	NOUN
dpc-2863	34	11	-	-	PUNCT
dpc-2863	34	12	cell	cell	NOUN
dpc-2863	34	13	subtype	subtype	NOUN
dpc-2863	34	14	responsible	responsible	ADJ
dpc-2863	34	15	for	for	ADP
dpc-2863	34	16	suppressing	suppress	VERB
dpc-2863	34	17	the	the	DET
dpc-2863	34	18	immune	immune	ADJ
dpc-2863	34	19	response	response	NOUN
dpc-2863	34	20	and	and	CCONJ
dpc-2863	34	21	maintaining	maintain	VERB
dpc-2863	34	22	immune	immune	ADJ
dpc-2863	34	23	tolerance	tolerance	NOUN
dpc-2863	34	24	.	.	PUNCT
dpc-2863	35	1	pd-1	pd-1	VERB
dpc-2863	35	2	surface	surface	NOUN
dpc-2863	35	3	molecules	molecule	NOUN
dpc-2863	35	4	on	on	ADP
dpc-2863	35	5	the	the	DET
dpc-2863	35	6	surface	surface	NOUN
dpc-2863	35	7	of	of	ADP
dpc-2863	35	8	treg	treg	PROPN
dpc-2863	35	9	cells	cell	NOUN
dpc-2863	35	10	play	play	VERB
dpc-2863	35	11	a	a	DET
dpc-2863	35	12	key	key	ADJ
dpc-2863	35	13	role	role	NOUN
dpc-2863	35	14	in	in	ADP
dpc-2863	35	15	immune	immune	ADJ
dpc-2863	35	16	tolerance	tolerance	NOUN
dpc-2863	35	17	.	.	PUNCT
dpc-2863	36	1	pd-1	pd-1	VERB
dpc-2863	36	2	binds	bind	VERB
dpc-2863	36	3	to	to	ADP
dpc-2863	36	4	pd	pd	NOUN
dpc-2863	36	5	-	-	PUNCT
dpc-2863	36	6	l1	l1	PROPN
dpc-2863	36	7	,	,	PUNCT
dpc-2863	36	8	inhibiting	inhibit	VERB
dpc-2863	36	9	the	the	DET
dpc-2863	36	10	function	function	NOUN
dpc-2863	36	11	of	of	ADP
dpc-2863	36	12	the	the	DET
dpc-2863	36	13	effector	effector	NOUN
dpc-2863	36	14	t	t	PROPN
dpc-2863	36	15	-	-	PUNCT
dpc-2863	36	16	cells	cell	NOUN
dpc-2863	36	17	and	and	CCONJ
dpc-2863	36	18	supporting	support	VERB
dpc-2863	36	19	the	the	DET
dpc-2863	36	20	treg	treg	PROPN
dpc-2863	36	21	cells	cell	NOUN
dpc-2863	36	22	activity	activity	NOUN
dpc-2863	36	23	.	.	PUNCT
dpc-2863	37	1	likely	likely	ADJ
dpc-2863	37	2	to	to	PART
dpc-2863	37	3	be	be	AUX
dpc-2863	37	4	dysfunctional	dysfunctional	ADJ
dpc-2863	37	5	in	in	ADP
dpc-2863	37	6	psoriatic	psoriatic	ADJ
dpc-2863	37	7	patients	patient	NOUN
dpc-2863	37	8	,	,	PUNCT
dpc-2863	37	9	t	t	NOUN
dpc-2863	37	10	-	-	PUNCT
dpc-2863	37	11	cell	cell	NOUN
dpc-2863	37	12	surface	surface	NOUN
dpc-2863	37	13	molecules	molecule	NOUN
dpc-2863	37	14	are	be	AUX
dpc-2863	37	15	unable	unable	ADJ
dpc-2863	37	16	to	to	PART
dpc-2863	37	17	inhibit	inhibit	VERB
dpc-2863	37	18	the	the	DET
dpc-2863	37	19	activity	activity	NOUN
dpc-2863	37	20	of	of	ADP
dpc-2863	37	21	the	the	DET
dpc-2863	37	22	inflammatory	inflammatory	ADJ
dpc-2863	37	23	cells	cell	NOUN
dpc-2863	37	24	[	[	X
dpc-2863	37	25	4,5	4,5	NUM
dpc-2863	37	26	]	]	PUNCT
dpc-2863	37	27	.	.	PUNCT
dpc-2863	38	1	in	in	ADP
dpc-2863	38	2	addition	addition	NOUN
dpc-2863	38	3	,	,	PUNCT
dpc-2863	38	4	the	the	DET
dpc-2863	38	5	pd-1	pd-1	ADJ
dpc-2863	38	6	and	and	CCONJ
dpc-2863	38	7	pdl-1	pdl-1	ADJ
dpc-2863	38	8	pathways	pathway	NOUN
dpc-2863	38	9	are	be	AUX
dpc-2863	38	10	among	among	ADP
dpc-2863	38	11	the	the	DET
dpc-2863	38	12	most	most	ADV
dpc-2863	38	13	important	important	ADJ
dpc-2863	38	14	mechanisms	mechanism	NOUN
dpc-2863	38	15	in	in	ADP
dpc-2863	38	16	tumor	tumor	NOUN
dpc-2863	38	17	cells	cell	NOUN
dpc-2863	38	18	escape	escape	VERB
dpc-2863	38	19	from	from	ADP
dpc-2863	38	20	the	the	DET
dpc-2863	38	21	immune	immune	ADJ
dpc-2863	38	22	system	system	NOUN
dpc-2863	38	23	.	.	PUNCT
dpc-2863	39	1	pd	pd	PROPN
dpc-2863	39	2	-	-	PUNCT
dpc-2863	39	3	l1	l1	PROPN
dpc-2863	39	4	expression	expression	NOUN
dpc-2863	39	5	of	of	ADP
dpc-2863	39	6	tumors	tumor	NOUN
dpc-2863	39	7	is	be	AUX
dpc-2863	39	8	a	a	DET
dpc-2863	39	9	key	key	ADJ
dpc-2863	39	10	determinant	determinant	NOUN
dpc-2863	39	11	of	of	ADP
dpc-2863	39	12	the	the	DET
dpc-2863	39	13	response	response	NOUN
dpc-2863	39	14	to	to	ADP
dpc-2863	39	15	immune	immune	ADJ
dpc-2863	39	16	check	check	NOUN
dpc-2863	39	17	point	point	NOUN
dpc-2863	39	18	inhibitors	inhibitor	NOUN
dpc-2863	39	19	.	.	PUNCT
dpc-2863	40	1	it	it	PRON
dpc-2863	40	2	was	be	AUX
dpc-2863	40	3	reported	report	VERB
dpc-2863	40	4	that	that	SCONJ
dpc-2863	40	5	,	,	PUNCT
dpc-2863	40	6	in	in	ADP
dpc-2863	40	7	patients	patient	NOUN
dpc-2863	40	8	treated	treat	VERB
dpc-2863	40	9	with	with	ADP
dpc-2863	40	10	anti	anti	ADJ
dpc-2863	40	11	-	-	ADJ
dpc-2863	40	12	pd-1	pd-1	ADJ
dpc-2863	40	13	molecules	molecule	NOUN
dpc-2863	40	14	,	,	PUNCT
dpc-2863	40	15	eczema	eczema	NOUN
dpc-2863	40	16	,	,	PUNCT
dpc-2863	40	17	lichenoid	lichenoid	PROPN
dpc-2863	40	18	dermatoses	dermatosis	NOUN
dpc-2863	40	19	,	,	PUNCT
dpc-2863	40	20	vitiligo	vitiligo	NOUN
dpc-2863	40	21	and	and	CCONJ
dpc-2863	40	22	psoriasis	psoriasis	NOUN
dpc-2863	40	23	lesions	lesion	NOUN
dpc-2863	40	24	emerged	emerge	VERB
dpc-2863	40	25	,	,	PUNCT
dpc-2863	40	26	or	or	CCONJ
dpc-2863	40	27	previously	previously	ADV
dpc-2863	40	28	existing	exist	VERB
dpc-2863	40	29	psoriasis	psoriasis	NOUN
dpc-2863	40	30	became	become	VERB
dpc-2863	40	31	more	more	ADV
dpc-2863	40	32	severe	severe	ADJ
dpc-2863	41	1	[	[	X
dpc-2863	41	2	7	7	NUM
dpc-2863	41	3	-	-	SYM
dpc-2863	41	4	9	9	NUM
dpc-2863	41	5	]	]	PUNCT
dpc-2863	41	6	.	.	PUNCT
dpc-2863	42	1	the	the	DET
dpc-2863	42	2	fact	fact	NOUN
dpc-2863	42	3	that	that	SCONJ
dpc-2863	42	4	anti	anti	ADJ
dpc-2863	42	5	-	-	ADJ
dpc-2863	42	6	pd-1	pd-1	ADJ
dpc-2863	42	7	/	/	SYM
dpc-2863	42	8	pd	pd	NOUN
dpc-2863	42	9	-	-	PUNCT
dpc-2863	42	10	l1	l1	PROPN
dpc-2863	42	11	antibodies	antibodie	VERB
dpc-2863	42	12	trigger	trigger	NOUN
dpc-2863	42	13	psoriasis	psoriasis	NOUN
dpc-2863	42	14	suggests	suggest	VERB
dpc-2863	42	15	that	that	SCONJ
dpc-2863	42	16	pd-1	pd-1	ADP
dpc-2863	42	17	and	and	CCONJ
dpc-2863	42	18	pd	pd	PROPN
dpc-2863	42	19	-	-	PROPN
dpc-2863	42	20	l1	l1	PROPN
dpc-2863	42	21	pathways	pathway	NOUN
dpc-2863	42	22	are	be	AUX
dpc-2863	42	23	somehow	somehow	ADV
dpc-2863	42	24	involved	involve	VERB
dpc-2863	42	25	in	in	ADP
dpc-2863	42	26	the	the	DET
dpc-2863	42	27	pathogenesis	pathogenesis	NOUN
dpc-2863	42	28	of	of	ADP
dpc-2863	42	29	psoriasis	psoriasis	NOUN
dpc-2863	42	30	.	.	PUNCT
dpc-2863	43	1	few	few	ADJ
dpc-2863	43	2	studies	study	NOUN
dpc-2863	43	3	have	have	AUX
dpc-2863	43	4	investigated	investigate	VERB
dpc-2863	43	5	the	the	DET
dpc-2863	43	6	expression	expression	NOUN
dpc-2863	43	7	of	of	ADP
dpc-2863	43	8	pd-1	pd-1	ADJ
dpc-2863	43	9	and	and	CCONJ
dpc-2863	43	10	pd	pd	PROPN
dpc-2863	43	11	-	-	PROPN
dpc-2863	43	12	l	l	NOUN
dpc-2863	43	13	in	in	ADP
dpc-2863	43	14	the	the	DET
dpc-2863	43	15	t	t	NOUN
dpc-2863	43	16	lymphocytes	lymphocyte	NOUN
dpc-2863	43	17	of	of	ADP
dpc-2863	43	18	the	the	DET
dpc-2863	43	19	peripheral	peripheral	ADJ
dpc-2863	43	20	blood	blood	NOUN
dpc-2863	43	21	of	of	ADP
dpc-2863	43	22	psoriasis	psoriasis	NOUN
dpc-2863	43	23	patients	patient	NOUN
dpc-2863	43	24	.	.	PUNCT
dpc-2863	44	1	even	even	ADV
dpc-2863	44	2	fewer	few	ADJ
dpc-2863	44	3	studies	study	NOUN
dpc-2863	44	4	investigate	investigate	VERB
dpc-2863	44	5	the	the	DET
dpc-2863	44	6	expression	expression	NOUN
dpc-2863	44	7	of	of	ADP
dpc-2863	44	8	pd-1	pd-1	ADJ
dpc-2863	44	9	and	and	CCONJ
dpc-2863	44	10	pd	pd	PROPN
dpc-2863	44	11	-	-	PROPN
dpc-2863	44	12	l1	l1	PROPN
dpc-2863	44	13	in	in	ADP
dpc-2863	44	14	the	the	DET
dpc-2863	44	15	lesional	lesional	ADJ
dpc-2863	44	16	skins	skin	NOUN
dpc-2863	44	17	of	of	ADP
dpc-2863	44	18	psoriatic	psoriatic	ADJ
dpc-2863	44	19	patients	patient	NOUN
dpc-2863	44	20	.	.	PUNCT
dpc-2863	45	1	objectives	objective	NOUN
dpc-2863	45	2	in	in	ADP
dpc-2863	45	3	this	this	DET
dpc-2863	45	4	study	study	NOUN
dpc-2863	45	5	,	,	PUNCT
dpc-2863	45	6	we	we	PRON
dpc-2863	45	7	aimed	aim	VERB
dpc-2863	45	8	to	to	PART
dpc-2863	45	9	investigate	investigate	VERB
dpc-2863	45	10	the	the	DET
dpc-2863	45	11	expression	expression	NOUN
dpc-2863	45	12	of	of	ADP
dpc-2863	45	13	pd-1	pd-1	NOUN
dpc-2863	45	14	/	/	SYM
dpc-2863	45	15	pd	pd	ADJ
dpc-2863	45	16	-	-	ADJ
dpc-2863	45	17	l	l	NOUN
dpc-2863	45	18	molecules	molecule	NOUN
dpc-2863	45	19	in	in	ADP
dpc-2863	45	20	the	the	DET
dpc-2863	45	21	lesional	lesional	ADJ
dpc-2863	45	22	skins	skin	NOUN
dpc-2863	45	23	of	of	ADP
dpc-2863	45	24	psoriasis	psoriasis	NOUN
dpc-2863	45	25	patients	patient	NOUN
dpc-2863	45	26	.	.	PUNCT
dpc-2863	46	1	methods	method	NOUN
dpc-2863	46	2	thirty	thirty	NUM
dpc-2863	46	3	psoriasis	psoriasis	NOUN
dpc-2863	46	4	patients	patient	NOUN
dpc-2863	46	5	aged	age	VERB
dpc-2863	46	6	between	between	ADP
dpc-2863	46	7	18	18	NUM
dpc-2863	46	8	and	and	CCONJ
dpc-2863	46	9	70	70	NUM
dpc-2863	46	10	years	year	NOUN
dpc-2863	46	11	who	who	PRON
dpc-2863	46	12	were	be	AUX
dpc-2863	46	13	admitted	admit	VERB
dpc-2863	46	14	to	to	ADP
dpc-2863	46	15	the	the	DET
dpc-2863	46	16	dermatology	dermatology	NOUN
dpc-2863	46	17	outpatient	outpatient	NOUN
dpc-2863	46	18	clinic	clinic	NOUN
dpc-2863	46	19	were	be	AUX
dpc-2863	46	20	included	include	VERB
dpc-2863	46	21	in	in	ADP
dpc-2863	46	22	the	the	DET
dpc-2863	46	23	study	study	NOUN
dpc-2863	46	24	.	.	PUNCT
dpc-2863	47	1	skin	skin	NOUN
dpc-2863	47	2	biopsy	biopsy	NOUN
dpc-2863	47	3	specimens	specimen	NOUN
dpc-2863	47	4	of	of	ADP
dpc-2863	47	5	the	the	DET
dpc-2863	47	6	patients	patient	NOUN
dpc-2863	47	7	who	who	PRON
dpc-2863	47	8	were	be	AUX
dpc-2863	47	9	histopathologically	histopathologically	ADV
dpc-2863	47	10	diagnosed	diagnose	VERB
dpc-2863	47	11	with	with	ADP
dpc-2863	47	12	psoriasis	psoriasis	NOUN
dpc-2863	47	13	,	,	PUNCT
dpc-2863	47	14	and	and	CCONJ
dpc-2863	47	15	had	have	VERB
dpc-2863	47	16	the	the	DET
dpc-2863	47	17	appropriate	appropriate	ADJ
dpc-2863	47	18	characteristics	characteristic	NOUN
dpc-2863	47	19	for	for	ADP
dpc-2863	47	20	the	the	DET
dpc-2863	47	21	study	study	NOUN
dpc-2863	47	22	,	,	PUNCT
dpc-2863	47	23	were	be	AUX
dpc-2863	47	24	included	include	VERB
dpc-2863	47	25	in	in	ADP
dpc-2863	47	26	the	the	DET
dpc-2863	47	27	immunohistochemical	immunohistochemical	ADJ
dpc-2863	47	28	study	study	NOUN
dpc-2863	47	29	.	.	PUNCT
dpc-2863	48	1	those	those	PRON
dpc-2863	48	2	who	who	PRON
dpc-2863	48	3	had	have	VERB
dpc-2863	48	4	another	another	DET
dpc-2863	48	5	autoimmune	autoimmune	ADJ
dpc-2863	48	6	disease	disease	NOUN
dpc-2863	48	7	such	such	ADJ
dpc-2863	48	8	as	as	ADP
dpc-2863	48	9	type	type	NOUN
dpc-2863	48	10	1	1	NUM
dpc-2863	48	11	diabetes	diabetes	NOUN
dpc-2863	48	12	mellitus	mellitus	NOUN
dpc-2863	48	13	,	,	PUNCT
dpc-2863	48	14	inflammatory	inflammatory	ADJ
dpc-2863	48	15	bowel	bowel	NOUN
dpc-2863	48	16	disease	disease	NOUN
dpc-2863	48	17	,	,	PUNCT
dpc-2863	48	18	rheumatoid	rheumatoid	NOUN
dpc-2863	48	19	arthritis	arthritis	NOUN
dpc-2863	48	20	,	,	PUNCT
dpc-2863	48	21	systemic	systemic	ADJ
dpc-2863	48	22	lupus	lupus	PROPN
dpc-2863	48	23	erythematosus	erythematosus	PROPN
dpc-2863	48	24	,	,	PUNCT
dpc-2863	48	25	ankylosing	ankylose	VERB
dpc-2863	48	26	spondylitis	spondylitis	NOUN
dpc-2863	48	27	,	,	PUNCT
dpc-2863	48	28	vitiligo	vitiligo	VERB
dpc-2863	48	29	,	,	PUNCT
dpc-2863	48	30	alopecia	alopecia	NOUN
dpc-2863	48	31	areata	areata	ADJ
dpc-2863	48	32	or	or	CCONJ
dpc-2863	48	33	encephalomyelitis	encephalomyelitis	NOUN
dpc-2863	48	34	were	be	AUX
dpc-2863	48	35	excluded	exclude	VERB
dpc-2863	48	36	.	.	PUNCT
dpc-2863	49	1	none	none	NOUN
dpc-2863	49	2	of	of	ADP
dpc-2863	49	3	the	the	DET
dpc-2863	49	4	patients	patient	NOUN
dpc-2863	49	5	included	include	VERB
dpc-2863	49	6	in	in	ADP
dpc-2863	49	7	the	the	DET
dpc-2863	49	8	study	study	NOUN
dpc-2863	49	9	,	,	PUNCT
dpc-2863	49	10	had	have	VERB
dpc-2863	49	11	any	any	DET
dpc-2863	49	12	malignity	malignity	NOUN
dpc-2863	49	13	or	or	CCONJ
dpc-2863	49	14	was	be	AUX
dpc-2863	49	15	being	be	AUX
dpc-2863	49	16	treated	treat	VERB
dpc-2863	49	17	with	with	ADP
dpc-2863	49	18	anti	anti	ADJ
dpc-2863	49	19	-	-	ADJ
dpc-2863	49	20	pd-1	pd-1	ADJ
dpc-2863	49	21	molecules	molecule	NOUN
dpc-2863	49	22	for	for	ADP
dpc-2863	49	23	malignity	malignity	NOUN
dpc-2863	49	24	.	.	PUNCT
dpc-2863	50	1	intact	intact	ADJ
dpc-2863	50	2	skin	skin	NOUN
dpc-2863	50	3	biopsy	biopsy	NOUN
dpc-2863	50	4	samples	sample	NOUN
dpc-2863	50	5	of	of	ADP
dpc-2863	50	6	healthy	healthy	ADJ
dpc-2863	50	7	volunteers	volunteer	NOUN
dpc-2863	50	8	aged	age	VERB
dpc-2863	50	9	19	19	NUM
dpc-2863	50	10	to	to	PART
dpc-2863	50	11	60	60	NUM
dpc-2863	50	12	years	year	NOUN
dpc-2863	50	13	who	who	PRON
dpc-2863	50	14	did	do	AUX
dpc-2863	50	15	not	not	PART
dpc-2863	50	16	have	have	VERB
dpc-2863	50	17	any	any	DET
dpc-2863	50	18	disease	disease	NOUN
dpc-2863	50	19	were	be	AUX
dpc-2863	50	20	included	include	VERB
dpc-2863	50	21	in	in	ADP
dpc-2863	50	22	the	the	DET
dpc-2863	50	23	study	study	NOUN
dpc-2863	50	24	as	as	ADP
dpc-2863	50	25	the	the	DET
dpc-2863	50	26	control	control	NOUN
dpc-2863	50	27	group	group	NOUN
dpc-2863	50	28	.	.	PUNCT
dpc-2863	51	1	all	all	DET
dpc-2863	51	2	participants	participant	NOUN
dpc-2863	51	3	were	be	AUX
dpc-2863	51	4	informed	inform	VERB
dpc-2863	51	5	about	about	ADP
dpc-2863	51	6	the	the	DET
dpc-2863	51	7	study	study	NOUN
dpc-2863	51	8	and	and	CCONJ
dpc-2863	51	9	their	their	PRON
dpc-2863	51	10	written	write	VERB
dpc-2863	51	11	consent	consent	NOUN
dpc-2863	51	12	was	be	AUX
dpc-2863	51	13	obtained	obtain	VERB
dpc-2863	51	14	prior	prior	ADV
dpc-2863	51	15	to	to	ADP
dpc-2863	51	16	their	their	PRON
dpc-2863	51	17	enrollment	enrollment	NOUN
dpc-2863	51	18	in	in	ADP
dpc-2863	51	19	the	the	DET
dpc-2863	51	20	study	study	NOUN
dpc-2863	51	21	.	.	PUNCT
dpc-2863	52	1	before	before	ADP
dpc-2863	52	2	starting	start	VERB
dpc-2863	52	3	the	the	DET
dpc-2863	52	4	study	study	NOUN
dpc-2863	52	5	,	,	PUNCT
dpc-2863	52	6	approval	approval	NOUN
dpc-2863	52	7	was	be	AUX
dpc-2863	52	8	received	receive	VERB
dpc-2863	52	9	from	from	ADP
dpc-2863	52	10	the	the	DET
dpc-2863	52	11	local	local	ADJ
dpc-2863	52	12	ethics	ethic	NOUN
dpc-2863	52	13	board	board	NOUN
dpc-2863	52	14	of	of	ADP
dpc-2863	52	15	our	our	PRON
dpc-2863	52	16	hospital	hospital	NOUN
dpc-2863	52	17	with	with	ADP
dpc-2863	52	18	the	the	DET
dpc-2863	52	19	decision	decision	NOUN
dpc-2863	52	20	date	date	NOUN
dpc-2863	52	21	05.03.2018	05.03.2018	PROPN
dpc-2863	52	22	and	and	CCONJ
dpc-2863	52	23	number	number	NOUN
dpc-2863	52	24	52	52	NUM
dpc-2863	52	25	.	.	PUNCT
dpc-2863	53	1	the	the	DET
dpc-2863	53	2	skin	skin	NOUN
dpc-2863	53	3	biopsy	biopsy	NOUN
dpc-2863	53	4	samples	sample	NOUN
dpc-2863	53	5	collected	collect	VERB
dpc-2863	53	6	from	from	ADP
dpc-2863	53	7	the	the	DET
dpc-2863	53	8	patients	patient	NOUN
dpc-2863	53	9	were	be	AUX
dpc-2863	53	10	put	put	VERB
dpc-2863	53	11	into	into	ADP
dpc-2863	53	12	formalin	formalin	NOUN
dpc-2863	53	13	solutions	solution	NOUN
dpc-2863	53	14	.	.	PUNCT
dpc-2863	54	1	after	after	ADP
dpc-2863	54	2	formaldehyde	formaldehyde	NOUN
dpc-2863	54	3	fixation	fixation	NOUN
dpc-2863	54	4	,	,	PUNCT
dpc-2863	54	5	the	the	DET
dpc-2863	54	6	tissues	tissue	NOUN
dpc-2863	54	7	were	be	AUX
dpc-2863	54	8	embedded	embed	VERB
dpc-2863	54	9	in	in	ADP
dpc-2863	54	10	paraffin	paraffin	NOUN
dpc-2863	54	11	.	.	PUNCT
dpc-2863	55	1	four	four	NUM
dpc-2863	55	2	cross	cros	NOUN
dpc-2863	55	3	-	-	NOUN
dpc-2863	55	4	sections	section	NOUN
dpc-2863	55	5	were	be	AUX
dpc-2863	55	6	taken	take	VERB
dpc-2863	55	7	from	from	ADP
dpc-2863	55	8	the	the	DET
dpc-2863	55	9	paraffin	paraffin	NOUN
dpc-2863	55	10	blocks	block	NOUN
dpc-2863	55	11	.	.	PUNCT
dpc-2863	56	1	one	one	NUM
dpc-2863	56	2	of	of	ADP
dpc-2863	56	3	the	the	DET
dpc-2863	56	4	cross	cros	NOUN
dpc-2863	56	5	-	-	NOUN
dpc-2863	56	6	sections	section	NOUN
dpc-2863	56	7	was	be	AUX
dpc-2863	56	8	stained	stain	VERB
dpc-2863	56	9	with	with	ADP
dpc-2863	56	10	h&e	h&e	PROPN
dpc-2863	56	11	.	.	PUNCT
dpc-2863	57	1	the	the	DET
dpc-2863	57	2	diagnosis	diagnosis	NOUN
dpc-2863	57	3	of	of	ADP
dpc-2863	57	4	psoriasis	psoriasis	NOUN
dpc-2863	57	5	was	be	AUX
dpc-2863	57	6	histopathologically	histopathologically	ADV
dpc-2863	57	7	confirmed	confirm	VERB
dpc-2863	57	8	by	by	ADP
dpc-2863	57	9	the	the	DET
dpc-2863	57	10	h&e	h&e	PROPN
dpc-2863	57	11	cross	cross	NOUN
dpc-2863	57	12	-	-	NOUN
dpc-2863	57	13	sections	section	NOUN
dpc-2863	57	14	.	.	PUNCT
dpc-2863	58	1	immunohistochemical	immunohistochemical	ADJ
dpc-2863	58	2	study	study	NOUN
dpc-2863	58	3	procedure	procedure	NOUN
dpc-2863	58	4	all	all	DET
dpc-2863	58	5	cases	case	NOUN
dpc-2863	58	6	were	be	AUX
dpc-2863	58	7	applied	apply	VERB
dpc-2863	58	8	,	,	PUNCT
dpc-2863	58	9	a	a	DET
dpc-2863	58	10	1/250	1/250	NUM
dpc-2863	58	11	dilution	dilution	NOUN
dpc-2863	58	12	rate	rate	NOUN
dpc-2863	58	13	of	of	ADP
dpc-2863	58	14	anti	anti	ADJ
dpc-2863	58	15	pd-1	pd-1	ADJ
dpc-2863	58	16	antibody	antibody	NOUN
dpc-2863	58	17	(	(	PUNCT
dpc-2863	58	18	ab137132	ab137132	PROPN
dpc-2863	58	19	,	,	PUNCT
dpc-2863	58	20	abcam	abcam	PROPN
dpc-2863	58	21	)	)	PUNCT
dpc-2863	58	22	,	,	PUNCT
dpc-2863	58	23	1/200	1/200	NUM
dpc-2863	58	24	dilution	dilution	NOUN
dpc-2863	58	25	rate	rate	NOUN
dpc-2863	58	26	of	of	ADP
dpc-2863	58	27	anti	anti	PROPN
dpc-2863	58	28	pd	pd	PROPN
dpc-2863	58	29	-	-	ADJ
dpc-2863	58	30	l1	l1	PROPN
dpc-2863	58	31	antibody	antibody	NOUN
dpc-2863	58	32	(	(	PUNCT
dpc-2863	58	33	ab205921	ab205921	PROPN
dpc-2863	58	34	,	,	PUNCT
dpc-2863	58	35	abcam	abcam	PROPN
dpc-2863	58	36	)	)	PUNCT
dpc-2863	58	37	and	and	CCONJ
dpc-2863	58	38	1/100	1/100	NUM
dpc-2863	58	39	dilution	dilution	NOUN
dpc-2863	58	40	rate	rate	NOUN
dpc-2863	58	41	of	of	ADP
dpc-2863	58	42	anti	anti	ADJ
dpc-2863	58	43	pd	pd	ADJ
dpc-2863	58	44	-	-	PUNCT
dpc-2863	58	45	l2	l2	NOUN
dpc-2863	58	46	antibody	antibody	NOUN
dpc-2863	58	47	(	(	PUNCT
dpc-2863	58	48	ab200377	ab200377	NOUN
dpc-2863	58	49	,	,	PUNCT
dpc-2863	58	50	abcam	abcam	PROPN
dpc-2863	58	51	)	)	PUNCT
dpc-2863	58	52	.	.	PUNCT
dpc-2863	59	1	from	from	ADP
dpc-2863	59	2	the	the	DET
dpc-2863	59	3	formalin	formalin	NOUN
dpc-2863	59	4	-	-	PUNCT
dpc-2863	59	5	fixed	fix	VERB
dpc-2863	59	6	paraffin	paraffin	NOUN
dpc-2863	59	7	blocks	block	NOUN
dpc-2863	59	8	,	,	PUNCT
dpc-2863	59	9	3	3	NUM
dpc-2863	59	10	-	-	SYM
dpc-2863	59	11	4	4	NUM
dpc-2863	59	12	-	-	PUNCT
dpc-2863	59	13	μ	μ	NUM
dpc-2863	59	14	-	-	PUNCT
dpc-2863	59	15	thick	thick	ADJ
dpc-2863	59	16	sections	section	NOUN
dpc-2863	59	17	were	be	AUX
dpc-2863	59	18	prepared	prepare	VERB
dpc-2863	59	19	on	on	ADP
dpc-2863	59	20	slides	slide	NOUN
dpc-2863	59	21	coated	coat	VERB
dpc-2863	59	22	with	with	ADP
dpc-2863	59	23	poly	poly	ADJ
dpc-2863	59	24	-	-	PUNCT
dpc-2863	59	25	l	l	NOUN
dpc-2863	59	26	-	-	NOUN
dpc-2863	59	27	lysine	lysine	NOUN
dpc-2863	59	28	.	.	PUNCT
dpc-2863	60	1	the	the	DET
dpc-2863	60	2	cross	cros	NOUN
dpc-2863	60	3	-	-	NOUN
dpc-2863	60	4	sections	section	NOUN
dpc-2863	60	5	were	be	AUX
dpc-2863	60	6	left	leave	VERB
dpc-2863	60	7	overnight	overnight	ADV
dpc-2863	60	8	in	in	ADP
dpc-2863	60	9	a	a	DET
dpc-2863	60	10	stove	stove	NOUN
dpc-2863	60	11	at	at	ADP
dpc-2863	60	12	37	37	NUM
dpc-2863	60	13	-	-	SYM
dpc-2863	60	14	40	40	NUM
dpc-2863	60	15	°	°	NOUN
dpc-2863	60	16	c	c	NOUN
dpc-2863	60	17	,	,	PUNCT
dpc-2863	60	18	and	and	CCONJ
dpc-2863	60	19	in	in	ADP
dpc-2863	60	20	the	the	DET
dpc-2863	60	21	morning	morning	NOUN
dpc-2863	60	22	,	,	PUNCT
dpc-2863	60	23	they	they	PRON
dpc-2863	60	24	were	be	AUX
dpc-2863	60	25	kept	keep	VERB
dpc-2863	60	26	in	in	ADP
dpc-2863	60	27	a	a	DET
dpc-2863	60	28	stove	stove	NOUN
dpc-2863	60	29	at	at	ADP
dpc-2863	60	30	65	65	NUM
dpc-2863	60	31	°	°	NOUN
dpc-2863	60	32	c	c	NOUN
dpc-2863	60	33	for	for	ADP
dpc-2863	60	34	45	45	NUM
dpc-2863	60	35	minutes	minute	NOUN
dpc-2863	60	36	so	so	SCONJ
dpc-2863	60	37	that	that	SCONJ
dpc-2863	60	38	the	the	DET
dpc-2863	60	39	paraffin	paraffin	NOUN
dpc-2863	60	40	could	could	AUX
dpc-2863	60	41	melt	melt	VERB
dpc-2863	60	42	.	.	PUNCT
dpc-2863	61	1	the	the	DET
dpc-2863	61	2	cross	cross	NOUN
dpc-2863	61	3	sections	section	NOUN
dpc-2863	61	4	were	be	AUX
dpc-2863	61	5	then	then	ADV
dpc-2863	61	6	kept	keep	VERB
dpc-2863	61	7	in	in	ADP
dpc-2863	61	8	xylol	xylol	PROPN
dpc-2863	61	9	for	for	ADP
dpc-2863	61	10	20	20	NUM
dpc-2863	61	11	minutes	minute	NOUN
dpc-2863	61	12	to	to	PART
dpc-2863	61	13	deparaffinize	deparaffinize	VERB
dpc-2863	61	14	.	.	PUNCT
dpc-2863	62	1	they	they	PRON
dpc-2863	62	2	were	be	AUX
dpc-2863	62	3	rehydrated	rehydrate	VERB
dpc-2863	62	4	in	in	ADP
dpc-2863	62	5	alcohol	alcohol	NOUN
dpc-2863	62	6	and	and	CCONJ
dpc-2863	62	7	hydrated	hydrated	ADJ
dpc-2863	62	8	in	in	ADP
dpc-2863	62	9	distilled	distil	VERB
dpc-2863	62	10	water	water	NOUN
dpc-2863	62	11	.	.	PUNCT
dpc-2863	63	1	original	original	ADJ
dpc-2863	63	2	article	article	NOUN
dpc-2863	63	3	|	|	ADV
dpc-2863	63	4	dermatol	dermatol	ADJ
dpc-2863	63	5	pract	pract	NOUN
dpc-2863	63	6	concept	concept	NOUN
dpc-2863	63	7	.	.	PUNCT
dpc-2863	64	1	2023;13(2):e2023134	2023;13(2):e2023134	NUM
dpc-2863	64	2	3	3	NUM
dpc-2863	64	3	in	in	ADP
dpc-2863	64	4	the	the	DET
dpc-2863	64	5	immunohistochemical	immunohistochemical	ADJ
dpc-2863	64	6	staining	staining	ADJ
dpc-2863	64	7	process	process	NOUN
dpc-2863	64	8	that	that	PRON
dpc-2863	64	9	was	be	AUX
dpc-2863	64	10	carried	carry	VERB
dpc-2863	64	11	out	out	ADP
dpc-2863	64	12	using	use	VERB
dpc-2863	64	13	a	a	DET
dpc-2863	64	14	leica	leica	PROPN
dpc-2863	64	15	bond	bond	NOUN
dpc-2863	64	16	-	-	PUNCT
dpc-2863	64	17	max	max	NOUN
dpc-2863	64	18	automated	automate	VERB
dpc-2863	64	19	immunohistochemical	immunohistochemical	ADJ
dpc-2863	64	20	staining	staining	ADJ
dpc-2863	64	21	device	device	NOUN
dpc-2863	64	22	,	,	PUNCT
dpc-2863	64	23	the	the	DET
dpc-2863	64	24	slides	slide	NOUN
dpc-2863	64	25	were	be	AUX
dpc-2863	64	26	boiled	boil	VERB
dpc-2863	64	27	in	in	ADP
dpc-2863	64	28	water	water	NOUN
dpc-2863	64	29	containing	contain	VERB
dpc-2863	64	30	a	a	DET
dpc-2863	64	31	citrate	citrate	NOUN
dpc-2863	64	32	buffer	buffer	NOUN
dpc-2863	64	33	(	(	PUNCT
dpc-2863	64	34	ph	ph	NOUN
dpc-2863	64	35	6.0	6.0	NUM
dpc-2863	64	36	)	)	PUNCT
dpc-2863	64	37	solution	solution	NOUN
dpc-2863	64	38	at	at	ADP
dpc-2863	64	39	95	95	NUM
dpc-2863	64	40	-	-	SYM
dpc-2863	64	41	99	99	NUM
dpc-2863	64	42	°	°	PROPN
dpc-2863	64	43	c	c	NOUN
dpc-2863	64	44	for	for	ADP
dpc-2863	64	45	10	10	NUM
dpc-2863	64	46	minutes	minute	NOUN
dpc-2863	64	47	to	to	PART
dpc-2863	64	48	recover	recover	VERB
dpc-2863	64	49	the	the	DET
dpc-2863	64	50	antigen	antigen	NOUN
dpc-2863	64	51	before	before	ADP
dpc-2863	64	52	applying	apply	VERB
dpc-2863	64	53	the	the	DET
dpc-2863	64	54	antibody	antibody	NOUN
dpc-2863	64	55	.	.	PUNCT
dpc-2863	65	1	they	they	PRON
dpc-2863	65	2	were	be	AUX
dpc-2863	65	3	then	then	ADV
dpc-2863	65	4	left	leave	VERB
dpc-2863	65	5	to	to	PART
dpc-2863	65	6	cool	cool	VERB
dpc-2863	65	7	at	at	ADP
dpc-2863	65	8	room	room	NOUN
dpc-2863	65	9	temperature	temperature	NOUN
dpc-2863	65	10	for	for	ADP
dpc-2863	65	11	15	15	NUM
dpc-2863	65	12	-	-	SYM
dpc-2863	65	13	20	20	NUM
dpc-2863	65	14	minutes	minute	NOUN
dpc-2863	65	15	.	.	PUNCT
dpc-2863	66	1	the	the	DET
dpc-2863	66	2	slides	slide	NOUN
dpc-2863	66	3	were	be	AUX
dpc-2863	66	4	washed	wash	VERB
dpc-2863	66	5	with	with	ADP
dpc-2863	66	6	distilled	distil	VERB
dpc-2863	66	7	water	water	NOUN
dpc-2863	66	8	,	,	PUNCT
dpc-2863	66	9	treated	treat	VERB
dpc-2863	66	10	with	with	ADP
dpc-2863	66	11	3	3	NUM
dpc-2863	66	12	%	%	NOUN
dpc-2863	66	13	hydrogen	hydrogen	NOUN
dpc-2863	66	14	peroxide	peroxide	NOUN
dpc-2863	66	15	for	for	ADP
dpc-2863	66	16	15	15	NUM
dpc-2863	66	17	minutes	minute	NOUN
dpc-2863	66	18	at	at	ADP
dpc-2863	66	19	room	room	NOUN
dpc-2863	66	20	temperature	temperature	NOUN
dpc-2863	66	21	to	to	PART
dpc-2863	66	22	block	block	VERB
dpc-2863	66	23	endogenous	endogenous	ADJ
dpc-2863	66	24	peroxidase	peroxidase	NOUN
dpc-2863	66	25	activity	activity	NOUN
dpc-2863	66	26	,	,	PUNCT
dpc-2863	66	27	and	and	CCONJ
dpc-2863	66	28	put	put	VERB
dpc-2863	66	29	in	in	ADP
dpc-2863	66	30	distilled	distil	VERB
dpc-2863	66	31	water	water	NOUN
dpc-2863	66	32	once	once	ADV
dpc-2863	66	33	more	more	ADV
dpc-2863	66	34	.	.	PUNCT
dpc-2863	67	1	superblock	superblock	PROPN
dpc-2863	67	2	was	be	AUX
dpc-2863	67	3	dripped	drip	VERB
dpc-2863	67	4	on	on	ADP
dpc-2863	67	5	the	the	DET
dpc-2863	67	6	cross	cross	NOUN
dpc-2863	67	7	-	-	NOUN
dpc-2863	67	8	sections	section	NOUN
dpc-2863	67	9	which	which	PRON
dpc-2863	67	10	were	be	AUX
dpc-2863	67	11	washed	wash	VERB
dpc-2863	67	12	with	with	ADP
dpc-2863	67	13	pbs	pbs	PROPN
dpc-2863	67	14	(	(	PUNCT
dpc-2863	67	15	0.01	0.01	NUM
dpc-2863	67	16	m	m	NOUN
dpc-2863	67	17	phosphate	phosphate	ADJ
dpc-2863	67	18	buffer	buffer	NOUN
dpc-2863	67	19	saline	saline	NOUN
dpc-2863	67	20	)	)	PUNCT
dpc-2863	67	21	and	and	CCONJ
dpc-2863	67	22	left	leave	VERB
dpc-2863	67	23	for	for	ADP
dpc-2863	67	24	3	3	NUM
dpc-2863	67	25	-	-	SYM
dpc-2863	67	26	5	5	NUM
dpc-2863	67	27	minutes	minute	NOUN
dpc-2863	67	28	.	.	PUNCT
dpc-2863	68	1	then	then	ADV
dpc-2863	68	2	,	,	PUNCT
dpc-2863	68	3	primary	primary	ADJ
dpc-2863	68	4	antibodies	antibody	NOUN
dpc-2863	68	5	were	be	AUX
dpc-2863	68	6	dripped	drip	VERB
dpc-2863	68	7	on	on	ADP
dpc-2863	68	8	the	the	DET
dpc-2863	68	9	cross	cross	NOUN
dpc-2863	68	10	sections	section	NOUN
dpc-2863	68	11	,	,	PUNCT
dpc-2863	68	12	which	which	PRON
dpc-2863	68	13	were	be	AUX
dpc-2863	68	14	left	leave	VERB
dpc-2863	68	15	for	for	ADP
dpc-2863	68	16	30	30	NUM
dpc-2863	68	17	-	-	SYM
dpc-2863	68	18	45	45	NUM
dpc-2863	68	19	minutes	minute	NOUN
dpc-2863	68	20	.	.	PUNCT
dpc-2863	69	1	following	follow	VERB
dpc-2863	69	2	the	the	DET
dpc-2863	69	3	pbs	pbs	NOUN
dpc-2863	69	4	washing	washing	NOUN
dpc-2863	69	5	process	process	NOUN
dpc-2863	69	6	,	,	PUNCT
dpc-2863	69	7	the	the	DET
dpc-2863	69	8	cross	cros	NOUN
dpc-2863	69	9	-	-	NOUN
dpc-2863	69	10	sections	section	NOUN
dpc-2863	69	11	were	be	AUX
dpc-2863	69	12	kept	keep	VERB
dpc-2863	69	13	at	at	ADP
dpc-2863	69	14	room	room	NOUN
dpc-2863	69	15	temperature	temperature	NOUN
dpc-2863	69	16	for	for	ADP
dpc-2863	69	17	20	20	NUM
dpc-2863	69	18	minutes	minute	NOUN
dpc-2863	69	19	by	by	ADP
dpc-2863	69	20	dripping	dripping	ADJ
dpc-2863	69	21	biotinylated	biotinylated	ADJ
dpc-2863	69	22	secondary	secondary	ADJ
dpc-2863	69	23	antibodies	antibody	NOUN
dpc-2863	69	24	,	,	PUNCT
dpc-2863	69	25	and	and	CCONJ
dpc-2863	69	26	then	then	ADV
dpc-2863	69	27	,	,	PUNCT
dpc-2863	69	28	washed	wash	VERB
dpc-2863	69	29	with	with	ADP
dpc-2863	69	30	pbs	pbs	PROPN
dpc-2863	69	31	for	for	ADP
dpc-2863	69	32	5	5	NUM
dpc-2863	69	33	minutes	minute	NOUN
dpc-2863	69	34	.	.	PUNCT
dpc-2863	70	1	conjugated	conjugate	VERB
dpc-2863	70	2	streptavidin	streptavidin	NOUN
dpc-2863	70	3	enzyme	enzyme	NOUN
dpc-2863	70	4	was	be	AUX
dpc-2863	70	5	dripped	drip	VERB
dpc-2863	70	6	on	on	ADP
dpc-2863	70	7	the	the	DET
dpc-2863	70	8	cross	cross	NOUN
dpc-2863	70	9	-	-	NOUN
dpc-2863	70	10	sections	section	NOUN
dpc-2863	70	11	,	,	PUNCT
dpc-2863	70	12	which	which	PRON
dpc-2863	70	13	were	be	AUX
dpc-2863	70	14	kept	keep	VERB
dpc-2863	70	15	at	at	ADP
dpc-2863	70	16	room	room	NOUN
dpc-2863	70	17	temperature	temperature	NOUN
dpc-2863	70	18	for	for	ADP
dpc-2863	70	19	10	10	NUM
dpc-2863	70	20	minutes	minute	NOUN
dpc-2863	70	21	,	,	PUNCT
dpc-2863	70	22	and	and	CCONJ
dpc-2863	70	23	washed	wash	VERB
dpc-2863	70	24	again	again	ADV
dpc-2863	70	25	with	with	ADP
dpc-2863	70	26	pbs	pbs	PROPN
dpc-2863	70	27	.	.	PUNCT
dpc-2863	71	1	later	later	ADV
dpc-2863	71	2	,	,	PUNCT
dpc-2863	71	3	dam	dam	PROPN
dpc-2863	71	4	chromogen	chromogen	NOUN
dpc-2863	71	5	was	be	AUX
dpc-2863	71	6	dripped	drip	VERB
dpc-2863	71	7	,	,	PUNCT
dpc-2863	71	8	and	and	CCONJ
dpc-2863	71	9	the	the	DET
dpc-2863	71	10	cross	cros	NOUN
dpc-2863	71	11	-	-	NOUN
dpc-2863	71	12	sections	section	NOUN
dpc-2863	71	13	were	be	AUX
dpc-2863	71	14	washed	wash	VERB
dpc-2863	71	15	with	with	ADP
dpc-2863	71	16	distilled	distil	VERB
dpc-2863	71	17	water	water	NOUN
dpc-2863	71	18	.	.	PUNCT
dpc-2863	72	1	following	follow	VERB
dpc-2863	72	2	a	a	DET
dpc-2863	72	3	preliminary	preliminary	ADJ
dpc-2863	72	4	staining	staining	NOUN
dpc-2863	72	5	with	with	ADP
dpc-2863	72	6	harris	harris	PROPN
dpc-2863	72	7	hematoxylin	hematoxylin	PROPN
dpc-2863	72	8	for	for	ADP
dpc-2863	72	9	10	10	NUM
dpc-2863	72	10	seconds	second	NOUN
dpc-2863	72	11	,	,	PUNCT
dpc-2863	72	12	and	and	CCONJ
dpc-2863	72	13	washing	wash	VERB
dpc-2863	72	14	with	with	ADP
dpc-2863	72	15	distilled	distil	VERB
dpc-2863	72	16	water	water	NOUN
dpc-2863	72	17	,	,	PUNCT
dpc-2863	72	18	the	the	DET
dpc-2863	72	19	slides	slide	NOUN
dpc-2863	72	20	were	be	AUX
dpc-2863	72	21	dried	dry	VERB
dpc-2863	72	22	by	by	ADP
dpc-2863	72	23	dipping	dip	VERB
dpc-2863	72	24	into	into	ADP
dpc-2863	72	25	alcohol	alcohol	NOUN
dpc-2863	72	26	and	and	CCONJ
dpc-2863	72	27	coated	coat	VERB
dpc-2863	72	28	with	with	ADP
dpc-2863	72	29	balm	balm	PROPN
dpc-2863	72	30	.	.	PUNCT
dpc-2863	73	1	analysis	analysis	NOUN
dpc-2863	73	2	of	of	ADP
dpc-2863	73	3	the	the	DET
dpc-2863	73	4	immunohistochemical	immunohistochemical	ADJ
dpc-2863	73	5	study	study	NOUN
dpc-2863	73	6	 	 	SPACE
dpc-2863	73	7	results	result	VERB
dpc-2863	73	8	anti	anti	ADJ
dpc-2863	73	9	pd-1	pd-1	ADJ
dpc-2863	73	10	and	and	CCONJ
dpc-2863	73	11	pd	pd	PROPN
dpc-2863	73	12	-	-	PUNCT
dpc-2863	73	13	l1	l1	PROPN
dpc-2863	73	14	antibodies	antibody	NOUN
dpc-2863	73	15	were	be	AUX
dpc-2863	73	16	applied	apply	VERB
dpc-2863	73	17	on	on	ADP
dpc-2863	73	18	the	the	DET
dpc-2863	73	19	cross	cross	NOUN
dpc-2863	73	20	-	-	NOUN
dpc-2863	73	21	sections	section	NOUN
dpc-2863	73	22	obtained	obtain	VERB
dpc-2863	73	23	from	from	ADP
dpc-2863	73	24	the	the	DET
dpc-2863	73	25	prepared	prepare	VERB
dpc-2863	73	26	paraffin	paraffin	NOUN
dpc-2863	73	27	blocks	block	NOUN
dpc-2863	73	28	.	.	PUNCT
dpc-2863	74	1	cytoplasmic	cytoplasmic	ADJ
dpc-2863	74	2	and	and	CCONJ
dpc-2863	74	3	membranous	membranous	ADJ
dpc-2863	74	4	staining	staining	NOUN
dpc-2863	74	5	of	of	ADP
dpc-2863	74	6	pd-1	pd-1	ADJ
dpc-2863	74	7	and	and	CCONJ
dpc-2863	74	8	pd	pd	PROPN
dpc-2863	74	9	-	-	PROPN
dpc-2863	74	10	l1	l1	PROPN
dpc-2863	74	11	was	be	AUX
dpc-2863	74	12	considered	consider	VERB
dpc-2863	74	13	positive	positive	ADJ
dpc-2863	74	14	.	.	PUNCT
dpc-2863	75	1	the	the	DET
dpc-2863	75	2	number	number	NOUN
dpc-2863	75	3	of	of	ADP
dpc-2863	75	4	the	the	DET
dpc-2863	75	5	stained	stain	VERB
dpc-2863	75	6	immune	immune	ADJ
dpc-2863	75	7	cells	cell	NOUN
dpc-2863	75	8	was	be	AUX
dpc-2863	75	9	examined	examine	VERB
dpc-2863	75	10	,	,	PUNCT
dpc-2863	75	11	counted	count	VERB
dpc-2863	75	12	and	and	CCONJ
dpc-2863	75	13	recorded	record	VERB
dpc-2863	75	14	for	for	ADP
dpc-2863	75	15	each	each	DET
dpc-2863	75	16	case	case	NOUN
dpc-2863	75	17	.	.	PUNCT
dpc-2863	76	1	additionally	additionally	ADV
dpc-2863	76	2	,	,	PUNCT
dpc-2863	76	3	tissues	tissue	NOUN
dpc-2863	76	4	were	be	AUX
dpc-2863	76	5	divided	divide	VERB
dpc-2863	76	6	into	into	ADP
dpc-2863	76	7	two	two	NUM
dpc-2863	76	8	groups	group	NOUN
dpc-2863	76	9	according	accord	VERB
dpc-2863	76	10	to	to	ADP
dpc-2863	76	11	their	their	PRON
dpc-2863	76	12	pd-1	pd-1	ADJ
dpc-2863	76	13	and	and	CCONJ
dpc-2863	76	14	pd	pd	PROPN
dpc-2863	76	15	-	-	PROPN
dpc-2863	76	16	l1	l1	PROPN
dpc-2863	76	17	positive	positive	ADJ
dpc-2863	76	18	immune	immune	ADJ
dpc-2863	76	19	cell	cell	NOUN
dpc-2863	76	20	counts	count	NOUN
dpc-2863	76	21	:	:	PUNCT
dpc-2863	76	22	tissues	tissue	NOUN
dpc-2863	76	23	with	with	ADP
dpc-2863	76	24	low	low	ADJ
dpc-2863	76	25	pd-1	pd-1	ADJ
dpc-2863	76	26	and	and	CCONJ
dpc-2863	76	27	pd	pd	PROPN
dpc-2863	76	28	-	-	PROPN
dpc-2863	76	29	l1	l1	PROPN
dpc-2863	76	30	(	(	PUNCT
dpc-2863	76	31	+	+	ADJ
dpc-2863	76	32	)	)	PUNCT
dpc-2863	76	33	immune	immune	ADJ
dpc-2863	76	34	cell	cell	NOUN
dpc-2863	76	35	counts	count	NOUN
dpc-2863	76	36	(	(	PUNCT
dpc-2863	76	37	number	number	NOUN
dpc-2863	76	38	of	of	ADP
dpc-2863	76	39	pd-1	pd-1	ADJ
dpc-2863	76	40	and	and	CCONJ
dpc-2863	76	41	pd	pd	PROPN
dpc-2863	76	42	-	-	PROPN
dpc-2863	76	43	l1	l1	PROPN
dpc-2863	76	44	positive	positive	ADJ
dpc-2863	76	45	immune	immune	ADJ
dpc-2863	76	46	cell	cell	NOUN
dpc-2863	76	47	<	<	NOUN
dpc-2863	76	48	10	10	NUM
dpc-2863	76	49	)	)	PUNCT
dpc-2863	76	50	and	and	CCONJ
dpc-2863	76	51	tissues	tissue	NOUN
dpc-2863	76	52	with	with	ADP
dpc-2863	76	53	high	high	ADJ
dpc-2863	76	54	pd-1	pd-1	ADJ
dpc-2863	76	55	and	and	CCONJ
dpc-2863	76	56	pd	pd	PROPN
dpc-2863	76	57	-	-	PROPN
dpc-2863	76	58	l1	l1	PROPN
dpc-2863	76	59	(	(	PUNCT
dpc-2863	76	60	+	+	ADJ
dpc-2863	76	61	)	)	PUNCT
dpc-2863	76	62	immune	immune	ADJ
dpc-2863	76	63	cell	cell	NOUN
dpc-2863	76	64	counts	count	NOUN
dpc-2863	76	65	(	(	PUNCT
dpc-2863	76	66	number	number	NOUN
dpc-2863	76	67	of	of	ADP
dpc-2863	76	68	pd-1	pd-1	ADJ
dpc-2863	76	69	and	and	CCONJ
dpc-2863	76	70	pd	pd	PROPN
dpc-2863	76	71	-	-	PROPN
dpc-2863	76	72	l1	l1	PROPN
dpc-2863	76	73	positive	positive	ADJ
dpc-2863	76	74	immune	immune	ADJ
dpc-2863	76	75	cells	cell	NOUN
dpc-2863	76	76	≥10	≥10	ADJ
dpc-2863	76	77	)	)	PUNCT
dpc-2863	76	78	statistical	statistical	ADJ
dpc-2863	76	79	analyses	analysis	NOUN
dpc-2863	76	80	all	all	DET
dpc-2863	76	81	statistical	statistical	ADJ
dpc-2863	76	82	analyses	analysis	NOUN
dpc-2863	76	83	were	be	AUX
dpc-2863	76	84	conducted	conduct	VERB
dpc-2863	76	85	using	use	VERB
dpc-2863	76	86	ibm	ibm	PROPN
dpc-2863	76	87	statistical	statistical	ADJ
dpc-2863	76	88	package	package	NOUN
dpc-2863	76	89	for	for	ADP
dpc-2863	76	90	the	the	DET
dpc-2863	76	91	statistical	statistical	ADJ
dpc-2863	76	92	package	package	NOUN
dpc-2863	76	93	for	for	ADP
dpc-2863	76	94	the	the	DET
dpc-2863	76	95	social	social	ADJ
dpc-2863	76	96	sciences	sciences	PROPN
dpc-2863	76	97	(	(	PUNCT
dpc-2863	76	98	spss	spss	PROPN
dpc-2863	76	99	)	)	PUNCT
dpc-2863	76	100	version	version	NOUN
dpc-2863	76	101	23.0	23.0	NUM
dpc-2863	76	102	(	(	PUNCT
dpc-2863	76	103	ibm	ibm	PROPN
dpc-2863	76	104	spss	spss	PROPN
dpc-2863	76	105	corp	corp	PROPN
dpc-2863	76	106	.	.	PROPN
dpc-2863	76	107	)	)	PUNCT
dpc-2863	76	108	.	.	PUNCT
dpc-2863	77	1	categorical	categorical	ADJ
dpc-2863	77	2	variables	variable	NOUN
dpc-2863	77	3	were	be	AUX
dpc-2863	77	4	presented	present	VERB
dpc-2863	77	5	as	as	ADP
dpc-2863	77	6	frequency	frequency	NOUN
dpc-2863	77	7	and	and	CCONJ
dpc-2863	77	8	percentage	percentage	NOUN
dpc-2863	77	9	.	.	PUNCT
dpc-2863	78	1	visual	visual	ADJ
dpc-2863	78	2	methods	method	NOUN
dpc-2863	78	3	,	,	PUNCT
dpc-2863	78	4	kolmogorov	kolmogorov	PROPN
dpc-2863	78	5	–	–	PUNCT
dpc-2863	78	6	smirnov	smirnov	ADJ
dpc-2863	78	7	test	test	NOUN
dpc-2863	78	8	and	and	CCONJ
dpc-2863	78	9	shapiro	shapiro	PROPN
dpc-2863	78	10	-	-	PUNCT
dpc-2863	78	11	wilk	wilk	NOUN
dpc-2863	78	12	test	test	NOUN
dpc-2863	78	13	were	be	AUX
dpc-2863	78	14	used	use	VERB
dpc-2863	78	15	to	to	PART
dpc-2863	78	16	evaluate	evaluate	VERB
dpc-2863	78	17	if	if	SCONJ
dpc-2863	78	18	the	the	DET
dpc-2863	78	19	numerical	numerical	ADJ
dpc-2863	78	20	variables	variable	NOUN
dpc-2863	78	21	were	be	AUX
dpc-2863	78	22	normally	normally	ADV
dpc-2863	78	23	distributed	distribute	VERB
dpc-2863	78	24	.	.	PUNCT
dpc-2863	79	1	normally	normally	ADV
dpc-2863	79	2	distributed	distribute	VERB
dpc-2863	79	3	variables	variable	NOUN
dpc-2863	79	4	were	be	AUX
dpc-2863	79	5	presented	present	VERB
dpc-2863	79	6	as	as	ADP
dpc-2863	79	7	mean	mean	NOUN
dpc-2863	79	8	(	(	PUNCT
dpc-2863	79	9	standard	standard	ADJ
dpc-2863	79	10	deviation	deviation	NOUN
dpc-2863	79	11	,	,	PUNCT
dpc-2863	79	12	sd	sd	NOUN
dpc-2863	79	13	)	)	PUNCT
dpc-2863	79	14	and	and	CCONJ
dpc-2863	79	15	continuous	continuous	ADJ
dpc-2863	79	16	variables	variable	NOUN
dpc-2863	79	17	which	which	PRON
dpc-2863	79	18	were	be	AUX
dpc-2863	79	19	not	not	PART
dpc-2863	79	20	normally	normally	ADV
dpc-2863	79	21	distributed	distribute	VERB
dpc-2863	79	22	were	be	AUX
dpc-2863	79	23	presented	present	VERB
dpc-2863	79	24	as	as	ADP
dpc-2863	79	25	median	median	NOUN
dpc-2863	79	26	(	(	PUNCT
dpc-2863	79	27	interquartile	interquartile	NOUN
dpc-2863	79	28	range	range	PROPN
dpc-2863	79	29	,	,	PUNCT
dpc-2863	79	30	iqr	iqr	NOUN
dpc-2863	79	31	)	)	PUNCT
dpc-2863	79	32	.	.	PUNCT
dpc-2863	80	1	categorical	categorical	ADJ
dpc-2863	80	2	variables	variable	NOUN
dpc-2863	80	3	were	be	AUX
dpc-2863	80	4	analyzed	analyze	VERB
dpc-2863	80	5	using	use	VERB
dpc-2863	80	6	chi	chi	NOUN
dpc-2863	80	7	-	-	PUNCT
dpc-2863	80	8	squared	square	VERB
dpc-2863	80	9	test	test	NOUN
dpc-2863	80	10	or	or	CCONJ
dpc-2863	80	11	fischer	fischer	PROPN
dpc-2863	80	12	exact	exact	ADJ
dpc-2863	80	13	and	and	CCONJ
dpc-2863	80	14	numerical	numerical	ADJ
dpc-2863	80	15	variables	variable	NOUN
dpc-2863	80	16	were	be	AUX
dpc-2863	80	17	analyzed	analyze	VERB
dpc-2863	80	18	using	use	VERB
dpc-2863	80	19	student	student	NOUN
dpc-2863	80	20	t	t	PROPN
dpc-2863	80	21	-	-	PUNCT
dpc-2863	80	22	test	test	NOUN
dpc-2863	80	23	or	or	CCONJ
dpc-2863	80	24	mann	mann	PROPN
dpc-2863	80	25	–	–	PUNCT
dpc-2863	80	26	whitney	whitney	PROPN
dpc-2863	80	27	u	u	PROPN
dpc-2863	80	28	test	test	NOUN
dpc-2863	80	29	.	.	PUNCT
dpc-2863	81	1	spearman	spearman	NOUN
dpc-2863	81	2	and	and	CCONJ
dpc-2863	81	3	pearson	pearson	NOUN
dpc-2863	81	4	tests	test	NOUN
dpc-2863	81	5	were	be	AUX
dpc-2863	81	6	used	use	VERB
dpc-2863	81	7	to	to	PART
dpc-2863	81	8	evaluate	evaluate	VERB
dpc-2863	81	9	the	the	DET
dpc-2863	81	10	correlations	correlation	NOUN
dpc-2863	81	11	of	of	ADP
dpc-2863	81	12	continuous	continuous	ADJ
dpc-2863	81	13	variables	variable	NOUN
dpc-2863	81	14	.	.	PUNCT
dpc-2863	82	1	the	the	DET
dpc-2863	82	2	level	level	NOUN
dpc-2863	82	3	of	of	ADP
dpc-2863	82	4	statistical	statistical	ADJ
dpc-2863	82	5	significance	significance	NOUN
dpc-2863	82	6	was	be	AUX
dpc-2863	82	7	accepted	accept	VERB
dpc-2863	82	8	as	as	ADP
dpc-2863	82	9	p	p	NOUN
dpc-2863	82	10	<	<	X
dpc-2863	82	11	0.05	0.05	NUM
dpc-2863	82	12	.	.	PUNCT
dpc-2863	83	1	results	result	NOUN
dpc-2863	83	2	among	among	ADP
dpc-2863	83	3	the	the	DET
dpc-2863	83	4	patients	patient	NOUN
dpc-2863	83	5	in	in	ADP
dpc-2863	83	6	the	the	DET
dpc-2863	83	7	study	study	NOUN
dpc-2863	83	8	,	,	PUNCT
dpc-2863	83	9	22	22	NUM
dpc-2863	83	10	were	be	AUX
dpc-2863	83	11	male	male	ADJ
dpc-2863	83	12	,	,	PUNCT
dpc-2863	83	13	8	8	NUM
dpc-2863	83	14	were	be	AUX
dpc-2863	83	15	female	female	ADJ
dpc-2863	83	16	.	.	PUNCT
dpc-2863	84	1	among	among	ADP
dpc-2863	84	2	the	the	DET
dpc-2863	84	3	individuals	individual	NOUN
dpc-2863	84	4	in	in	ADP
dpc-2863	84	5	the	the	DET
dpc-2863	84	6	control	control	NOUN
dpc-2863	84	7	group	group	NOUN
dpc-2863	84	8	,	,	PUNCT
dpc-2863	84	9	13	13	NUM
dpc-2863	84	10	were	be	AUX
dpc-2863	84	11	female	female	ADJ
dpc-2863	84	12	,	,	PUNCT
dpc-2863	84	13	2	2	NUM
dpc-2863	84	14	were	be	AUX
dpc-2863	84	15	male	male	ADJ
dpc-2863	84	16	.	.	PUNCT
dpc-2863	85	1	the	the	DET
dpc-2863	85	2	mean	mean	ADJ
dpc-2863	85	3	age	age	NOUN
dpc-2863	85	4	of	of	ADP
dpc-2863	85	5	the	the	DET
dpc-2863	85	6	patients	patient	NOUN
dpc-2863	85	7	was	be	AUX
dpc-2863	85	8	40.07	40.07	NUM
dpc-2863	85	9	±	±	NUM
dpc-2863	85	10	16.99	16.99	NUM
dpc-2863	85	11	,	,	PUNCT
dpc-2863	85	12	the	the	DET
dpc-2863	85	13	mean	mean	ADJ
dpc-2863	85	14	age	age	NOUN
dpc-2863	85	15	of	of	ADP
dpc-2863	85	16	the	the	DET
dpc-2863	85	17	control	control	NOUN
dpc-2863	85	18	group	group	NOUN
dpc-2863	85	19	was	be	AUX
dpc-2863	85	20	44.13	44.13	NUM
dpc-2863	85	21	 	 	SPACE
dpc-2863	85	22	±	±	NOUN
dpc-2863	85	23	 	 	SPACE
dpc-2863	85	24	12.35	12.35	NUM
dpc-2863	85	25	,	,	PUNCT
dpc-2863	85	26	and	and	CCONJ
dpc-2863	85	27	there	there	PRON
dpc-2863	85	28	was	be	VERB
dpc-2863	85	29	no	no	DET
dpc-2863	85	30	significant	significant	ADJ
dpc-2863	85	31	difference	difference	NOUN
dpc-2863	85	32	between	between	ADP
dpc-2863	85	33	the	the	DET
dpc-2863	85	34	groups	group	NOUN
dpc-2863	85	35	in	in	ADP
dpc-2863	85	36	terms	term	NOUN
dpc-2863	85	37	of	of	ADP
dpc-2863	85	38	age	age	NOUN
dpc-2863	85	39	(	(	PUNCT
dpc-2863	85	40	p	p	NOUN
dpc-2863	85	41	=	=	NOUN
dpc-2863	85	42	0.415	0.415	NUM
dpc-2863	85	43	)	)	PUNCT
dpc-2863	85	44	(	(	PUNCT
dpc-2863	85	45	table	table	NOUN
dpc-2863	85	46	1	1	NUM
dpc-2863	85	47	)	)	PUNCT
dpc-2863	85	48	.	.	PUNCT
dpc-2863	86	1	for	for	ADP
dpc-2863	86	2	all	all	DET
dpc-2863	86	3	the	the	DET
dpc-2863	86	4	samples	sample	NOUN
dpc-2863	86	5	studied	study	VERB
dpc-2863	86	6	,	,	PUNCT
dpc-2863	86	7	only	only	ADV
dpc-2863	86	8	the	the	DET
dpc-2863	86	9	immune	immune	ADJ
dpc-2863	86	10	cells	cell	NOUN
dpc-2863	86	11	in	in	ADP
dpc-2863	86	12	the	the	DET
dpc-2863	86	13	dermis	dermis	NOUN
dpc-2863	86	14	showed	show	VERB
dpc-2863	86	15	positive	positive	ADJ
dpc-2863	86	16	staining	staining	NOUN
dpc-2863	86	17	with	with	ADP
dpc-2863	86	18	pd-1	pd-1	ADJ
dpc-2863	86	19	and	and	CCONJ
dpc-2863	86	20	pdl-1	pdl-1	NUM
dpc-2863	86	21	.	.	PUNCT
dpc-2863	86	22	epidermis	epidermis	NOUN
dpc-2863	86	23	did	do	AUX
dpc-2863	86	24	not	not	PART
dpc-2863	86	25	show	show	VERB
dpc-2863	86	26	any	any	DET
dpc-2863	86	27	staining	staining	NOUN
dpc-2863	86	28	.	.	PUNCT
dpc-2863	87	1	86.7	86.7	NUM
dpc-2863	87	2	%	%	NOUN
dpc-2863	87	3	of	of	ADP
dpc-2863	87	4	the	the	DET
dpc-2863	87	5	psoriasis	psoriasis	NOUN
dpc-2863	87	6	patients	patient	NOUN
dpc-2863	87	7	had	have	VERB
dpc-2863	87	8	high	high	ADJ
dpc-2863	87	9	pd-1	pd-1	ADP
dpc-2863	87	10	(	(	PUNCT
dpc-2863	87	11	+	+	ADJ
dpc-2863	87	12	)	)	PUNCT
dpc-2863	87	13	immune	immune	ADJ
dpc-2863	87	14	cell	cell	NOUN
dpc-2863	87	15	counts	count	NOUN
dpc-2863	87	16	(	(	PUNCT
dpc-2863	87	17	figure	figure	NOUN
dpc-2863	87	18	1	1	NUM
dpc-2863	87	19	)	)	PUNCT
dpc-2863	87	20	.	.	PUNCT
dpc-2863	88	1	in	in	ADP
dpc-2863	88	2	the	the	DET
dpc-2863	88	3	control	control	NOUN
dpc-2863	88	4	group	group	NOUN
dpc-2863	88	5	,	,	PUNCT
dpc-2863	88	6	40	40	NUM
dpc-2863	88	7	%	%	NOUN
dpc-2863	88	8	of	of	ADP
dpc-2863	88	9	the	the	DET
dpc-2863	88	10	tissues	tissue	NOUN
dpc-2863	88	11	had	have	VERB
dpc-2863	88	12	high	high	ADJ
dpc-2863	88	13	pd-1	pd-1	ADP
dpc-2863	88	14	(	(	PUNCT
dpc-2863	88	15	+	+	ADJ
dpc-2863	88	16	)	)	PUNCT
dpc-2863	88	17	immune	immune	ADJ
dpc-2863	88	18	cell	cell	NOUN
dpc-2863	88	19	counts	count	NOUN
dpc-2863	88	20	,	,	PUNCT
dpc-2863	88	21	which	which	PRON
dpc-2863	88	22	was	be	AUX
dpc-2863	88	23	significantly	significantly	ADV
dpc-2863	88	24	lower	low	ADJ
dpc-2863	88	25	than	than	ADP
dpc-2863	88	26	the	the	DET
dpc-2863	88	27	table	table	NOUN
dpc-2863	88	28	1	1	NUM
dpc-2863	88	29	.	.	PUNCT
dpc-2863	88	30	basic	basic	ADJ
dpc-2863	88	31	characteristics	characteristic	NOUN
dpc-2863	88	32	of	of	ADP
dpc-2863	88	33	patient	patient	ADJ
dpc-2863	88	34	and	and	CCONJ
dpc-2863	88	35	control	control	NOUN
dpc-2863	88	36	groups	group	NOUN
dpc-2863	88	37	,	,	PUNCT
dpc-2863	88	38	comparison	comparison	NOUN
dpc-2863	88	39	of	of	ADP
dpc-2863	88	40	pd-1	pd-1	ADJ
dpc-2863	88	41	and	and	CCONJ
dpc-2863	88	42	pdl-1	pdl-1	ADV
dpc-2863	88	43	results	result	NOUN
dpc-2863	88	44	.	.	PUNCT
dpc-2863	89	1	patients	patient	NOUN
dpc-2863	89	2	(	(	PUNCT
dpc-2863	89	3	n	n	NOUN
dpc-2863	89	4	=	=	SYM
dpc-2863	89	5	30	30	NUM
dpc-2863	89	6	)	)	PUNCT
dpc-2863	89	7	controls	control	NOUN
dpc-2863	89	8	(	(	PUNCT
dpc-2863	89	9	n	n	NOUN
dpc-2863	89	10	=	=	SYM
dpc-2863	89	11	15	15	NUM
dpc-2863	89	12	)	)	PUNCT
dpc-2863	89	13	p	p	NOUN
dpc-2863	89	14	age	age	NOUN
dpc-2863	89	15	(	(	PUNCT
dpc-2863	89	16	years	year	NOUN
dpc-2863	89	17	,	,	PUNCT
dpc-2863	89	18	mean	mean	PROPN
dpc-2863	89	19	±	±	NUM
dpc-2863	89	20	sd	sd	NOUN
dpc-2863	89	21	)	)	PUNCT
dpc-2863	89	22	40.07±16.99	40.07±16.99	PROPN
dpc-2863	89	23	41.13±12.35	41.13±12.35	NOUN
dpc-2863	89	24	0.415	0.415	NUM
dpc-2863	89	25	gender	gender	NOUN
dpc-2863	89	26	(	(	PUNCT
dpc-2863	89	27	n	n	CCONJ
dpc-2863	89	28	(	(	PUNCT
dpc-2863	89	29	%	%	NOUN
dpc-2863	89	30	)	)	PUNCT
dpc-2863	89	31	)	)	PUNCT
dpc-2863	89	32	female	female	ADJ
dpc-2863	89	33	male	male	NOUN
dpc-2863	89	34	8	8	NUM
dpc-2863	89	35	(	(	PUNCT
dpc-2863	89	36	26.7	26.7	NUM
dpc-2863	89	37	)	)	PUNCT
dpc-2863	89	38	22	22	NUM
dpc-2863	89	39	(	(	PUNCT
dpc-2863	89	40	73.3	73.3	NUM
dpc-2863	89	41	)	)	PUNCT
dpc-2863	89	42	13	13	NUM
dpc-2863	89	43	(	(	PUNCT
dpc-2863	89	44	86.7	86.7	NUM
dpc-2863	89	45	)	)	SYM
dpc-2863	89	46	2	2	NUM
dpc-2863	89	47	(	(	PUNCT
dpc-2863	89	48	13.3	13.3	NUM
dpc-2863	89	49	)	)	PUNCT
dpc-2863	89	50	<	<	X
dpc-2863	89	51	0.001	0.001	NUM
dpc-2863	89	52	pasi	pasi	NOUN
dpc-2863	89	53	(	(	PUNCT
dpc-2863	89	54	median	median	PROPN
dpc-2863	89	55	(	(	PUNCT
dpc-2863	89	56	iqr	iqr	NOUN
dpc-2863	89	57	)	)	PUNCT
dpc-2863	89	58	)	)	PUNCT
dpc-2863	89	59	5.4	5.4	NUM
dpc-2863	89	60	(	(	PUNCT
dpc-2863	89	61	4.6	4.6	NUM
dpc-2863	89	62	-	-	SYM
dpc-2863	89	63	6.9	6.9	NUM
dpc-2863	89	64	)	)	PUNCT
dpc-2863	89	65	disease	disease	NOUN
dpc-2863	89	66	duration	duration	NOUN
dpc-2863	89	67	(	(	PUNCT
dpc-2863	89	68	years	year	NOUN
dpc-2863	89	69	,	,	PUNCT
dpc-2863	89	70	median	median	NOUN
dpc-2863	89	71	(	(	PUNCT
dpc-2863	89	72	iqr	iqr	NOUN
dpc-2863	89	73	)	)	PUNCT
dpc-2863	89	74	)	)	PUNCT
dpc-2863	89	75	2	2	NUM
dpc-2863	89	76	(	(	PUNCT
dpc-2863	89	77	1.5	1.5	NUM
dpc-2863	89	78	-	-	SYM
dpc-2863	89	79	9	9	NUM
dpc-2863	89	80	)	)	PUNCT
dpc-2863	89	81	pd-1	pd-1	ADP
dpc-2863	89	82	positive	positive	ADJ
dpc-2863	89	83	cell	cell	NOUN
dpc-2863	89	84	number	number	NOUN
dpc-2863	89	85	(	(	PUNCT
dpc-2863	89	86	n	n	CCONJ
dpc-2863	89	87	(	(	PUNCT
dpc-2863	89	88	%	%	NOUN
dpc-2863	89	89	)	)	PUNCT
dpc-2863	89	90	)	)	PUNCT
dpc-2863	89	91	low	low	ADV
dpc-2863	89	92	(	(	PUNCT
dpc-2863	89	93	<	<	NOUN
dpc-2863	89	94	10	10	NUM
dpc-2863	89	95	)	)	PUNCT
dpc-2863	89	96	high	high	ADJ
dpc-2863	89	97	(	(	PUNCT
dpc-2863	89	98	≥10	≥10	ADJ
dpc-2863	89	99	)	)	PUNCT
dpc-2863	89	100	4	4	NUM
dpc-2863	89	101	(	(	PUNCT
dpc-2863	89	102	13.3	13.3	NUM
dpc-2863	89	103	)	)	PUNCT
dpc-2863	89	104	26	26	NUM
dpc-2863	89	105	(	(	PUNCT
dpc-2863	89	106	86.7	86.7	NUM
dpc-2863	89	107	)	)	PUNCT
dpc-2863	89	108	9	9	NUM
dpc-2863	89	109	(	(	PUNCT
dpc-2863	89	110	60	60	NUM
dpc-2863	89	111	)	)	PUNCT
dpc-2863	89	112	6	6	NUM
dpc-2863	89	113	(	(	PUNCT
dpc-2863	89	114	40	40	NUM
dpc-2863	89	115	)	)	PUNCT
dpc-2863	89	116	0.004	0.004	NUM
dpc-2863	89	117	pdl-1	pdl-1	CCONJ
dpc-2863	89	118	positive	positive	ADJ
dpc-2863	89	119	cell	cell	NOUN
dpc-2863	89	120	number	number	NOUN
dpc-2863	89	121	(	(	PUNCT
dpc-2863	89	122	n	n	CCONJ
dpc-2863	89	123	(	(	PUNCT
dpc-2863	89	124	%	%	NOUN
dpc-2863	89	125	)	)	PUNCT
dpc-2863	89	126	)	)	PUNCT
dpc-2863	89	127	low	low	ADV
dpc-2863	89	128	(	(	PUNCT
dpc-2863	89	129	<	<	NOUN
dpc-2863	89	130	10	10	NUM
dpc-2863	89	131	)	)	PUNCT
dpc-2863	89	132	high	high	ADJ
dpc-2863	89	133	(	(	PUNCT
dpc-2863	89	134	≥10	≥10	ADJ
dpc-2863	89	135	)	)	PUNCT
dpc-2863	89	136	17	17	NUM
dpc-2863	89	137	(	(	PUNCT
dpc-2863	89	138	56.7	56.7	NUM
dpc-2863	89	139	)	)	PUNCT
dpc-2863	89	140	13	13	NUM
dpc-2863	89	141	(	(	PUNCT
dpc-2863	89	142	43.3	43.3	NUM
dpc-2863	89	143	)	)	PUNCT
dpc-2863	89	144	15	15	NUM
dpc-2863	89	145	(	(	PUNCT
dpc-2863	89	146	100	100	NUM
dpc-2863	89	147	)	)	PUNCT
dpc-2863	89	148	0	0	NUM
dpc-2863	89	149	(	(	PUNCT
dpc-2863	89	150	0	0	NUM
dpc-2863	89	151	)	)	PUNCT
dpc-2863	89	152	0.002	0.002	NUM
dpc-2863	89	153	iqr	iqr	NOUN
dpc-2863	89	154	=	=	NOUN
dpc-2863	89	155	interquartile	interquartile	ADJ
dpc-2863	89	156	range	range	NOUN
dpc-2863	89	157	;	;	PUNCT
dpc-2863	89	158	pasi	pasi	NOUN
dpc-2863	89	159	:	:	PUNCT
dpc-2863	89	160	psoriasis	psoriasis	NOUN
dpc-2863	89	161	area	area	NOUN
dpc-2863	89	162	and	and	CCONJ
dpc-2863	89	163	severity	severity	NOUN
dpc-2863	89	164	index	index	NOUN
dpc-2863	89	165	;	;	PUNCT
dpc-2863	89	166	sd	sd	NOUN
dpc-2863	89	167	=	=	SYM
dpc-2863	89	168	standard	standard	ADJ
dpc-2863	89	169	deviation	deviation	NOUN
dpc-2863	89	170	.	.	PUNCT
dpc-2863	90	1	4	4	NUM
dpc-2863	90	2	original	original	ADJ
dpc-2863	90	3	article	article	NOUN
dpc-2863	90	4	|	|	ADV
dpc-2863	90	5	dermatol	dermatol	ADJ
dpc-2863	90	6	pract	pract	NOUN
dpc-2863	90	7	concept	concept	NOUN
dpc-2863	90	8	.	.	PUNCT
dpc-2863	91	1	2023;13(2):e2023134	2023;13(2):e2023134	NUM
dpc-2863	91	2	while	while	SCONJ
dpc-2863	91	3	stimulation	stimulation	NOUN
dpc-2863	91	4	of	of	ADP
dpc-2863	91	5	the	the	DET
dpc-2863	91	6	pd-1	pd-1	ADJ
dpc-2863	91	7	pathway	pathway	NOUN
dpc-2863	91	8	inhibited	inhibit	VERB
dpc-2863	91	9	the	the	DET
dpc-2863	91	10	th-1/	th-1/	NOUN
dpc-2863	91	11	th17	th17	NOUN
dpc-2863	91	12	-	-	PUNCT
dpc-2863	91	13	mediated	mediate	VERB
dpc-2863	91	14	cutaneous	cutaneous	ADJ
dpc-2863	91	15	reactions	reaction	NOUN
dpc-2863	91	16	[	[	X
dpc-2863	91	17	6,11	6,11	NOUN
dpc-2863	91	18	]	]	PUNCT
dpc-2863	91	19	.	.	PUNCT
dpc-2863	92	1	high	high	ADJ
dpc-2863	92	2	-	-	PUNCT
dpc-2863	92	3	affinity	affinity	NOUN
dpc-2863	92	4	anti	anti	NOUN
dpc-2863	92	5	-	-	NOUN
dpc-2863	92	6	pd-1	pd-1	ADJ
dpc-2863	92	7	or	or	CCONJ
dpc-2863	92	8	anti	anti	ADJ
dpc-2863	92	9	-	-	ADJ
dpc-2863	92	10	pd	pd	ADJ
dpc-2863	92	11	-	-	PUNCT
dpc-2863	92	12	l1	l1	PROPN
dpc-2863	92	13	monoclonal	monoclonal	NOUN
dpc-2863	92	14	antibodies	antibodie	VERB
dpc-2863	92	15	that	that	PRON
dpc-2863	92	16	block	block	VERB
dpc-2863	92	17	the	the	DET
dpc-2863	92	18	pd-1	pd-1	ADJ
dpc-2863	92	19	and	and	CCONJ
dpc-2863	92	20	pd	pd	PROPN
dpc-2863	92	21	-	-	PROPN
dpc-2863	92	22	l1	l1	PROPN
dpc-2863	92	23	interaction	interaction	NOUN
dpc-2863	92	24	may	may	AUX
dpc-2863	92	25	eliminate	eliminate	VERB
dpc-2863	92	26	the	the	DET
dpc-2863	92	27	control	control	NOUN
dpc-2863	92	28	mechanism	mechanism	NOUN
dpc-2863	92	29	over	over	ADP
dpc-2863	92	30	t	t	NOUN
dpc-2863	92	31	cells	cell	NOUN
dpc-2863	92	32	by	by	ADP
dpc-2863	92	33	reversing	reverse	VERB
dpc-2863	92	34	the	the	DET
dpc-2863	92	35	immune	immune	ADJ
dpc-2863	92	36	control	control	NOUN
dpc-2863	92	37	point	point	NOUN
dpc-2863	92	38	.	.	PUNCT
dpc-2863	93	1	in	in	ADP
dpc-2863	93	2	recent	recent	ADJ
dpc-2863	93	3	years	year	NOUN
dpc-2863	93	4	,	,	PUNCT
dpc-2863	93	5	anti	anti	ADJ
dpc-2863	93	6	-	-	ADJ
dpc-2863	93	7	pd-1	pd-1	ADJ
dpc-2863	93	8	antibodies	antibody	NOUN
dpc-2863	93	9	have	have	AUX
dpc-2863	93	10	been	be	AUX
dpc-2863	93	11	used	use	VERB
dpc-2863	93	12	in	in	ADP
dpc-2863	93	13	cancer	cancer	NOUN
dpc-2863	93	14	treatment	treatment	NOUN
dpc-2863	93	15	,	,	PUNCT
dpc-2863	93	16	controlling	control	VERB
dpc-2863	93	17	tumor	tumor	NOUN
dpc-2863	93	18	progression	progression	NOUN
dpc-2863	93	19	and	and	CCONJ
dpc-2863	93	20	mobilizing	mobilize	VERB
dpc-2863	93	21	the	the	DET
dpc-2863	93	22	immune	immune	ADJ
dpc-2863	93	23	system	system	NOUN
dpc-2863	93	24	.	.	PUNCT
dpc-2863	94	1	using	use	VERB
dpc-2863	94	2	anti	anti	ADJ
dpc-2863	94	3	-	-	ADJ
dpc-2863	94	4	pd-1	pd-1	ADJ
dpc-2863	94	5	antibodies	antibody	NOUN
dpc-2863	94	6	for	for	ADP
dpc-2863	94	7	treatment	treatment	NOUN
dpc-2863	94	8	has	have	AUX
dpc-2863	94	9	brought	bring	VERB
dpc-2863	94	10	about	about	ADP
dpc-2863	94	11	some	some	DET
dpc-2863	94	12	side	side	NOUN
dpc-2863	94	13	effects	effect	NOUN
dpc-2863	94	14	.	.	PUNCT
dpc-2863	95	1	skin	skin	NOUN
dpc-2863	95	2	toxicity	toxicity	NOUN
dpc-2863	95	3	is	be	AUX
dpc-2863	95	4	the	the	DET
dpc-2863	95	5	most	most	ADV
dpc-2863	95	6	frequently	frequently	ADV
dpc-2863	95	7	observed	observe	VERB
dpc-2863	95	8	side	side	NOUN
dpc-2863	95	9	effect	effect	NOUN
dpc-2863	95	10	encountered	encounter	VERB
dpc-2863	95	11	in	in	ADP
dpc-2863	95	12	anti	anti	ADJ
dpc-2863	95	13	-	-	ADJ
dpc-2863	95	14	pd-1	pd-1	ADJ
dpc-2863	95	15	treatments	treatment	NOUN
dpc-2863	95	16	.	.	PUNCT
dpc-2863	96	1	some	some	DET
dpc-2863	96	2	skin	skin	NOUN
dpc-2863	96	3	diseases	disease	NOUN
dpc-2863	96	4	such	such	ADJ
dpc-2863	96	5	as	as	ADP
dpc-2863	96	6	vitiligo	vitiligo	NOUN
dpc-2863	96	7	,	,	PUNCT
dpc-2863	96	8	photosensitivity	photosensitivity	NOUN
dpc-2863	96	9	,	,	PUNCT
dpc-2863	96	10	lichenoid	lichenoid	PROPN
dpc-2863	96	11	eruption	eruption	NOUN
dpc-2863	96	12	and	and	CCONJ
dpc-2863	96	13	psoriasis	psoriasis	NOUN
dpc-2863	96	14	were	be	AUX
dpc-2863	96	15	triggered	trigger	VERB
dpc-2863	96	16	in	in	ADP
dpc-2863	96	17	patients	patient	NOUN
dpc-2863	96	18	,	,	PUNCT
dpc-2863	96	19	on	on	ADP
dpc-2863	96	20	whom	whom	PRON
dpc-2863	96	21	the	the	DET
dpc-2863	96	22	anti	anti	ADJ
dpc-2863	96	23	-	-	ADJ
dpc-2863	96	24	pd-1	pd-1	ADJ
dpc-2863	96	25	antibody	antibody	NOUN
dpc-2863	96	26	was	be	AUX
dpc-2863	96	27	used	use	VERB
dpc-2863	96	28	.	.	PUNCT
dpc-2863	97	1	in	in	ADP
dpc-2863	97	2	the	the	DET
dpc-2863	97	3	literature	literature	NOUN
dpc-2863	97	4	,	,	PUNCT
dpc-2863	97	5	lichenoid	lichenoid	PROPN
dpc-2863	97	6	reactions	reaction	NOUN
dpc-2863	97	7	,	,	PUNCT
dpc-2863	97	8	eczema	eczema	NOUN
dpc-2863	97	9	,	,	PUNCT
dpc-2863	97	10	pruritus	pruritus	PROPN
dpc-2863	97	11	and	and	CCONJ
dpc-2863	97	12	vitiligo	vitiligo	PROPN
dpc-2863	97	13	are	be	AUX
dpc-2863	97	14	reported	report	VERB
dpc-2863	97	15	as	as	ADP
dpc-2863	97	16	the	the	DET
dpc-2863	97	17	most	most	ADV
dpc-2863	97	18	frequently	frequently	ADV
dpc-2863	97	19	encountered	encounter	VERB
dpc-2863	97	20	cutaneous	cutaneous	ADJ
dpc-2863	97	21	side	side	NOUN
dpc-2863	97	22	effects	effect	NOUN
dpc-2863	97	23	[	[	X
dpc-2863	97	24	7,9,12,13	7,9,12,13	NOUN
dpc-2863	97	25	]	]	PUNCT
dpc-2863	97	26	.	.	PUNCT
dpc-2863	98	1	psoriasis	psoriasis	NOUN
dpc-2863	98	2	is	be	AUX
dpc-2863	98	3	a	a	DET
dpc-2863	98	4	well	well	ADV
dpc-2863	98	5	-	-	PUNCT
dpc-2863	98	6	established	establish	VERB
dpc-2863	98	7	side	side	NOUN
dpc-2863	98	8	effect	effect	NOUN
dpc-2863	98	9	secondary	secondary	ADJ
dpc-2863	98	10	to	to	ADP
dpc-2863	98	11	pd-1	pd-1	ADJ
dpc-2863	98	12	and	and	CCONJ
dpc-2863	98	13	pdl1	pdl1	PROPN
dpc-2863	98	14	blockade	blockade	NOUN
dpc-2863	98	15	,	,	PUNCT
dpc-2863	98	16	and	and	CCONJ
dpc-2863	98	17	the	the	DET
dpc-2863	98	18	number	number	NOUN
dpc-2863	98	19	of	of	ADP
dpc-2863	98	20	anti	anti	ADJ
dpc-2863	98	21	-	-	ADJ
dpc-2863	98	22	pd-1	pd-1	ADV
dpc-2863	98	23	-	-	PUNCT
dpc-2863	98	24	induced	induced	ADJ
dpc-2863	98	25	psoriasis	psoriasis	NOUN
dpc-2863	98	26	cases	case	NOUN
dpc-2863	98	27	in	in	ADP
dpc-2863	98	28	the	the	DET
dpc-2863	98	29	literature	literature	NOUN
dpc-2863	98	30	continues	continue	VERB
dpc-2863	98	31	to	to	PART
dpc-2863	98	32	increase	increase	VERB
dpc-2863	98	33	[	[	X
dpc-2863	98	34	8,14	8,14	NUM
dpc-2863	98	35	-	-	SYM
dpc-2863	98	36	17	17	NUM
dpc-2863	98	37	]	]	PUNCT
dpc-2863	98	38	.	.	PUNCT
dpc-2863	99	1	how	how	SCONJ
dpc-2863	99	2	the	the	DET
dpc-2863	99	3	pd-1	pd-1	ADJ
dpc-2863	99	4	/	/	SYM
dpc-2863	99	5	pd	pd	ADJ
dpc-2863	99	6	-	-	PUNCT
dpc-2863	99	7	l1	l1	PROPN
dpc-2863	99	8	pathway	pathway	NOUN
dpc-2863	99	9	affects	affect	VERB
dpc-2863	99	10	psoriasis	psoriasis	NOUN
dpc-2863	99	11	or	or	CCONJ
dpc-2863	99	12	other	other	ADJ
dpc-2863	99	13	skin	skin	NOUN
dpc-2863	99	14	diseases	disease	NOUN
dpc-2863	99	15	is	be	AUX
dpc-2863	99	16	unknown	unknown	ADJ
dpc-2863	99	17	.	.	PUNCT
dpc-2863	100	1	in	in	ADP
dpc-2863	100	2	patients	patient	NOUN
dpc-2863	100	3	receiving	receive	VERB
dpc-2863	100	4	anti	anti	ADJ
dpc-2863	100	5	-	-	ADJ
dpc-2863	100	6	pd-1	pd-1	ADJ
dpc-2863	100	7	therapy	therapy	NOUN
dpc-2863	100	8	,	,	PUNCT
dpc-2863	100	9	pd-1	pd-1	ADP
dpc-2863	100	10	blockade	blockade	NOUN
dpc-2863	100	11	may	may	AUX
dpc-2863	100	12	be	be	AUX
dpc-2863	100	13	inducing	induce	VERB
dpc-2863	100	14	a	a	DET
dpc-2863	100	15	pro	pro	ADJ
dpc-2863	100	16	-	-	ADJ
dpc-2863	100	17	inflammatory	inflammatory	ADJ
dpc-2863	100	18	th-1	th-1	NOUN
dpc-2863	100	19	/	/	SYM
dpc-2863	100	20	th-17	th-17	PART
dpc-2863	100	21	response	response	NOUN
dpc-2863	100	22	by	by	ADP
dpc-2863	100	23	increasing	increase	VERB
dpc-2863	100	24	interferon	interferon	ADJ
dpc-2863	100	25	-	-	PUNCT
dpc-2863	100	26	gamma	gamma	NOUN
dpc-2863	100	27	,	,	PUNCT
dpc-2863	100	28	tumor	tumor	NOUN
dpc-2863	100	29	necrosis	necrosis	NOUN
dpc-2863	100	30	factor	factor	NOUN
dpc-2863	100	31	-	-	PUNCT
dpc-2863	100	32	alpha	alpha	NOUN
dpc-2863	100	33	(	(	PUNCT
dpc-2863	100	34	tnf	tnf	PROPN
dpc-2863	100	35	-	-	PUNCT
dpc-2863	100	36	alpha	alpha	NOUN
dpc-2863	100	37	)	)	PUNCT
dpc-2863	100	38	,	,	PUNCT
dpc-2863	100	39	and	and	CCONJ
dpc-2863	100	40	il-2	il-2	NUM
dpc-2863	100	41	,	,	PUNCT
dpc-2863	100	42	il-6	il-6	NUM
dpc-2863	100	43	,	,	PUNCT
dpc-2863	100	44	and	and	CCONJ
dpc-2863	100	45	il-17	il-17	X
dpc-2863	101	1	[	[	X
dpc-2863	101	2	17	17	NUM
dpc-2863	101	3	]	]	PUNCT
dpc-2863	101	4	.	.	PUNCT
dpc-2863	102	1	psoriasis	psoriasis	NOUN
dpc-2863	102	2	patients	patient	NOUN
dpc-2863	102	3	(	(	PUNCT
dpc-2863	102	4	p	p	X
dpc-2863	102	5	=	=	NOUN
dpc-2863	102	6	0.004	0.004	NUM
dpc-2863	102	7	)	)	PUNCT
dpc-2863	102	8	.	.	PUNCT
dpc-2863	103	1	similarly	similarly	ADV
dpc-2863	103	2	,	,	PUNCT
dpc-2863	103	3	the	the	DET
dpc-2863	103	4	percentage	percentage	NOUN
dpc-2863	103	5	of	of	ADP
dpc-2863	103	6	the	the	DET
dpc-2863	103	7	tissues	tissue	NOUN
dpc-2863	103	8	with	with	ADP
dpc-2863	103	9	high	high	ADJ
dpc-2863	103	10	pdl-1	pdl-1	ADV
dpc-2863	103	11	(	(	PUNCT
dpc-2863	103	12	+	+	ADJ
dpc-2863	103	13	)	)	PUNCT
dpc-2863	103	14	immune	immune	ADJ
dpc-2863	103	15	cell	cell	NOUN
dpc-2863	103	16	counts	count	NOUN
dpc-2863	103	17	was	be	AUX
dpc-2863	103	18	significantly	significantly	ADV
dpc-2863	103	19	higher	high	ADJ
dpc-2863	103	20	in	in	ADP
dpc-2863	103	21	the	the	DET
dpc-2863	103	22	psoriasis	psoriasis	NOUN
dpc-2863	103	23	patients	patient	NOUN
dpc-2863	103	24	compared	compare	VERB
dpc-2863	103	25	to	to	ADP
dpc-2863	103	26	healthy	healthy	ADJ
dpc-2863	103	27	controls	control	NOUN
dpc-2863	103	28	(	(	PUNCT
dpc-2863	103	29	43.3	43.3	NUM
dpc-2863	103	30	%	%	NOUN
dpc-2863	103	31	versus	versus	ADP
dpc-2863	103	32	0	0	NUM
dpc-2863	103	33	%	%	NOUN
dpc-2863	103	34	,	,	PUNCT
dpc-2863	103	35	p	p	X
dpc-2863	103	36	=	=	NOUN
dpc-2863	103	37	0.002	0.002	NUM
dpc-2863	103	38	)	)	PUNCT
dpc-2863	103	39	(	(	PUNCT
dpc-2863	103	40	figure	figure	NOUN
dpc-2863	103	41	2	2	NUM
dpc-2863	103	42	)	)	PUNCT
dpc-2863	103	43	.	.	PUNCT
dpc-2863	104	1	the	the	DET
dpc-2863	104	2	median	median	ADJ
dpc-2863	104	3	pasi	pasi	PROPN
dpc-2863	104	4	score	score	NOUN
dpc-2863	104	5	was	be	AUX
dpc-2863	104	6	calculated	calculate	VERB
dpc-2863	104	7	as	as	ADP
dpc-2863	104	8	5.4	5.4	NUM
dpc-2863	104	9	(	(	PUNCT
dpc-2863	104	10	iqr	iqr	NOUN
dpc-2863	104	11	:	:	PUNCT
dpc-2863	104	12	4.6	4.6	NUM
dpc-2863	104	13	-	-	SYM
dpc-2863	104	14	6.9	6.9	NUM
dpc-2863	104	15	)	)	PUNCT
dpc-2863	104	16	and	and	CCONJ
dpc-2863	104	17	the	the	DET
dpc-2863	104	18	median	median	ADJ
dpc-2863	104	19	disease	disease	NOUN
dpc-2863	104	20	duration	duration	NOUN
dpc-2863	104	21	was	be	AUX
dpc-2863	104	22	2	2	NUM
dpc-2863	104	23	years	year	NOUN
dpc-2863	104	24	(	(	PUNCT
dpc-2863	104	25	iqr	iqr	NOUN
dpc-2863	104	26	:	:	PUNCT
dpc-2863	104	27	1.5	1.5	NUM
dpc-2863	104	28	-	-	SYM
dpc-2863	104	29	9	9	NUM
dpc-2863	104	30	)	)	PUNCT
dpc-2863	104	31	.	.	PUNCT
dpc-2863	105	1	a	a	DET
dpc-2863	105	2	negative	negative	ADJ
dpc-2863	105	3	and	and	CCONJ
dpc-2863	105	4	statistically	statistically	ADV
dpc-2863	105	5	significant	significant	ADJ
dpc-2863	105	6	correlation	correlation	NOUN
dpc-2863	105	7	was	be	AUX
dpc-2863	105	8	detected	detect	VERB
dpc-2863	105	9	between	between	ADP
dpc-2863	105	10	pasi	pasi	NOUN
dpc-2863	105	11	scores	score	NOUN
dpc-2863	105	12	and	and	CCONJ
dpc-2863	105	13	pdl-1	pdl-1	ADV
dpc-2863	105	14	(	(	PUNCT
dpc-2863	105	15	+	+	ADJ
dpc-2863	105	16	)	)	PUNCT
dpc-2863	105	17	immune	immune	ADJ
dpc-2863	105	18	cell	cell	NOUN
dpc-2863	105	19	counts	count	NOUN
dpc-2863	105	20	(	(	PUNCT
dpc-2863	105	21	p	p	X
dpc-2863	105	22	=	=	NOUN
dpc-2863	105	23	0.033	0.033	NUM
dpc-2863	105	24	,	,	PUNCT
dpc-2863	105	25	r	r	NOUN
dpc-2863	105	26	=	=	SYM
dpc-2863	105	27	-0.57	-0.57	NUM
dpc-2863	105	28	)	)	PUNCT
dpc-2863	105	29	.	.	PUNCT
dpc-2863	106	1	there	there	PRON
dpc-2863	106	2	was	be	VERB
dpc-2863	106	3	no	no	DET
dpc-2863	106	4	significant	significant	ADJ
dpc-2863	106	5	correlation	correlation	NOUN
dpc-2863	106	6	between	between	ADP
dpc-2863	106	7	pasi	pasi	NOUN
dpc-2863	106	8	scores	score	NOUN
dpc-2863	106	9	and	and	CCONJ
dpc-2863	106	10	pd-1	pd-1	ADV
dpc-2863	106	11	(	(	PUNCT
dpc-2863	106	12	+	+	ADJ
dpc-2863	106	13	)	)	PUNCT
dpc-2863	106	14	immune	immune	ADJ
dpc-2863	106	15	cell	cell	NOUN
dpc-2863	106	16	counts	count	NOUN
dpc-2863	106	17	(	(	PUNCT
dpc-2863	106	18	p	p	X
dpc-2863	106	19	=	=	NOUN
dpc-2863	106	20	0.51	0.51	NUM
dpc-2863	106	21	,	,	PUNCT
dpc-2863	106	22	r	r	NOUN
dpc-2863	106	23	=	=	SYM
dpc-2863	106	24	-0.19	-0.19	NOUN
dpc-2863	106	25	)	)	PUNCT
dpc-2863	106	26	.	.	PUNCT
dpc-2863	107	1	disease	disease	NOUN
dpc-2863	107	2	duration	duration	NOUN
dpc-2863	107	3	did	do	AUX
dpc-2863	107	4	not	not	PART
dpc-2863	107	5	correlate	correlate	VERB
dpc-2863	107	6	with	with	ADP
dpc-2863	107	7	the	the	DET
dpc-2863	107	8	pd-1	pd-1	ADJ
dpc-2863	107	9	(	(	PUNCT
dpc-2863	107	10	+	+	ADJ
dpc-2863	107	11	)	)	PUNCT
dpc-2863	107	12	immune	immune	ADJ
dpc-2863	107	13	cell	cell	NOUN
dpc-2863	107	14	counts	count	NOUN
dpc-2863	107	15	or	or	CCONJ
dpc-2863	107	16	pdl-1	pdl-1	ADV
dpc-2863	107	17	(	(	PUNCT
dpc-2863	107	18	+	+	ADJ
dpc-2863	107	19	)	)	PUNCT
dpc-2863	107	20	immune	immune	ADJ
dpc-2863	107	21	cell	cell	NOUN
dpc-2863	107	22	counts	count	NOUN
dpc-2863	107	23	(	(	PUNCT
dpc-2863	107	24	p	p	X
dpc-2863	107	25	=	=	NOUN
dpc-2863	107	26	0.43	0.43	NUM
dpc-2863	107	27	,	,	PUNCT
dpc-2863	107	28	r	r	NOUN
dpc-2863	107	29	=	=	SYM
dpc-2863	107	30	0.29	0.29	NUM
dpc-2863	107	31	;	;	PUNCT
dpc-2863	107	32	p	p	X
dpc-2863	107	33	=	=	NOUN
dpc-2863	107	34	0.61	0.61	NUM
dpc-2863	107	35	,	,	PUNCT
dpc-2863	107	36	r	r	NOUN
dpc-2863	107	37	=	=	NOUN
dpc-2863	107	38	0.19	0.19	NUM
dpc-2863	107	39	,	,	PUNCT
dpc-2863	107	40	respectively	respectively	ADV
dpc-2863	107	41	)	)	PUNCT
dpc-2863	107	42	.	.	PUNCT
dpc-2863	108	1	among	among	ADP
dpc-2863	108	2	psoriasis	psoriasis	NOUN
dpc-2863	108	3	patients	patient	NOUN
dpc-2863	108	4	,	,	PUNCT
dpc-2863	108	5	one	one	NUM
dpc-2863	108	6	patient	patient	NOUN
dpc-2863	108	7	had	have	VERB
dpc-2863	108	8	pustular	pustular	ADJ
dpc-2863	108	9	psoriasis	psoriasis	NOUN
dpc-2863	108	10	,	,	PUNCT
dpc-2863	108	11	one	one	PRON
dpc-2863	108	12	had	have	VERB
dpc-2863	108	13	guttate	guttate	NOUN
dpc-2863	108	14	and	and	CCONJ
dpc-2863	108	15	one	one	NUM
dpc-2863	108	16	had	have	VERB
dpc-2863	108	17	palmoplantar	palmoplantar	NOUN
dpc-2863	108	18	psoriasis	psoriasis	NOUN
dpc-2863	108	19	.	.	PUNCT
dpc-2863	109	1	all	all	DET
dpc-2863	109	2	three	three	NUM
dpc-2863	109	3	patients	patient	NOUN
dpc-2863	109	4	had	have	VERB
dpc-2863	109	5	high	high	ADJ
dpc-2863	109	6	pd-1	pd-1	ADP
dpc-2863	109	7	(	(	PUNCT
dpc-2863	109	8	+	+	ADJ
dpc-2863	109	9	)	)	PUNCT
dpc-2863	109	10	immune	immune	ADJ
dpc-2863	109	11	cell	cell	NOUN
dpc-2863	109	12	counts	count	VERB
dpc-2863	109	13	however	however	ADV
dpc-2863	109	14	pdl-1	pdl-1	CCONJ
dpc-2863	109	15	(	(	PUNCT
dpc-2863	109	16	+	+	ADJ
dpc-2863	109	17	)	)	PUNCT
dpc-2863	109	18	immune	immune	ADJ
dpc-2863	109	19	cell	cell	NOUN
dpc-2863	109	20	counts	count	NOUN
dpc-2863	109	21	differed	differ	VERB
dpc-2863	109	22	with	with	ADP
dpc-2863	109	23	subtype	subtype	NOUN
dpc-2863	109	24	.	.	PUNCT
dpc-2863	110	1	patient	patient	ADJ
dpc-2863	110	2	with	with	ADP
dpc-2863	110	3	pustular	pustular	ADJ
dpc-2863	110	4	psoriasis	psoriasis	NOUN
dpc-2863	110	5	had	have	VERB
dpc-2863	110	6	high	high	ADJ
dpc-2863	110	7	pdl-1	pdl-1	ADV
dpc-2863	110	8	(	(	PUNCT
dpc-2863	110	9	+	+	ADJ
dpc-2863	110	10	)	)	PUNCT
dpc-2863	110	11	immune	immune	ADJ
dpc-2863	110	12	cell	cell	NOUN
dpc-2863	110	13	counts	count	VERB
dpc-2863	110	14	whereas	whereas	SCONJ
dpc-2863	110	15	patients	patient	NOUN
dpc-2863	110	16	with	with	ADP
dpc-2863	110	17	guttate	guttate	NOUN
dpc-2863	110	18	and	and	CCONJ
dpc-2863	110	19	palmoplantar	palmoplantar	NOUN
dpc-2863	110	20	psoriasis	psoriasis	NOUN
dpc-2863	110	21	had	have	VERB
dpc-2863	110	22	low	low	ADJ
dpc-2863	110	23	pdl-1	pdl-1	NOUN
dpc-2863	110	24	(	(	PUNCT
dpc-2863	110	25	+	+	ADJ
dpc-2863	110	26	)	)	PUNCT
dpc-2863	110	27	immune	immune	ADJ
dpc-2863	110	28	cell	cell	NOUN
dpc-2863	110	29	counts	count	NOUN
dpc-2863	110	30	.	.	PUNCT
dpc-2863	111	1	conclusions	conclusion	NOUN
dpc-2863	111	2	pd-1	pd-1	ADJ
dpc-2863	111	3	is	be	AUX
dpc-2863	111	4	an	an	DET
dpc-2863	111	5	inhibitor	inhibitor	NOUN
dpc-2863	111	6	receptor	receptor	NOUN
dpc-2863	111	7	that	that	PRON
dpc-2863	111	8	is	be	AUX
dpc-2863	111	9	highly	highly	ADV
dpc-2863	111	10	expressed	express	VERB
dpc-2863	111	11	in	in	ADP
dpc-2863	111	12	t	t	PROPN
dpc-2863	111	13	lymphocytes	lymphocyte	NOUN
dpc-2863	111	14	.	.	PUNCT
dpc-2863	112	1	when	when	SCONJ
dpc-2863	112	2	the	the	DET
dpc-2863	112	3	pd-1	pd-1	ADJ
dpc-2863	112	4	pathway	pathway	NOUN
dpc-2863	112	5	is	be	AUX
dpc-2863	112	6	activated	activate	VERB
dpc-2863	112	7	,	,	PUNCT
dpc-2863	112	8	its	its	PRON
dpc-2863	112	9	inhibiting	inhibit	VERB
dpc-2863	112	10	effect	effect	NOUN
dpc-2863	112	11	on	on	ADP
dpc-2863	112	12	the	the	DET
dpc-2863	112	13	immune	immune	ADJ
dpc-2863	112	14	system	system	NOUN
dpc-2863	112	15	emerges	emerge	VERB
dpc-2863	112	16	[	[	X
dpc-2863	112	17	10	10	NUM
dpc-2863	112	18	]	]	PUNCT
dpc-2863	112	19	.	.	PUNCT
dpc-2863	113	1	it	it	PRON
dpc-2863	113	2	was	be	AUX
dpc-2863	113	3	reported	report	VERB
dpc-2863	113	4	in	in	ADP
dpc-2863	113	5	previous	previous	ADJ
dpc-2863	113	6	studies	study	NOUN
dpc-2863	113	7	that	that	SCONJ
dpc-2863	113	8	the	the	DET
dpc-2863	113	9	pd-1	pd-1	ADJ
dpc-2863	113	10	signal	signal	PROPN
dpc-2863	113	11	pathway	pathway	NOUN
dpc-2863	113	12	regulates	regulate	VERB
dpc-2863	113	13	the	the	DET
dpc-2863	113	14	production	production	NOUN
dpc-2863	113	15	of	of	ADP
dpc-2863	113	16	cytokines	cytokine	NOUN
dpc-2863	113	17	such	such	ADJ
dpc-2863	113	18	as	as	ADP
dpc-2863	113	19	inf	inf	NOUN
dpc-2863	113	20	,	,	PUNCT
dpc-2863	113	21	il-2	il-2	PROPN
dpc-2863	113	22	,	,	PUNCT
dpc-2863	113	23	il-17	il-17	X
dpc-2863	113	24	,	,	PUNCT
dpc-2863	113	25	and	and	CCONJ
dpc-2863	113	26	tnf	tnf	PROPN
dpc-2863	113	27	-	-	PUNCT
dpc-2863	113	28	α	α	PROPN
dpc-2863	113	29	,	,	PUNCT
dpc-2863	113	30	thus	thus	ADV
dpc-2863	113	31	regulating	regulate	VERB
dpc-2863	113	32	the	the	DET
dpc-2863	113	33	axes	axis	NOUN
dpc-2863	113	34	of	of	ADP
dpc-2863	113	35	pd-1	pd-1	NOUN
dpc-2863	113	36	,	,	PUNCT
dpc-2863	113	37	th1	th1	NOUN
dpc-2863	113	38	,	,	PUNCT
dpc-2863	113	39	and	and	CCONJ
dpc-2863	113	40	th17	th17	PROPN
dpc-2863	113	41	.	.	PUNCT
dpc-2863	114	1	in	in	ADP
dpc-2863	114	2	murine	murine	ADJ
dpc-2863	114	3	models	model	NOUN
dpc-2863	114	4	,	,	PUNCT
dpc-2863	114	5	pd-1	pd-1	ADP
dpc-2863	114	6	deficiency	deficiency	NOUN
dpc-2863	114	7	induced	induce	VERB
dpc-2863	114	8	psoriasiform	psoriasiform	NOUN
dpc-2863	114	9	dermatitis	dermatitis	NOUN
dpc-2863	114	10	figure	figure	NOUN
dpc-2863	114	11	1	1	NUM
dpc-2863	114	12	.	.	PUNCT
dpc-2863	114	13	positive	positive	ADJ
dpc-2863	114	14	staining	staining	NOUN
dpc-2863	114	15	of	of	ADP
dpc-2863	114	16	more	more	ADJ
dpc-2863	114	17	than	than	ADP
dpc-2863	114	18	10	10	NUM
dpc-2863	114	19	cells	cell	NOUN
dpc-2863	114	20	is	be	AUX
dpc-2863	114	21	present	present	ADJ
dpc-2863	114	22	in	in	ADP
dpc-2863	114	23	the	the	DET
dpc-2863	114	24	immune	immune	ADJ
dpc-2863	114	25	cells	cell	NOUN
dpc-2863	114	26	in	in	ADP
dpc-2863	114	27	the	the	DET
dpc-2863	114	28	upper	upper	ADJ
dpc-2863	114	29	dermis	dermis	NOUN
dpc-2863	114	30	under	under	ADP
dpc-2863	114	31	the	the	DET
dpc-2863	114	32	epidermis	epidermis	NOUN
dpc-2863	114	33	(	(	PUNCT
dpc-2863	114	34	pd-1	pd-1	X
dpc-2863	114	35	,	,	PUNCT
dpc-2863	114	36	x400	x400	PROPN
dpc-2863	114	37	)	)	PUNCT
dpc-2863	114	38	.	.	PUNCT
dpc-2863	115	1	figure	figure	NOUN
dpc-2863	115	2	2	2	NUM
dpc-2863	115	3	.	.	PUNCT
dpc-2863	115	4	positive	positive	ADJ
dpc-2863	115	5	staining	staining	NOUN
dpc-2863	115	6	is	be	AUX
dpc-2863	115	7	present	present	ADJ
dpc-2863	115	8	in	in	ADP
dpc-2863	115	9	more	more	ADJ
dpc-2863	115	10	than	than	ADP
dpc-2863	115	11	10	10	NUM
dpc-2863	115	12	cells	cell	NOUN
dpc-2863	115	13	in	in	ADP
dpc-2863	115	14	the	the	DET
dpc-2863	115	15	immune	immune	ADJ
dpc-2863	115	16	cells	cell	NOUN
dpc-2863	115	17	of	of	ADP
dpc-2863	115	18	the	the	DET
dpc-2863	115	19	upper	upper	ADJ
dpc-2863	115	20	dermis	dermis	NOUN
dpc-2863	115	21	under	under	ADP
dpc-2863	115	22	the	the	DET
dpc-2863	115	23	epidermis	epidermis	NOUN
dpc-2863	115	24	(	(	PUNCT
dpc-2863	115	25	pd	pd	NOUN
dpc-2863	115	26	-	-	NOUN
dpc-2863	115	27	l1	l1	PROPN
dpc-2863	115	28	,	,	PUNCT
dpc-2863	115	29	x400	x400	PROPN
dpc-2863	115	30	)	)	PUNCT
dpc-2863	115	31	.	.	PUNCT
dpc-2863	116	1	original	original	ADJ
dpc-2863	116	2	article	article	NOUN
dpc-2863	116	3	|	|	ADV
dpc-2863	116	4	dermatol	dermatol	ADJ
dpc-2863	116	5	pract	pract	NOUN
dpc-2863	116	6	concept	concept	NOUN
dpc-2863	116	7	.	.	PUNCT
dpc-2863	117	1	2023;13(2):e2023134	2023;13(2):e2023134	NUM
dpc-2863	117	2	5	5	NUM
dpc-2863	117	3	in	in	ADP
dpc-2863	117	4	our	our	PRON
dpc-2863	117	5	study	study	NOUN
dpc-2863	117	6	,	,	PUNCT
dpc-2863	117	7	we	we	PRON
dpc-2863	117	8	examined	examine	VERB
dpc-2863	117	9	pd-1	pd-1	ADP
dpc-2863	117	10	and	and	CCONJ
dpc-2863	117	11	pd	pd	PROPN
dpc-2863	117	12	-	-	PROPN
dpc-2863	117	13	l1	l1	PROPN
dpc-2863	117	14	expression	expression	NOUN
dpc-2863	117	15	in	in	ADP
dpc-2863	117	16	the	the	DET
dpc-2863	117	17	immune	immune	ADJ
dpc-2863	117	18	cells	cell	NOUN
dpc-2863	117	19	in	in	ADP
dpc-2863	117	20	the	the	DET
dpc-2863	117	21	epidermis	epidermis	NOUN
dpc-2863	117	22	and	and	CCONJ
dpc-2863	117	23	dermis	dermis	NOUN
dpc-2863	117	24	.	.	PUNCT
dpc-2863	118	1	there	there	PRON
dpc-2863	118	2	was	be	VERB
dpc-2863	118	3	no	no	DET
dpc-2863	118	4	pd	pd	NOUN
dpc-2863	118	5	-	-	PROPN
dpc-2863	118	6	l1	l1	PROPN
dpc-2863	118	7	and	and	CCONJ
dpc-2863	118	8	pd-1	pd-1	ADJ
dpc-2863	118	9	expression	expression	NOUN
dpc-2863	118	10	in	in	ADP
dpc-2863	118	11	the	the	DET
dpc-2863	118	12	keratinocytes	keratinocyte	NOUN
dpc-2863	118	13	in	in	ADP
dpc-2863	118	14	psoriatic	psoriatic	ADJ
dpc-2863	118	15	skin	skin	NOUN
dpc-2863	118	16	and	and	CCONJ
dpc-2863	118	17	healthy	healthy	ADJ
dpc-2863	118	18	controls	control	NOUN
dpc-2863	118	19	.	.	PUNCT
dpc-2863	119	1	in	in	ADP
dpc-2863	119	2	patient	patient	ADJ
dpc-2863	119	3	group	group	NOUN
dpc-2863	119	4	,	,	PUNCT
dpc-2863	119	5	we	we	PRON
dpc-2863	119	6	found	find	VERB
dpc-2863	119	7	the	the	DET
dpc-2863	119	8	pd-1	pd-1	ADJ
dpc-2863	119	9	and	and	CCONJ
dpc-2863	119	10	pd	pd	PROPN
dpc-2863	119	11	-	-	PROPN
dpc-2863	119	12	l1	l1	PROPN
dpc-2863	119	13	expression	expression	NOUN
dpc-2863	119	14	in	in	ADP
dpc-2863	119	15	the	the	DET
dpc-2863	119	16	immune	immune	ADJ
dpc-2863	119	17	cells	cell	NOUN
dpc-2863	119	18	in	in	ADP
dpc-2863	119	19	the	the	DET
dpc-2863	119	20	dermis	dermis	NOUN
dpc-2863	119	21	of	of	ADP
dpc-2863	119	22	psoriatic	psoriatic	ADJ
dpc-2863	119	23	skin	skin	NOUN
dpc-2863	119	24	to	to	PART
dpc-2863	119	25	be	be	AUX
dpc-2863	119	26	significantly	significantly	ADV
dpc-2863	119	27	higher	high	ADJ
dpc-2863	119	28	in	in	ADP
dpc-2863	119	29	comparison	comparison	NOUN
dpc-2863	119	30	to	to	ADP
dpc-2863	119	31	the	the	DET
dpc-2863	119	32	healthy	healthy	ADJ
dpc-2863	119	33	controls	control	NOUN
dpc-2863	119	34	.	.	PUNCT
dpc-2863	120	1	since	since	SCONJ
dpc-2863	120	2	pd-1	pd-1	ADV
dpc-2863	120	3	is	be	AUX
dpc-2863	120	4	an	an	DET
dpc-2863	120	5	inhibitor	inhibitor	NOUN
dpc-2863	120	6	co	co	NOUN
dpc-2863	120	7	-	-	NOUN
dpc-2863	120	8	receptor	receptor	NOUN
dpc-2863	120	9	in	in	ADP
dpc-2863	120	10	the	the	DET
dpc-2863	120	11	immune	immune	ADJ
dpc-2863	120	12	system	system	NOUN
dpc-2863	120	13	,	,	PUNCT
dpc-2863	120	14	it	it	PRON
dpc-2863	120	15	may	may	AUX
dpc-2863	120	16	seem	seem	VERB
dpc-2863	120	17	unreasonable	unreasonable	ADJ
dpc-2863	120	18	that	that	SCONJ
dpc-2863	120	19	its	its	PRON
dpc-2863	120	20	expression	expression	NOUN
dpc-2863	120	21	increases	increase	NOUN
dpc-2863	120	22	in	in	ADP
dpc-2863	120	23	autoimmune	autoimmune	ADJ
dpc-2863	120	24	diseases	disease	NOUN
dpc-2863	120	25	,	,	PUNCT
dpc-2863	120	26	whereas	whereas	SCONJ
dpc-2863	120	27	studies	study	NOUN
dpc-2863	120	28	in	in	ADP
dpc-2863	120	29	autoimmune	autoimmune	ADJ
dpc-2863	120	30	diseases	disease	NOUN
dpc-2863	120	31	including	include	VERB
dpc-2863	120	32	sle	sle	NOUN
dpc-2863	120	33	and	and	CCONJ
dpc-2863	120	34	rheumatoid	rheumatoid	VERB
dpc-2863	120	35	arthritis	arthritis	NOUN
dpc-2863	120	36	show	show	NOUN
dpc-2863	120	37	that	that	SCONJ
dpc-2863	120	38	the	the	DET
dpc-2863	120	39	pd-1	pd-1	NOUN
dpc-2863	120	40	/	/	SYM
dpc-2863	120	41	pd	pd	ADJ
dpc-2863	120	42	-	-	PUNCT
dpc-2863	120	43	l1	l1	PROPN
dpc-2863	120	44	pathway	pathway	NOUN
dpc-2863	120	45	is	be	AUX
dpc-2863	120	46	modulated	modulate	VERB
dpc-2863	120	47	under	under	ADP
dpc-2863	120	48	the	the	DET
dpc-2863	120	49	permanent	permanent	ADJ
dpc-2863	120	50	chronic	chronic	ADJ
dpc-2863	120	51	inflammation	inflammation	NOUN
dpc-2863	120	52	conditions	condition	NOUN
dpc-2863	120	53	[	[	X
dpc-2863	120	54	5	5	NUM
dpc-2863	120	55	]	]	PUNCT
dpc-2863	120	56	.	.	PUNCT
dpc-2863	121	1	it	it	PRON
dpc-2863	121	2	is	be	AUX
dpc-2863	121	3	reported	report	VERB
dpc-2863	121	4	that	that	SCONJ
dpc-2863	121	5	t	t	PROPN
dpc-2863	121	6	-	-	PUNCT
dpc-2863	121	7	cells	cell	NOUN
dpc-2863	121	8	express	express	VERB
dpc-2863	121	9	higher	high	ADJ
dpc-2863	121	10	amounts	amount	NOUN
dpc-2863	121	11	of	of	ADP
dpc-2863	121	12	pd-1	pd-1	ADV
dpc-2863	121	13	in	in	ADP
dpc-2863	121	14	autoimmune	autoimmune	ADJ
dpc-2863	121	15	diseases	disease	NOUN
dpc-2863	121	16	,	,	PUNCT
dpc-2863	121	17	neoplasms	neoplasm	NOUN
dpc-2863	121	18	and	and	CCONJ
dpc-2863	121	19	chronic	chronic	ADJ
dpc-2863	121	20	infections	infection	NOUN
dpc-2863	121	21	,	,	PUNCT
dpc-2863	121	22	limiting	limit	VERB
dpc-2863	121	23	the	the	DET
dpc-2863	121	24	protective	protective	ADJ
dpc-2863	121	25	immunity	immunity	NOUN
dpc-2863	121	26	.	.	PUNCT
dpc-2863	122	1	in	in	ADP
dpc-2863	122	2	addition	addition	NOUN
dpc-2863	122	3	,	,	PUNCT
dpc-2863	122	4	since	since	SCONJ
dpc-2863	122	5	pd-1	pd-1	ADV
dpc-2863	122	6	is	be	AUX
dpc-2863	122	7	also	also	ADV
dpc-2863	122	8	a	a	DET
dpc-2863	122	9	marker	marker	NOUN
dpc-2863	122	10	of	of	ADP
dpc-2863	122	11	the	the	DET
dpc-2863	122	12	t	t	NOUN
dpc-2863	122	13	-	-	PUNCT
dpc-2863	122	14	cell	cell	NOUN
dpc-2863	122	15	activation	activation	NOUN
dpc-2863	122	16	,	,	PUNCT
dpc-2863	122	17	it	it	PRON
dpc-2863	122	18	is	be	AUX
dpc-2863	122	19	not	not	PART
dpc-2863	122	20	surprising	surprising	ADJ
dpc-2863	122	21	to	to	PART
dpc-2863	122	22	see	see	VERB
dpc-2863	122	23	that	that	SCONJ
dpc-2863	122	24	it	it	PRON
dpc-2863	122	25	is	be	AUX
dpc-2863	122	26	increased	increase	VERB
dpc-2863	122	27	in	in	ADP
dpc-2863	122	28	psoriatic	psoriatic	ADJ
dpc-2863	122	29	lesions	lesion	NOUN
dpc-2863	122	30	[	[	X
dpc-2863	122	31	23	23	NUM
dpc-2863	122	32	]	]	PUNCT
dpc-2863	122	33	.	.	PUNCT
dpc-2863	123	1	in	in	ADP
dpc-2863	123	2	this	this	DET
dpc-2863	123	3	study	study	NOUN
dpc-2863	123	4	,	,	PUNCT
dpc-2863	123	5	we	we	PRON
dpc-2863	123	6	also	also	ADV
dpc-2863	123	7	evaluated	evaluate	VERB
dpc-2863	123	8	the	the	DET
dpc-2863	123	9	association	association	NOUN
dpc-2863	123	10	of	of	ADP
dpc-2863	123	11	clinical	clinical	ADJ
dpc-2863	123	12	features	feature	NOUN
dpc-2863	123	13	such	such	ADJ
dpc-2863	123	14	as	as	ADP
dpc-2863	123	15	disease	disease	NOUN
dpc-2863	123	16	duration	duration	NOUN
dpc-2863	123	17	and	and	CCONJ
dpc-2863	123	18	pasi	pasi	NOUN
dpc-2863	123	19	scores	score	NOUN
dpc-2863	123	20	of	of	ADP
dpc-2863	123	21	psoriasis	psoriasis	NOUN
dpc-2863	123	22	patients	patient	NOUN
dpc-2863	123	23	with	with	ADP
dpc-2863	123	24	pd-1	pd-1	ADP
dpc-2863	123	25	and	and	CCONJ
dpc-2863	123	26	pd	pd	PROPN
dpc-2863	123	27	-	-	PUNCT
dpc-2863	123	28	l1	l1	PROPN
dpc-2863	123	29	expressions	expression	NOUN
dpc-2863	123	30	.	.	PUNCT
dpc-2863	124	1	our	our	PRON
dpc-2863	124	2	results	result	NOUN
dpc-2863	124	3	showed	show	VERB
dpc-2863	124	4	a	a	DET
dpc-2863	124	5	significant	significant	ADJ
dpc-2863	124	6	negative	negative	ADJ
dpc-2863	124	7	correlation	correlation	NOUN
dpc-2863	124	8	between	between	ADP
dpc-2863	124	9	pdl-1	pdl-1	ADV
dpc-2863	124	10	(	(	PUNCT
dpc-2863	124	11	+	+	ADJ
dpc-2863	124	12	)	)	PUNCT
dpc-2863	124	13	immune	immune	ADJ
dpc-2863	124	14	cell	cell	NOUN
dpc-2863	124	15	counts	count	NOUN
dpc-2863	124	16	and	and	CCONJ
dpc-2863	124	17	pasi	pasi	NOUN
dpc-2863	124	18	.	.	PUNCT
dpc-2863	125	1	pdl-1	pdl-1	X
dpc-2863	125	2	(	(	PUNCT
dpc-2863	125	3	+	+	ADJ
dpc-2863	125	4	)	)	PUNCT
dpc-2863	125	5	immune	immune	ADJ
dpc-2863	125	6	cell	cell	NOUN
dpc-2863	125	7	counts	count	NOUN
dpc-2863	125	8	did	do	AUX
dpc-2863	125	9	not	not	PART
dpc-2863	125	10	correlate	correlate	VERB
dpc-2863	125	11	with	with	ADP
dpc-2863	125	12	disease	disease	NOUN
dpc-2863	125	13	duration	duration	NOUN
dpc-2863	125	14	.	.	PUNCT
dpc-2863	126	1	pd-1	pd-1	ADP
dpc-2863	126	2	(	(	PUNCT
dpc-2863	126	3	+	+	ADJ
dpc-2863	126	4	)	)	PUNCT
dpc-2863	126	5	immune	immune	ADJ
dpc-2863	126	6	cell	cell	NOUN
dpc-2863	126	7	counts	count	NOUN
dpc-2863	126	8	did	do	AUX
dpc-2863	126	9	not	not	PART
dpc-2863	126	10	correlate	correlate	VERB
dpc-2863	126	11	with	with	ADP
dpc-2863	126	12	pasi	pasi	NOUN
dpc-2863	126	13	or	or	CCONJ
dpc-2863	126	14	disease	disease	NOUN
dpc-2863	126	15	duration	duration	NOUN
dpc-2863	126	16	.	.	PUNCT
dpc-2863	127	1	few	few	ADJ
dpc-2863	127	2	studies	study	NOUN
dpc-2863	127	3	investigated	investigate	VERB
dpc-2863	127	4	the	the	DET
dpc-2863	127	5	association	association	NOUN
dpc-2863	127	6	of	of	ADP
dpc-2863	127	7	clinical	clinical	ADJ
dpc-2863	127	8	features	feature	NOUN
dpc-2863	127	9	with	with	ADP
dpc-2863	127	10	pd-1	pd-1	ADJ
dpc-2863	127	11	and	and	CCONJ
dpc-2863	127	12	pd	pd	PROPN
dpc-2863	127	13	-	-	PUNCT
dpc-2863	127	14	l1	l1	PROPN
dpc-2863	127	15	expressions	expression	NOUN
dpc-2863	127	16	.	.	PUNCT
dpc-2863	128	1	in	in	ADP
dpc-2863	128	2	the	the	DET
dpc-2863	128	3	study	study	NOUN
dpc-2863	128	4	by	by	ADP
dpc-2863	128	5	peled	pele	VERB
dpc-2863	128	6	et	et	PROPN
dpc-2863	128	7	al	al	PROPN
dpc-2863	128	8	,	,	PUNCT
dpc-2863	128	9	no	no	DET
dpc-2863	128	10	statistically	statistically	ADV
dpc-2863	128	11	significant	significant	ADJ
dpc-2863	128	12	correlation	correlation	NOUN
dpc-2863	128	13	was	be	AUX
dpc-2863	128	14	shown	show	VERB
dpc-2863	128	15	among	among	ADP
dpc-2863	128	16	the	the	DET
dpc-2863	128	17	percentage	percentage	NOUN
dpc-2863	128	18	of	of	ADP
dpc-2863	128	19	pd-1	pd-1	VERB
dpc-2863	128	20	expressing	express	VERB
dpc-2863	128	21	t	t	NOUN
dpc-2863	128	22	cells	cell	NOUN
dpc-2863	128	23	and	and	CCONJ
dpc-2863	128	24	pasi	pasi	VERB
dpc-2863	128	25	scores	score	NOUN
dpc-2863	128	26	of	of	ADP
dpc-2863	128	27	patients	patient	NOUN
dpc-2863	128	28	but	but	CCONJ
dpc-2863	128	29	the	the	DET
dpc-2863	128	30	percentage	percentage	NOUN
dpc-2863	128	31	of	of	ADP
dpc-2863	128	32	pd-1	pd-1	VERB
dpc-2863	128	33	expressing	express	VERB
dpc-2863	128	34	t	t	PROPN
dpc-2863	128	35	cells	cell	NOUN
dpc-2863	128	36	negatively	negatively	ADV
dpc-2863	128	37	correlated	correlate	VERB
dpc-2863	128	38	with	with	ADP
dpc-2863	128	39	psoriatic	psoriatic	ADJ
dpc-2863	128	40	arthritis	arthritis	NOUN
dpc-2863	128	41	articular	articular	ADJ
dpc-2863	128	42	disease	disease	NOUN
dpc-2863	128	43	activity	activity	NOUN
dpc-2863	128	44	[	[	X
dpc-2863	128	45	10	10	NUM
dpc-2863	128	46	]	]	PUNCT
dpc-2863	128	47	.	.	PUNCT
dpc-2863	129	1	jung	jung	PROPN
dpc-2863	129	2	et	et	PROPN
dpc-2863	129	3	al	al	PROPN
dpc-2863	129	4	showed	show	VERB
dpc-2863	129	5	that	that	SCONJ
dpc-2863	129	6	psoriasis	psoriasis	NOUN
dpc-2863	129	7	patients	patient	NOUN
dpc-2863	129	8	with	with	ADP
dpc-2863	129	9	high	high	ADJ
dpc-2863	129	10	epidermal	epidermal	ADJ
dpc-2863	129	11	pd-1	pd-1	NOUN
dpc-2863	129	12	expression	expression	NOUN
dpc-2863	129	13	had	have	VERB
dpc-2863	129	14	higher	high	ADJ
dpc-2863	129	15	pasi	pasi	NOUN
dpc-2863	129	16	scores	score	NOUN
dpc-2863	129	17	and	and	CCONJ
dpc-2863	129	18	longer	long	ADJ
dpc-2863	129	19	disease	disease	NOUN
dpc-2863	129	20	durations	duration	NOUN
dpc-2863	129	21	[	[	X
dpc-2863	129	22	20	20	NUM
dpc-2863	129	23	]	]	PUNCT
dpc-2863	129	24	.	.	PUNCT
dpc-2863	130	1	however	however	ADV
dpc-2863	130	2	,	,	PUNCT
dpc-2863	130	3	dermal	dermal	NOUN
dpc-2863	130	4	pd-1	pd-1	ADP
dpc-2863	130	5	expression	expression	NOUN
dpc-2863	130	6	and	and	CCONJ
dpc-2863	130	7	disease	disease	NOUN
dpc-2863	130	8	duration	duration	NOUN
dpc-2863	130	9	had	have	VERB
dpc-2863	130	10	an	an	DET
dpc-2863	130	11	opposite	opposite	ADJ
dpc-2863	130	12	relationship	relationship	NOUN
dpc-2863	130	13	.	.	PUNCT
dpc-2863	131	1	psoriasis	psoriasis	NOUN
dpc-2863	131	2	patients	patient	NOUN
dpc-2863	131	3	with	with	ADP
dpc-2863	131	4	lower	low	ADJ
dpc-2863	131	5	pd-1	pd-1	ADP
dpc-2863	131	6	expressions	expression	NOUN
dpc-2863	131	7	had	have	VERB
dpc-2863	131	8	longer	long	ADJ
dpc-2863	131	9	disease	disease	NOUN
dpc-2863	131	10	durations	duration	NOUN
dpc-2863	131	11	.	.	PUNCT
dpc-2863	132	1	dermal	dermal	NOUN
dpc-2863	132	2	pd-1	pd-1	ADP
dpc-2863	132	3	expression	expression	NOUN
dpc-2863	132	4	did	do	AUX
dpc-2863	132	5	not	not	PART
dpc-2863	132	6	correlate	correlate	VERB
dpc-2863	132	7	with	with	ADP
dpc-2863	132	8	pasi	pasi	NOUN
dpc-2863	132	9	.	.	PUNCT
dpc-2863	133	1	these	these	DET
dpc-2863	133	2	differences	difference	NOUN
dpc-2863	133	3	between	between	ADP
dpc-2863	133	4	the	the	DET
dpc-2863	133	5	results	result	NOUN
dpc-2863	133	6	of	of	ADP
dpc-2863	133	7	the	the	DET
dpc-2863	133	8	studies	study	NOUN
dpc-2863	133	9	may	may	AUX
dpc-2863	133	10	be	be	AUX
dpc-2863	133	11	due	due	ADJ
dpc-2863	133	12	to	to	ADP
dpc-2863	133	13	the	the	DET
dpc-2863	133	14	small	small	ADJ
dpc-2863	133	15	number	number	NOUN
dpc-2863	133	16	of	of	ADP
dpc-2863	133	17	patients	patient	NOUN
dpc-2863	133	18	included	include	VERB
dpc-2863	133	19	in	in	ADP
dpc-2863	133	20	the	the	DET
dpc-2863	133	21	studies	study	NOUN
dpc-2863	133	22	,	,	PUNCT
dpc-2863	133	23	the	the	DET
dpc-2863	133	24	fact	fact	NOUN
dpc-2863	133	25	that	that	SCONJ
dpc-2863	133	26	the	the	DET
dpc-2863	133	27	presence	presence	NOUN
dpc-2863	133	28	of	of	ADP
dpc-2863	133	29	psoriatic	psoriatic	ADJ
dpc-2863	133	30	arthritis	arthritis	NOUN
dpc-2863	133	31	was	be	AUX
dpc-2863	133	32	not	not	PART
dpc-2863	133	33	considered	consider	VERB
dpc-2863	133	34	in	in	ADP
dpc-2863	133	35	every	every	DET
dpc-2863	133	36	study	study	NOUN
dpc-2863	133	37	,	,	PUNCT
dpc-2863	133	38	different	different	ADJ
dpc-2863	133	39	sides	side	NOUN
dpc-2863	133	40	of	of	ADP
dpc-2863	133	41	the	the	DET
dpc-2863	133	42	pd-1	pd-1	ADJ
dpc-2863	133	43	and	and	CCONJ
dpc-2863	133	44	pdl-1	pdl-1	ADV
dpc-2863	133	45	positivity	positivity	NOUN
dpc-2863	133	46	(	(	PUNCT
dpc-2863	133	47	epidermal	epidermal	ADJ
dpc-2863	133	48	or	or	CCONJ
dpc-2863	133	49	dermal	dermal	ADJ
dpc-2863	133	50	area	area	NOUN
dpc-2863	133	51	)	)	PUNCT
dpc-2863	133	52	,	,	PUNCT
dpc-2863	133	53	and	and	CCONJ
dpc-2863	133	54	the	the	DET
dpc-2863	133	55	low	low	ADJ
dpc-2863	133	56	pasi	pasi	NOUN
dpc-2863	133	57	scores	score	NOUN
dpc-2863	133	58	of	of	ADP
dpc-2863	133	59	the	the	DET
dpc-2863	133	60	patients	patient	NOUN
dpc-2863	133	61	included	include	VERB
dpc-2863	133	62	in	in	ADP
dpc-2863	133	63	the	the	DET
dpc-2863	133	64	studies	study	NOUN
dpc-2863	133	65	.	.	PUNCT
dpc-2863	134	1	this	this	DET
dpc-2863	134	2	study	study	NOUN
dpc-2863	134	3	showed	show	VERB
dpc-2863	134	4	that	that	SCONJ
dpc-2863	134	5	,	,	PUNCT
dpc-2863	134	6	the	the	DET
dpc-2863	134	7	pd-1	pd-1	ADJ
dpc-2863	134	8	and	and	CCONJ
dpc-2863	134	9	pd	pd	PROPN
dpc-2863	134	10	-	-	PUNCT
dpc-2863	134	11	l1	l1	PROPN
dpc-2863	134	12	expressions	expression	NOUN
dpc-2863	134	13	in	in	ADP
dpc-2863	134	14	immune	immune	ADJ
dpc-2863	134	15	cells	cell	NOUN
dpc-2863	134	16	in	in	ADP
dpc-2863	134	17	the	the	DET
dpc-2863	134	18	lesioned	lesione	VERB
dpc-2863	134	19	skin	skin	NOUN
dpc-2863	134	20	samples	sample	NOUN
dpc-2863	134	21	of	of	ADP
dpc-2863	134	22	psoriasis	psoriasis	NOUN
dpc-2863	134	23	patients	patient	NOUN
dpc-2863	134	24	are	be	AUX
dpc-2863	134	25	significantly	significantly	ADV
dpc-2863	134	26	higher	high	ADJ
dpc-2863	134	27	than	than	ADP
dpc-2863	134	28	that	that	PRON
dpc-2863	134	29	in	in	ADP
dpc-2863	134	30	the	the	DET
dpc-2863	134	31	skin	skin	NOUN
dpc-2863	134	32	samples	sample	NOUN
dpc-2863	134	33	of	of	ADP
dpc-2863	134	34	healthy	healthy	ADJ
dpc-2863	134	35	controls	control	NOUN
dpc-2863	134	36	.	.	PUNCT
dpc-2863	135	1	previous	previous	ADJ
dpc-2863	135	2	studies	study	NOUN
dpc-2863	135	3	and	and	CCONJ
dpc-2863	135	4	our	our	PRON
dpc-2863	135	5	study	study	NOUN
dpc-2863	135	6	are	be	AUX
dpc-2863	135	7	preliminary	preliminary	ADJ
dpc-2863	135	8	studies	study	NOUN
dpc-2863	135	9	with	with	ADP
dpc-2863	135	10	small	small	ADJ
dpc-2863	135	11	numbers	number	NOUN
dpc-2863	135	12	of	of	ADP
dpc-2863	135	13	patients	patient	NOUN
dpc-2863	135	14	with	with	ADP
dpc-2863	135	15	psoriasis	psoriasis	NOUN
dpc-2863	135	16	.	.	PUNCT
dpc-2863	136	1	to	to	ADP
dpc-2863	136	2	the	the	DET
dpc-2863	136	3	best	good	ADJ
dpc-2863	136	4	of	of	ADP
dpc-2863	136	5	our	our	PRON
dpc-2863	136	6	knowledge	knowledge	NOUN
dpc-2863	136	7	,	,	PUNCT
dpc-2863	136	8	the	the	DET
dpc-2863	136	9	present	present	ADJ
dpc-2863	136	10	study	study	NOUN
dpc-2863	136	11	is	be	AUX
dpc-2863	136	12	one	one	NUM
dpc-2863	136	13	the	the	DET
dpc-2863	136	14	first	first	ADJ
dpc-2863	136	15	investigations	investigation	NOUN
dpc-2863	136	16	of	of	ADP
dpc-2863	136	17	the	the	DET
dpc-2863	136	18	expression	expression	NOUN
dpc-2863	136	19	of	of	ADP
dpc-2863	136	20	pd-1	pd-1	NOUN
dpc-2863	136	21	/	/	SYM
dpc-2863	136	22	pd	pd	ADJ
dpc-2863	136	23	-	-	ADJ
dpc-2863	136	24	l	l	NOUN
dpc-2863	136	25	molecules	molecule	NOUN
dpc-2863	136	26	in	in	ADP
dpc-2863	136	27	the	the	DET
dpc-2863	136	28	immune	immune	ADJ
dpc-2863	136	29	cells	cell	NOUN
dpc-2863	136	30	in	in	ADP
dpc-2863	136	31	the	the	DET
dpc-2863	136	32	lesioned	lesione	VERB
dpc-2863	136	33	skins	skin	NOUN
dpc-2863	136	34	of	of	ADP
dpc-2863	136	35	psoriasis	psoriasis	NOUN
dpc-2863	136	36	patients	patient	NOUN
dpc-2863	136	37	.	.	PUNCT
dpc-2863	137	1	the	the	DET
dpc-2863	137	2	role	role	NOUN
dpc-2863	137	3	that	that	PRON
dpc-2863	137	4	the	the	DET
dpc-2863	137	5	degradation	degradation	NOUN
dpc-2863	137	6	of	of	ADP
dpc-2863	137	7	the	the	DET
dpc-2863	137	8	pd-1	pd-1	NOUN
dpc-2863	137	9	/	/	SYM
dpc-2863	137	10	pd	pd	ADJ
dpc-2863	137	11	-	-	PUNCT
dpc-2863	137	12	l1	l1	PROPN
dpc-2863	137	13	axis	axis	NOUN
dpc-2863	137	14	plays	play	VERB
dpc-2863	137	15	in	in	ADP
dpc-2863	137	16	psoriatic	psoriatic	ADJ
dpc-2863	137	17	patients	patient	NOUN
dpc-2863	137	18	is	be	AUX
dpc-2863	137	19	backed	back	VERB
dpc-2863	137	20	by	by	ADP
dpc-2863	137	21	evidence	evidence	NOUN
dpc-2863	137	22	.	.	PUNCT
dpc-2863	138	1	however	however	ADV
dpc-2863	138	2	,	,	PUNCT
dpc-2863	138	3	there	there	PRON
dpc-2863	138	4	is	be	VERB
dpc-2863	138	5	a	a	DET
dpc-2863	138	6	few	few	ADJ
dpc-2863	138	7	studies	study	NOUN
dpc-2863	138	8	have	have	AUX
dpc-2863	138	9	been	be	AUX
dpc-2863	138	10	conducted	conduct	VERB
dpc-2863	138	11	to	to	PART
dpc-2863	138	12	investigate	investigate	VERB
dpc-2863	138	13	pd-1	pd-1	ADP
dpc-2863	138	14	and	and	CCONJ
dpc-2863	138	15	pd	pd	PROPN
dpc-2863	138	16	-	-	PROPN
dpc-2863	138	17	l1	l1	PROPN
dpc-2863	138	18	expression	expression	NOUN
dpc-2863	138	19	in	in	ADP
dpc-2863	138	20	the	the	DET
dpc-2863	138	21	t	t	NOUN
dpc-2863	138	22	lymphocytes	lymphocyte	VERB
dpc-2863	138	23	in	in	ADP
dpc-2863	138	24	the	the	DET
dpc-2863	138	25	peripheral	peripheral	ADJ
dpc-2863	138	26	blood	blood	NOUN
dpc-2863	138	27	of	of	ADP
dpc-2863	138	28	psoriasis	psoriasis	NOUN
dpc-2863	138	29	patients	patient	NOUN
dpc-2863	138	30	.	.	PUNCT
dpc-2863	139	1	bartosinska	bartosinska	PROPN
dpc-2863	139	2	et	et	PROPN
dpc-2863	139	3	al	al	PROPN
dpc-2863	139	4	examined	examine	VERB
dpc-2863	139	5	the	the	DET
dpc-2863	139	6	pd-1	pd-1	ADJ
dpc-2863	139	7	expressions	expression	NOUN
dpc-2863	139	8	in	in	ADP
dpc-2863	139	9	the	the	DET
dpc-2863	139	10	cd4	cd4	PROPN
dpc-2863	139	11	+	+	PROPN
dpc-2863	139	12	and	and	CCONJ
dpc-2863	139	13	cd8	cd8	PROPN
dpc-2863	139	14	+	+	PROPN
dpc-2863	139	15	t	t	PROPN
dpc-2863	139	16	-	-	PUNCT
dpc-2863	139	17	cells	cell	NOUN
dpc-2863	139	18	in	in	ADP
dpc-2863	139	19	the	the	DET
dpc-2863	139	20	peripheral	peripheral	ADJ
dpc-2863	139	21	blood	blood	NOUN
dpc-2863	139	22	samples	sample	NOUN
dpc-2863	139	23	of	of	ADP
dpc-2863	139	24	the	the	DET
dpc-2863	139	25	patients	patient	NOUN
dpc-2863	139	26	with	with	ADP
dpc-2863	139	27	psoriasis	psoriasis	NOUN
dpc-2863	139	28	and	and	CCONJ
dpc-2863	139	29	psoriatic	psoriatic	ADJ
dpc-2863	139	30	arthritis	arthritis	NOUN
dpc-2863	139	31	[	[	X
dpc-2863	139	32	18	18	NUM
dpc-2863	139	33	]	]	PUNCT
dpc-2863	139	34	.	.	PUNCT
dpc-2863	140	1	they	they	PRON
dpc-2863	140	2	concluded	conclude	VERB
dpc-2863	140	3	that	that	SCONJ
dpc-2863	140	4	the	the	DET
dpc-2863	140	5	pd-1	pd-1	ADJ
dpc-2863	140	6	expression	expression	NOUN
dpc-2863	140	7	in	in	ADP
dpc-2863	140	8	the	the	DET
dpc-2863	140	9	cd4	cd4	PROPN
dpc-2863	140	10	+	+	PROPN
dpc-2863	140	11	and	and	CCONJ
dpc-2863	140	12	cd8	cd8	PROPN
dpc-2863	140	13	+	+	PROPN
dpc-2863	140	14	t	t	PROPN
dpc-2863	140	15	lymphocytes	lymphocyte	NOUN
dpc-2863	140	16	of	of	ADP
dpc-2863	140	17	the	the	DET
dpc-2863	140	18	patient	patient	NOUN
dpc-2863	140	19	group	group	NOUN
dpc-2863	140	20	was	be	AUX
dpc-2863	140	21	significantly	significantly	ADV
dpc-2863	140	22	lower	low	ADJ
dpc-2863	140	23	than	than	ADP
dpc-2863	140	24	the	the	DET
dpc-2863	140	25	controls	control	NOUN
dpc-2863	140	26	.	.	PUNCT
dpc-2863	141	1	the	the	DET
dpc-2863	141	2	authors	author	NOUN
dpc-2863	141	3	argued	argue	VERB
dpc-2863	141	4	that	that	SCONJ
dpc-2863	141	5	reduced	reduce	VERB
dpc-2863	141	6	pd-1	pd-1	ADP
dpc-2863	141	7	expression	expression	NOUN
dpc-2863	141	8	may	may	AUX
dpc-2863	141	9	be	be	AUX
dpc-2863	141	10	responsible	responsible	ADJ
dpc-2863	141	11	for	for	ADP
dpc-2863	141	12	immune	immune	ADJ
dpc-2863	141	13	dysregulation	dysregulation	NOUN
dpc-2863	141	14	in	in	ADP
dpc-2863	141	15	the	the	DET
dpc-2863	141	16	pathogenesis	pathogenesis	NOUN
dpc-2863	141	17	of	of	ADP
dpc-2863	141	18	psoriasis	psoriasis	NOUN
dpc-2863	141	19	.	.	PUNCT
dpc-2863	142	1	in	in	ADP
dpc-2863	142	2	a	a	DET
dpc-2863	142	3	later	later	ADJ
dpc-2863	142	4	study	study	NOUN
dpc-2863	142	5	of	of	ADP
dpc-2863	142	6	theirs	theirs	PROPN
dpc-2863	142	7	,	,	PUNCT
dpc-2863	142	8	bartosinska	bartosinska	PROPN
dpc-2863	142	9	et	et	PROPN
dpc-2863	142	10	al	al	PROPN
dpc-2863	142	11	reported	report	VERB
dpc-2863	142	12	that	that	SCONJ
dpc-2863	142	13	there	there	PRON
dpc-2863	142	14	was	be	VERB
dpc-2863	142	15	no	no	DET
dpc-2863	142	16	difference	difference	NOUN
dpc-2863	142	17	between	between	ADP
dpc-2863	142	18	psoriatic	psoriatic	ADJ
dpc-2863	142	19	patients	patient	NOUN
dpc-2863	142	20	with	with	ADP
dpc-2863	142	21	and	and	CCONJ
dpc-2863	142	22	without	without	ADP
dpc-2863	142	23	psoa	psoa	PROPN
dpc-2863	142	24	in	in	ADP
dpc-2863	142	25	terms	term	NOUN
dpc-2863	142	26	of	of	ADP
dpc-2863	142	27	cd4	cd4	PROPN
dpc-2863	142	28	+	+	PROPN
dpc-2863	142	29	and	and	CCONJ
dpc-2863	142	30	cd8	cd8	PROPN
dpc-2863	142	31	+	+	PROPN
dpc-2863	142	32	t	t	PROPN
dpc-2863	142	33	lymphocytes	lymphocyte	VERB
dpc-2863	142	34	pd-1	pd-1	ADV
dpc-2863	142	35	in	in	ADP
dpc-2863	142	36	peripheral	peripheral	ADJ
dpc-2863	142	37	blood	blood	NOUN
dpc-2863	142	38	,	,	PUNCT
dpc-2863	142	39	and	and	CCONJ
dpc-2863	142	40	both	both	DET
dpc-2863	142	41	groups	group	NOUN
dpc-2863	142	42	had	have	VERB
dpc-2863	142	43	lower	low	ADJ
dpc-2863	142	44	cd4	cd4	PROPN
dpc-2863	142	45	+	+	PROPN
dpc-2863	142	46	and	and	CCONJ
dpc-2863	142	47	cd8	cd8	PROPN
dpc-2863	142	48	+	+	PROPN
dpc-2863	142	49	pd-1	pd-1	ADJ
dpc-2863	142	50	levels	level	NOUN
dpc-2863	142	51	than	than	ADP
dpc-2863	142	52	the	the	DET
dpc-2863	142	53	healthy	healthy	ADJ
dpc-2863	142	54	controls	control	NOUN
dpc-2863	142	55	[	[	X
dpc-2863	142	56	19	19	NUM
dpc-2863	142	57	]	]	PUNCT
dpc-2863	142	58	.	.	PUNCT
dpc-2863	143	1	the	the	DET
dpc-2863	143	2	authors	author	NOUN
dpc-2863	143	3	stated	state	VERB
dpc-2863	143	4	that	that	SCONJ
dpc-2863	143	5	,	,	PUNCT
dpc-2863	143	6	regardless	regardless	ADV
dpc-2863	143	7	of	of	ADP
dpc-2863	143	8	the	the	DET
dpc-2863	143	9	clinical	clinical	ADJ
dpc-2863	143	10	type	type	NOUN
dpc-2863	143	11	,	,	PUNCT
dpc-2863	143	12	mutual	mutual	ADJ
dpc-2863	143	13	inflammatory	inflammatory	ADJ
dpc-2863	143	14	pathways	pathway	NOUN
dpc-2863	143	15	and	and	CCONJ
dpc-2863	143	16	mediators	mediator	NOUN
dpc-2863	143	17	play	play	VERB
dpc-2863	143	18	a	a	DET
dpc-2863	143	19	role	role	NOUN
dpc-2863	143	20	in	in	ADP
dpc-2863	143	21	psoriasis	psoriasis	NOUN
dpc-2863	143	22	.	.	PUNCT
dpc-2863	144	1	in	in	ADP
dpc-2863	144	2	contrast	contrast	NOUN
dpc-2863	144	3	,	,	PUNCT
dpc-2863	144	4	peled	pele	VERB
dpc-2863	144	5	et	et	PROPN
dpc-2863	144	6	al	al	PROPN
dpc-2863	144	7	reported	report	VERB
dpc-2863	144	8	that	that	SCONJ
dpc-2863	144	9	the	the	DET
dpc-2863	144	10	pd-1	pd-1	ADJ
dpc-2863	144	11	expression	expression	NOUN
dpc-2863	144	12	in	in	ADP
dpc-2863	144	13	the	the	DET
dpc-2863	144	14	t	t	NOUN
dpc-2863	144	15	lymphocytes	lymphocyte	VERB
dpc-2863	144	16	in	in	ADP
dpc-2863	144	17	the	the	DET
dpc-2863	144	18	peripheral	peripheral	ADJ
dpc-2863	144	19	blood	blood	NOUN
dpc-2863	144	20	of	of	ADP
dpc-2863	144	21	psoriatic	psoriatic	ADJ
dpc-2863	144	22	arthritis	arthritis	NOUN
dpc-2863	144	23	patients	patient	NOUN
dpc-2863	144	24	was	be	AUX
dpc-2863	144	25	significantly	significantly	ADV
dpc-2863	144	26	higher	high	ADJ
dpc-2863	144	27	than	than	ADP
dpc-2863	144	28	the	the	DET
dpc-2863	144	29	healthy	healthy	ADJ
dpc-2863	144	30	controls	control	NOUN
dpc-2863	144	31	[	[	X
dpc-2863	144	32	10	10	NUM
dpc-2863	144	33	]	]	PUNCT
dpc-2863	144	34	.	.	PUNCT
dpc-2863	145	1	they	they	PRON
dpc-2863	145	2	showed	show	VERB
dpc-2863	145	3	that	that	SCONJ
dpc-2863	145	4	this	this	PRON
dpc-2863	145	5	was	be	AUX
dpc-2863	145	6	correlated	correlate	VERB
dpc-2863	145	7	with	with	ADP
dpc-2863	145	8	the	the	DET
dpc-2863	145	9	activity	activity	NOUN
dpc-2863	145	10	of	of	ADP
dpc-2863	145	11	arthritis	arthritis	NOUN
dpc-2863	145	12	.	.	PUNCT
dpc-2863	146	1	the	the	DET
dpc-2863	146	2	authors	author	NOUN
dpc-2863	146	3	argued	argue	VERB
dpc-2863	146	4	that	that	SCONJ
dpc-2863	146	5	pd-1	pd-1	ADV
dpc-2863	146	6	could	could	AUX
dpc-2863	146	7	be	be	AUX
dpc-2863	146	8	a	a	DET
dpc-2863	146	9	marker	marker	NOUN
dpc-2863	146	10	that	that	PRON
dpc-2863	146	11	shows	show	VERB
dpc-2863	146	12	psoriatic	psoriatic	ADJ
dpc-2863	146	13	arthritis	arthritis	NOUN
dpc-2863	146	14	activity	activity	NOUN
dpc-2863	146	15	.	.	PUNCT
dpc-2863	147	1	bommarito	bommarito	NOUN
dpc-2863	147	2	et	et	PROPN
dpc-2863	147	3	al	al	PROPN
dpc-2863	147	4	showed	show	VERB
dpc-2863	147	5	that	that	SCONJ
dpc-2863	147	6	rheumatoid	rheumatoid	VERB
dpc-2863	147	7	arthritis	arthritis	NOUN
dpc-2863	147	8	(	(	PUNCT
dpc-2863	147	9	ra	ra	NOUN
dpc-2863	147	10	)	)	PUNCT
dpc-2863	147	11	and	and	CCONJ
dpc-2863	147	12	psoriatic	psoriatic	ADJ
dpc-2863	147	13	arthritis	arthritis	NOUN
dpc-2863	147	14	(	(	PUNCT
dpc-2863	147	15	psoa	psoa	NOUN
dpc-2863	147	16	)	)	PUNCT
dpc-2863	147	17	patients	patient	NOUN
dpc-2863	147	18	had	have	VERB
dpc-2863	147	19	an	an	DET
dpc-2863	147	20	increased	increase	VERB
dpc-2863	147	21	expression	expression	NOUN
dpc-2863	147	22	of	of	ADP
dpc-2863	147	23	pd1	pd1	NOUN
dpc-2863	147	24	on	on	ADP
dpc-2863	147	25	their	their	PRON
dpc-2863	147	26	cd4	cd4	PROPN
dpc-2863	147	27	+	+	PROPN
dpc-2863	147	28	and	and	CCONJ
dpc-2863	147	29	cd8	cd8	PROPN
dpc-2863	147	30	+	+	PROPN
dpc-2863	147	31	t	t	NOUN
dpc-2863	147	32	cells	cell	NOUN
dpc-2863	147	33	in	in	ADP
dpc-2863	147	34	their	their	PRON
dpc-2863	147	35	peripheral	peripheral	ADJ
dpc-2863	147	36	blood	blood	NOUN
dpc-2863	147	37	and	and	CCONJ
dpc-2863	147	38	sinovial	sinovial	ADJ
dpc-2863	147	39	fluids	fluid	NOUN
dpc-2863	147	40	[	[	X
dpc-2863	147	41	20	20	NUM
dpc-2863	147	42	]	]	PUNCT
dpc-2863	147	43	.	.	PUNCT
dpc-2863	148	1	the	the	DET
dpc-2863	148	2	authors	author	NOUN
dpc-2863	148	3	showed	show	VERB
dpc-2863	148	4	that	that	SCONJ
dpc-2863	148	5	il-1β	il-1β	PROPN
dpc-2863	148	6	,	,	PUNCT
dpc-2863	148	7	il-6	il-6	NOUN
dpc-2863	148	8	,	,	PUNCT
dpc-2863	148	9	and	and	CCONJ
dpc-2863	148	10	tnf	tnf	PROPN
dpc-2863	148	11	-	-	PUNCT
dpc-2863	148	12	α	α	NOUN
dpc-2863	148	13	raised	raise	VERB
dpc-2863	148	14	the	the	DET
dpc-2863	148	15	soluble	soluble	ADJ
dpc-2863	148	16	pd-1	pd-1	ADP
dpc-2863	148	17	levels	level	NOUN
dpc-2863	148	18	,	,	PUNCT
dpc-2863	148	19	and	and	CCONJ
dpc-2863	148	20	that	that	SCONJ
dpc-2863	148	21	increased	increase	VERB
dpc-2863	148	22	expression	expression	NOUN
dpc-2863	148	23	of	of	ADP
dpc-2863	148	24	soluble	soluble	NOUN
dpc-2863	148	25	pd-1	pd-1	VERB
dpc-2863	148	26	interfered	interfere	VERB
dpc-2863	148	27	with	with	ADP
dpc-2863	148	28	the	the	DET
dpc-2863	148	29	pd-1	pd-1	NOUN
dpc-2863	148	30	/	/	SYM
dpc-2863	148	31	pd	pd	ADJ
dpc-2863	148	32	-	-	PROPN
dpc-2863	148	33	l1	l1	PROPN
dpc-2863	148	34	pathway	pathway	NOUN
dpc-2863	148	35	.	.	PUNCT
dpc-2863	149	1	few	few	ADJ
dpc-2863	149	2	studies	study	NOUN
dpc-2863	149	3	investigate	investigate	VERB
dpc-2863	149	4	the	the	DET
dpc-2863	149	5	pd-1	pd-1	ADJ
dpc-2863	149	6	and	and	CCONJ
dpc-2863	149	7	pd	pd	PROPN
dpc-2863	149	8	-	-	PROPN
dpc-2863	149	9	l1	l1	PROPN
dpc-2863	149	10	expression	expression	NOUN
dpc-2863	149	11	in	in	ADP
dpc-2863	149	12	the	the	DET
dpc-2863	149	13	lesional	lesional	ADJ
dpc-2863	149	14	skins	skin	NOUN
dpc-2863	149	15	of	of	ADP
dpc-2863	149	16	psoriatic	psoriatic	ADJ
dpc-2863	149	17	patients	patient	NOUN
dpc-2863	149	18	and	and	CCONJ
dpc-2863	149	19	reported	report	VERB
dpc-2863	149	20	variable	variable	ADJ
dpc-2863	149	21	results	result	NOUN
dpc-2863	149	22	.	.	PUNCT
dpc-2863	150	1	kim	kim	PROPN
dpc-2863	150	2	et	et	PROPN
dpc-2863	150	3	al	al	PROPN
dpc-2863	150	4	showed	show	VERB
dpc-2863	150	5	that	that	SCONJ
dpc-2863	150	6	the	the	DET
dpc-2863	150	7	pd	pd	PROPN
dpc-2863	150	8	-	-	PUNCT
dpc-2863	150	9	l1	l1	PROPN
dpc-2863	150	10	expression	expression	NOUN
dpc-2863	150	11	in	in	ADP
dpc-2863	150	12	keratinocytes	keratinocyte	NOUN
dpc-2863	150	13	in	in	ADP
dpc-2863	150	14	psoriatic	psoriatic	ADJ
dpc-2863	150	15	epidermis	epidermis	NOUN
dpc-2863	150	16	was	be	AUX
dpc-2863	150	17	significantly	significantly	ADV
dpc-2863	150	18	reduced	reduce	VERB
dpc-2863	150	19	compared	compare	VERB
dpc-2863	150	20	to	to	ADP
dpc-2863	150	21	normal	normal	ADJ
dpc-2863	150	22	skin	skin	NOUN
dpc-2863	150	23	,	,	PUNCT
dpc-2863	150	24	pityriasis	pityriasis	NOUN
dpc-2863	150	25	rosea	rosea	NOUN
dpc-2863	150	26	,	,	PUNCT
dpc-2863	150	27	liken	liken	VERB
dpc-2863	150	28	planus	planus	ADJ
dpc-2863	150	29	and	and	CCONJ
dpc-2863	150	30	allergic	allergic	ADJ
dpc-2863	150	31	contact	contact	NOUN
dpc-2863	150	32	dermatitis	dermatitis	NOUN
dpc-2863	150	33	epidermis	epidermis	NOUN
dpc-2863	150	34	samples	sample	NOUN
dpc-2863	150	35	[	[	X
dpc-2863	150	36	21	21	NUM
dpc-2863	150	37	]	]	PUNCT
dpc-2863	150	38	.	.	PUNCT
dpc-2863	151	1	the	the	DET
dpc-2863	151	2	authors	author	NOUN
dpc-2863	151	3	suggested	suggest	VERB
dpc-2863	151	4	that	that	SCONJ
dpc-2863	151	5	t	t	PROPN
dpc-2863	151	6	cell	cell	NOUN
dpc-2863	151	7	activation	activation	NOUN
dpc-2863	151	8	was	be	AUX
dpc-2863	151	9	not	not	PART
dpc-2863	151	10	suppressed	suppress	VERB
dpc-2863	151	11	due	due	ADP
dpc-2863	151	12	to	to	ADP
dpc-2863	151	13	the	the	DET
dpc-2863	151	14	reduced	reduce	VERB
dpc-2863	151	15	pd	pd	PROPN
dpc-2863	151	16	-	-	PROPN
dpc-2863	151	17	l1	l1	PROPN
dpc-2863	151	18	and	and	CCONJ
dpc-2863	151	19	2	2	NUM
dpc-2863	151	20	in	in	ADP
dpc-2863	151	21	psoriasis	psoriasis	NOUN
dpc-2863	151	22	.	.	PUNCT
dpc-2863	152	1	on	on	ADP
dpc-2863	152	2	the	the	DET
dpc-2863	152	3	other	other	ADJ
dpc-2863	152	4	hand	hand	NOUN
dpc-2863	152	5	,	,	PUNCT
dpc-2863	152	6	jung	jung	PROPN
dpc-2863	152	7	et	et	PROPN
dpc-2863	152	8	al	al	PROPN
dpc-2863	152	9	.	.	PUNCT
dpc-2863	153	1	[	[	X
dpc-2863	153	2	20	20	NUM
dpc-2863	153	3	]	]	PUNCT
dpc-2863	153	4	reported	report	VERB
dpc-2863	153	5	that	that	SCONJ
dpc-2863	153	6	among	among	ADP
dpc-2863	153	7	the	the	DET
dpc-2863	153	8	chronic	chronic	ADJ
dpc-2863	153	9	plaque	plaque	NOUN
dpc-2863	153	10	-	-	PUNCT
dpc-2863	153	11	type	type	NOUN
dpc-2863	153	12	psoriatic	psoriatic	ADJ
dpc-2863	153	13	patients	patient	NOUN
dpc-2863	153	14	,	,	PUNCT
dpc-2863	153	15	the	the	DET
dpc-2863	153	16	group	group	NOUN
dpc-2863	153	17	with	with	ADP
dpc-2863	153	18	a	a	DET
dpc-2863	153	19	higher	high	ADJ
dpc-2863	153	20	pd-1	pd-1	ADJ
dpc-2863	153	21	in	in	ADP
dpc-2863	153	22	epidermis	epidermis	NOUN
dpc-2863	153	23	had	have	VERB
dpc-2863	153	24	a	a	DET
dpc-2863	153	25	higher	high	ADJ
dpc-2863	153	26	pasi	pasi	NOUN
dpc-2863	153	27	score	score	NOUN
dpc-2863	153	28	and	and	CCONJ
dpc-2863	153	29	more	more	ADV
dpc-2863	153	30	typical	typical	ADJ
dpc-2863	153	31	histopathological	histopathological	ADJ
dpc-2863	153	32	changes	change	NOUN
dpc-2863	153	33	than	than	ADP
dpc-2863	153	34	the	the	DET
dpc-2863	153	35	lower	low	ADJ
dpc-2863	153	36	pd-1	pd-1	ADJ
dpc-2863	153	37	expression	expression	NOUN
dpc-2863	153	38	group	group	NOUN
dpc-2863	153	39	.	.	PUNCT
dpc-2863	154	1	authors	author	NOUN
dpc-2863	154	2	suggested	suggest	VERB
dpc-2863	154	3	that	that	SCONJ
dpc-2863	154	4	epidermal	epidermal	ADJ
dpc-2863	154	5	pd-1	pd-1	ADJ
dpc-2863	154	6	upregulation	upregulation	NOUN
dpc-2863	154	7	in	in	ADP
dpc-2863	154	8	chronic	chronic	ADJ
dpc-2863	154	9	plaque	plaque	NOUN
dpc-2863	154	10	psoriasis	psoriasis	NOUN
dpc-2863	154	11	is	be	AUX
dpc-2863	154	12	correlated	correlate	VERB
dpc-2863	154	13	with	with	ADP
dpc-2863	154	14	a	a	DET
dpc-2863	154	15	more	more	ADV
dpc-2863	154	16	chronic	chronic	ADJ
dpc-2863	154	17	and	and	CCONJ
dpc-2863	154	18	severe	severe	ADJ
dpc-2863	154	19	disease	disease	NOUN
dpc-2863	154	20	.	.	PUNCT
dpc-2863	155	1	they	they	PRON
dpc-2863	155	2	showed	show	VERB
dpc-2863	155	3	that	that	SCONJ
dpc-2863	155	4	guttate	guttate	VERB
dpc-2863	155	5	psoriatic	psoriatic	ADJ
dpc-2863	155	6	patients	patient	NOUN
dpc-2863	155	7	with	with	ADP
dpc-2863	155	8	a	a	DET
dpc-2863	155	9	longer	long	ADJ
dpc-2863	155	10	disease	disease	NOUN
dpc-2863	155	11	duration	duration	NOUN
dpc-2863	155	12	had	have	VERB
dpc-2863	155	13	a	a	DET
dpc-2863	155	14	lower	low	ADJ
dpc-2863	155	15	dermal	dermal	NOUN
dpc-2863	155	16	pd-1	pd-1	ADP
dpc-2863	155	17	expression	expression	NOUN
dpc-2863	155	18	than	than	ADP
dpc-2863	155	19	those	those	PRON
dpc-2863	155	20	with	with	ADP
dpc-2863	155	21	a	a	DET
dpc-2863	155	22	shorter	short	ADJ
dpc-2863	155	23	disease	disease	NOUN
dpc-2863	155	24	duration	duration	NOUN
dpc-2863	155	25	,	,	PUNCT
dpc-2863	155	26	and	and	CCONJ
dpc-2863	155	27	downregulated	downregulate	VERB
dpc-2863	155	28	dermal	dermal	NOUN
dpc-2863	155	29	pd-1	pd-1	ADP
dpc-2863	155	30	expression	expression	NOUN
dpc-2863	155	31	is	be	AUX
dpc-2863	155	32	correlated	correlate	VERB
dpc-2863	155	33	with	with	ADP
dpc-2863	155	34	a	a	DET
dpc-2863	155	35	poorer	poor	ADJ
dpc-2863	155	36	prognosis	prognosis	NOUN
dpc-2863	155	37	in	in	ADP
dpc-2863	155	38	guttate	guttate	NOUN
dpc-2863	155	39	psoriasis	psoriasis	NOUN
dpc-2863	155	40	.	.	PUNCT
dpc-2863	156	1	çetinözman	çetinözman	ADJ
dpc-2863	156	2	,	,	PUNCT
dpc-2863	156	3	et	et	PROPN
dpc-2863	156	4	al	al	PROPN
dpc-2863	156	5	also	also	ADV
dpc-2863	156	6	found	find	VERB
dpc-2863	156	7	increased	increased	ADJ
dpc-2863	156	8	levels	level	NOUN
dpc-2863	156	9	of	of	ADP
dpc-2863	156	10	pd-1	pd-1	VERB
dpc-2863	156	11	in	in	ADP
dpc-2863	156	12	the	the	DET
dpc-2863	156	13	cd8	cd8	PROPN
dpc-2863	156	14	+	+	PROPN
dpc-2863	156	15	t	t	PROPN
dpc-2863	156	16	-	-	PUNCT
dpc-2863	156	17	cells	cell	NOUN
dpc-2863	156	18	in	in	ADP
dpc-2863	156	19	the	the	DET
dpc-2863	156	20	epidermis	epidermis	NOUN
dpc-2863	156	21	and	and	CCONJ
dpc-2863	156	22	dermis	dermis	NOUN
dpc-2863	156	23	of	of	ADP
dpc-2863	156	24	the	the	DET
dpc-2863	156	25	skin	skin	NOUN
dpc-2863	156	26	biopsies	biopsy	NOUN
dpc-2863	156	27	taken	take	VERB
dpc-2863	156	28	from	from	ADP
dpc-2863	156	29	the	the	DET
dpc-2863	156	30	lesions	lesion	NOUN
dpc-2863	156	31	of	of	ADP
dpc-2863	156	32	6	6	NUM
dpc-2863	156	33	patients	patient	NOUN
dpc-2863	156	34	with	with	ADP
dpc-2863	156	35	psoriatic	psoriatic	ADJ
dpc-2863	156	36	erythroderma	erythroderma	NOUN
dpc-2863	156	37	[	[	X
dpc-2863	156	38	22	22	NUM
dpc-2863	156	39	]	]	PUNCT
dpc-2863	156	40	.	.	PUNCT
dpc-2863	157	1	6	6	NUM
dpc-2863	157	2	original	original	ADJ
dpc-2863	157	3	article	article	NOUN
dpc-2863	157	4	|	|	ADV
dpc-2863	157	5	dermatol	dermatol	ADJ
dpc-2863	157	6	pract	pract	NOUN
dpc-2863	157	7	concept	concept	NOUN
dpc-2863	157	8	.	.	PUNCT
dpc-2863	158	1	2023;13(2):e2023134	2023;13(2):e2023134	NUM
dpc-2863	158	2	11	11	NUM
dpc-2863	158	3	.	.	PUNCT
dpc-2863	159	1	fujiwara	fujiwara	PROPN
dpc-2863	159	2	h	h	PROPN
dpc-2863	159	3	,	,	PUNCT
dpc-2863	159	4	maeda	maeda	PROPN
dpc-2863	159	5	y	y	PROPN
dpc-2863	159	6	,	,	PUNCT
dpc-2863	159	7	kobayashi	kobayashi	PROPN
dpc-2863	159	8	k	k	PROPN
dpc-2863	159	9	,	,	PUNCT
dpc-2863	159	10	et	et	PROPN
dpc-2863	159	11	al	al	PROPN
dpc-2863	159	12	.	.	PROPN
dpc-2863	159	13	programmed	program	VERB
dpc-2863	159	14	death-1	death-1	NUM
dpc-2863	159	15	pathway	pathway	NOUN
dpc-2863	159	16	in	in	ADP
dpc-2863	159	17	host	host	NOUN
dpc-2863	159	18	tissues	tissue	NOUN
dpc-2863	159	19	ameliorates	ameliorate	VERB
dpc-2863	159	20	th17	th17	NOUN
dpc-2863	159	21	/	/	SYM
dpc-2863	159	22	th1	th1	NOUN
dpc-2863	159	23	-	-	PUNCT
dpc-2863	159	24	mediated	mediate	VERB
dpc-2863	159	25	experimental	experimental	ADJ
dpc-2863	159	26	chronic	chronic	ADJ
dpc-2863	159	27	graft	graft	NOUN
dpc-2863	159	28	-	-	PUNCT
dpc-2863	159	29	versus	versus	ADP
dpc-2863	159	30	-	-	PUNCT
dpc-2863	159	31	host	host	NOUN
dpc-2863	159	32	disease	disease	NOUN
dpc-2863	159	33	.	.	PUNCT
dpc-2863	160	1	j	j	PROPN
dpc-2863	160	2	immunol	immunol	NOUN
dpc-2863	160	3	.	.	PUNCT
dpc-2863	161	1	2014;193(5):2565	2014;193(5):2565	NUM
dpc-2863	161	2	-	-	SYM
dpc-2863	161	3	2573	2573	NUM
dpc-2863	161	4	.	.	PUNCT
dpc-2863	162	1	doi	doi	NOUN
dpc-2863	162	2	:	:	PUNCT
dpc-2863	162	3	10.4049	10.4049	NUM
dpc-2863	162	4	/	/	SYM
dpc-2863	162	5	jimmunol.1400954	jimmunol.1400954	PROPN
dpc-2863	162	6	.	.	PUNCT
dpc-2863	162	7	pmid	pmid	NOUN
dpc-2863	162	8	:	:	PUNCT
dpc-2863	162	9	25080485	25080485	NUM
dpc-2863	162	10	.	.	PUNCT
dpc-2863	163	1	12	12	NUM
dpc-2863	163	2	.	.	PUNCT
dpc-2863	164	1	hwang	hwang	PROPN
dpc-2863	164	2	sje	sje	PROPN
dpc-2863	164	3	,	,	PUNCT
dpc-2863	164	4	carlos	carlos	PROPN
dpc-2863	164	5	g	g	PROPN
dpc-2863	164	6	,	,	PUNCT
dpc-2863	164	7	wakade	wakade	NOUN
dpc-2863	164	8	d	d	NOUN
dpc-2863	164	9	,	,	PUNCT
dpc-2863	164	10	et	et	PROPN
dpc-2863	164	11	al	al	PROPN
dpc-2863	164	12	.	.	PUNCT
dpc-2863	165	1	cutaneous	cutaneous	ADJ
dpc-2863	165	2	adverse	adverse	ADJ
dpc-2863	165	3	events	event	NOUN
dpc-2863	165	4	(	(	PUNCT
dpc-2863	165	5	aes	aes	NOUN
dpc-2863	165	6	)	)	PUNCT
dpc-2863	165	7	of	of	ADP
dpc-2863	165	8	anti	anti	ADJ
dpc-2863	165	9	-	-	ADJ
dpc-2863	165	10	programmed	programmed	ADJ
dpc-2863	165	11	cell	cell	NOUN
dpc-2863	165	12	death	death	NOUN
dpc-2863	165	13	(	(	PUNCT
dpc-2863	165	14	pd)-1	pd)-1	NOUN
dpc-2863	165	15	therapy	therapy	NOUN
dpc-2863	165	16	in	in	ADP
dpc-2863	165	17	patients	patient	NOUN
dpc-2863	165	18	with	with	ADP
dpc-2863	165	19	metastatic	metastatic	ADJ
dpc-2863	165	20	melanoma	melanoma	NOUN
dpc-2863	165	21	:	:	PUNCT
dpc-2863	165	22	a	a	DET
dpc-2863	165	23	single	single	ADJ
dpc-2863	165	24	-	-	PUNCT
dpc-2863	165	25	institution	institution	NOUN
dpc-2863	165	26	cohort	cohort	NOUN
dpc-2863	165	27	.	.	PUNCT
dpc-2863	166	1	j	j	PROPN
dpc-2863	166	2	am	be	AUX
dpc-2863	166	3	acad	acad	ADJ
dpc-2863	166	4	dermatol	dermatol	NOUN
dpc-2863	166	5	.	.	PUNCT
dpc-2863	167	1	2016;74(3):455	2016;74(3):455	NUM
dpc-2863	167	2	-	-	PUNCT
dpc-2863	167	3	461.e1	461.e1	PROPN
dpc-2863	167	4	.	.	PUNCT
dpc-2863	168	1	doi	doi	NOUN
dpc-2863	168	2	:	:	PUNCT
dpc-2863	168	3	10.1016	10.1016	NUM
dpc-2863	168	4	/	/	SYM
dpc-2863	168	5	j.	j.	PROPN
dpc-2863	168	6	jaad.2015.10.029	jaad.2015.10.029	PROPN
dpc-2863	168	7	.	.	PUNCT
dpc-2863	169	1	pmid	pmid	PROPN
dpc-2863	169	2	:	:	PUNCT
dpc-2863	169	3	26793994	26793994	NUM
dpc-2863	169	4	.	.	PUNCT
dpc-2863	170	1	13	13	NUM
dpc-2863	170	2	.	.	PUNCT
dpc-2863	170	3	sibaud	sibaud	NOUN
dpc-2863	170	4	v.	v.	ADP
dpc-2863	170	5	dermatologic	dermatologic	ADJ
dpc-2863	170	6	reactions	reaction	NOUN
dpc-2863	170	7	to	to	ADP
dpc-2863	170	8	immune	immune	ADJ
dpc-2863	170	9	checkpoint	checkpoint	NOUN
dpc-2863	170	10	inhibitors	inhibitor	NOUN
dpc-2863	170	11	:	:	PUNCT
dpc-2863	170	12	skin	skin	NOUN
dpc-2863	170	13	toxicities	toxicity	NOUN
dpc-2863	170	14	and	and	CCONJ
dpc-2863	170	15	immunotherapy	immunotherapy	NOUN
dpc-2863	170	16	.	.	PUNCT
dpc-2863	171	1	am	be	AUX
dpc-2863	171	2	j	j	PROPN
dpc-2863	171	3	clin	clin	PROPN
dpc-2863	171	4	dermatol	dermatol	NOUN
dpc-2863	171	5	.	.	PUNCT
dpc-2863	172	1	2018;19(3):345	2018;19(3):345	NUM
dpc-2863	172	2	-	-	SYM
dpc-2863	172	3	361	361	NUM
dpc-2863	172	4	.	.	PUNCT
dpc-2863	173	1	doi	doi	NOUN
dpc-2863	173	2	:	:	PUNCT
dpc-2863	173	3	10.1007	10.1007	NUM
dpc-2863	173	4	/	/	SYM
dpc-2863	173	5	s40257	s40257	NOUN
dpc-2863	173	6	-	-	PUNCT
dpc-2863	173	7	017	017	NUM
dpc-2863	173	8	-	-	PUNCT
dpc-2863	173	9	0336	0336	NUM
dpc-2863	173	10	-	-	PUNCT
dpc-2863	173	11	3	3	NUM
dpc-2863	173	12	.	.	PUNCT
dpc-2863	174	1	pmid	pmid	NOUN
dpc-2863	174	2	:	:	PUNCT
dpc-2863	174	3	29256113	29256113	NUM
dpc-2863	174	4	.	.	PUNCT
dpc-2863	175	1	14	14	NUM
dpc-2863	175	2	.	.	PUNCT
dpc-2863	175	3	voudouri	voudouri	PROPN
dpc-2863	175	4	d	d	PROPN
dpc-2863	175	5	,	,	PUNCT
dpc-2863	175	6	nikolaou	nikolaou	NOUN
dpc-2863	175	7	v	v	PROPN
dpc-2863	175	8	,	,	PUNCT
dpc-2863	175	9	laschos	laschos	PROPN
dpc-2863	175	10	k	k	PROPN
dpc-2863	175	11	,	,	PUNCT
dpc-2863	175	12	et	et	PROPN
dpc-2863	175	13	al	al	PROPN
dpc-2863	175	14	.	.	PUNCT
dpc-2863	175	15	anti	anti	ADJ
dpc-2863	175	16	-	-	ADJ
dpc-2863	175	17	pd1	pd1	VERB
dpc-2863	175	18	/	/	SYM
dpc-2863	175	19	pdl1	pdl1	NOUN
dpc-2863	175	20	induced	induce	VERB
dpc-2863	175	21	psoriasis	psoriasis	NOUN
dpc-2863	175	22	.	.	PUNCT
dpc-2863	176	1	curr	curr	PROPN
dpc-2863	176	2	probl	probl	PROPN
dpc-2863	176	3	cancer	cancer	NOUN
dpc-2863	176	4	.	.	PUNCT
dpc-2863	177	1	2017;41(6):407	2017;41(6):407	NUM
dpc-2863	177	2	-	-	SYM
dpc-2863	177	3	412	412	NUM
dpc-2863	177	4	.	.	PUNCT
dpc-2863	178	1	doi	doi	NOUN
dpc-2863	178	2	:	:	PUNCT
dpc-2863	178	3	10.1016	10.1016	NUM
dpc-2863	178	4	/	/	SYM
dpc-2863	178	5	j.currproblcancer.2017.10.003	j.currproblcancer.2017.10.003	PROPN
dpc-2863	178	6	.	.	PUNCT
dpc-2863	179	1	pmid	pmid	NOUN
dpc-2863	179	2	:	:	PUNCT
dpc-2863	179	3	29096940	29096940	NUM
dpc-2863	179	4	.	.	PUNCT
dpc-2863	180	1	15	15	NUM
dpc-2863	180	2	.	.	PUNCT
dpc-2863	181	1	kato	kato	PROPN
dpc-2863	181	2	y	y	PROPN
dpc-2863	181	3	,	,	PUNCT
dpc-2863	181	4	otsuka	otsuka	PROPN
dpc-2863	181	5	a	a	X
dpc-2863	181	6	,	,	PUNCT
dpc-2863	181	7	miyachi	miyachi	PROPN
dpc-2863	181	8	y	y	PROPN
dpc-2863	181	9	,	,	PUNCT
dpc-2863	181	10	kabashima	kabashima	PROPN
dpc-2863	181	11	k.	k.	PROPN
dpc-2863	181	12	exacerbation	exacerbation	NOUN
dpc-2863	181	13	of	of	ADP
dpc-2863	181	14	psoriasis	psoriasis	NOUN
dpc-2863	181	15	vulgaris	vulgaris	NOUN
dpc-2863	181	16	during	during	ADP
dpc-2863	181	17	nivolumab	nivolumab	NOUN
dpc-2863	181	18	for	for	ADP
dpc-2863	181	19	oral	oral	ADJ
dpc-2863	181	20	mucosal	mucosal	ADJ
dpc-2863	181	21	melanoma	melanoma	NOUN
dpc-2863	181	22	.	.	PUNCT
dpc-2863	182	1	j	j	PROPN
dpc-2863	182	2	eur	eur	PROPN
dpc-2863	182	3	acad	acad	PROPN
dpc-2863	182	4	dermatol	dermatol	NOUN
dpc-2863	182	5	venereol	venereol	NOUN
dpc-2863	182	6	.	.	PUNCT
dpc-2863	183	1	2016;30(10):e89	2016;30(10):e89	NOUN
dpc-2863	183	2	-	-	PUNCT
dpc-2863	183	3	e91	e91	NOUN
dpc-2863	183	4	.	.	PUNCT
dpc-2863	183	5	doi	doi	PROPN
dpc-2863	183	6	:	:	PUNCT
dpc-2863	183	7	10.1111	10.1111	NUM
dpc-2863	183	8	/	/	SYM
dpc-2863	183	9	jdv.13336	jdv.13336	NOUN
dpc-2863	183	10	.	.	PUNCT
dpc-2863	184	1	pmid	pmid	NOUN
dpc-2863	184	2	:	:	PUNCT
dpc-2863	184	3	26388113	26388113	NUM
dpc-2863	184	4	.	.	PUNCT
dpc-2863	185	1	16	16	NUM
dpc-2863	185	2	.	.	X
dpc-2863	185	3	elousa	elousa	PROPN
dpc-2863	185	4	-	-	PUNCT
dpc-2863	185	5	gonzalez	gonzalez	PROPN
dpc-2863	185	6	m	m	PROPN
dpc-2863	185	7	,	,	PUNCT
dpc-2863	185	8	pampin	pampin	NOUN
dpc-2863	185	9	-	-	PUNCT
dpc-2863	185	10	franco	franco	PROPN
dpc-2863	185	11	a	a	DET
dpc-2863	185	12	,	,	PUNCT
dpc-2863	185	13	mazzuchelli	mazzuchelli	NOUN
dpc-2863	185	14	-	-	PUNCT
dpc-2863	185	15	esteban	esteban	NOUN
dpc-2863	185	16	r	r	NOUN
dpc-2863	185	17	,	,	PUNCT
dpc-2863	185	18	et	et	PROPN
dpc-2863	185	19	al	al	PROPN
dpc-2863	185	20	.	.	PUNCT
dpc-2863	186	1	a	a	DET
dpc-2863	186	2	case	case	NOUN
dpc-2863	186	3	of	of	ADP
dpc-2863	186	4	de	de	X
dpc-2863	186	5	novo	novo	NOUN
dpc-2863	186	6	palmoplantar	palmoplantar	NOUN
dpc-2863	186	7	psoriasis	psoriasis	NOUN
dpc-2863	186	8	with	with	ADP
dpc-2863	186	9	psoriatic	psoriatic	ADJ
dpc-2863	186	10	arthritis	arthritis	NOUN
dpc-2863	186	11	and	and	CCONJ
dpc-2863	186	12	autoimmune	autoimmune	ADJ
dpc-2863	186	13	hypothyroidism	hypothyroidism	NOUN
dpc-2863	186	14	after	after	ADP
dpc-2863	186	15	receiving	receive	VERB
dpc-2863	186	16	nivolumab	nivolumab	NOUN
dpc-2863	186	17	therapy	therapy	NOUN
dpc-2863	186	18	.	.	PUNCT
dpc-2863	187	1	dermatol	dermatol	NOUN
dpc-2863	187	2	online	online	PROPN
dpc-2863	187	3	j.	j.	PROPN
dpc-2863	187	4	2017;23(8):13030	2017;23(8):13030	PROPN
dpc-2863	187	5	/	/	SYM
dpc-2863	187	6	qt12n4m6pm	qt12n4m6pm	PROPN
dpc-2863	187	7	.	.	PUNCT
dpc-2863	188	1	pmid	pmid	NOUN
dpc-2863	188	2	:	:	PUNCT
dpc-2863	188	3	29469753	29469753	NUM
dpc-2863	188	4	.	.	PUNCT
dpc-2863	189	1	17	17	NUM
dpc-2863	189	2	.	.	PUNCT
dpc-2863	190	1	ellis	ellis	PROPN
dpc-2863	190	2	s	s	PROPN
dpc-2863	190	3	,	,	PUNCT
dpc-2863	190	4	vierra	vierra	PROPN
dpc-2863	190	5	at	at	ADP
dpc-2863	190	6	,	,	PUNCT
dpc-2863	190	7	millsop	millsop	PROPN
dpc-2863	190	8	jw	jw	PROPN
dpc-2863	190	9	,	,	PUNCT
dpc-2863	190	10	lacouture	lacouture	VERB
dpc-2863	190	11	me	i	PRON
dpc-2863	190	12	,	,	PUNCT
dpc-2863	190	13	kiuru	kiuru	NOUN
dpc-2863	190	14	m.	m.	NOUN
dpc-2863	190	15	dermatologic	dermatologic	ADJ
dpc-2863	190	16	toxicities	toxicity	NOUN
dpc-2863	190	17	to	to	ADP
dpc-2863	190	18	immune	immune	ADJ
dpc-2863	190	19	checkpoint	checkpoint	NOUN
dpc-2863	190	20	inhibitor	inhibitor	NOUN
dpc-2863	190	21	therapy	therapy	NOUN
dpc-2863	190	22	:	:	PUNCT
dpc-2863	190	23	a	a	DET
dpc-2863	190	24	review	review	NOUN
dpc-2863	190	25	of	of	ADP
dpc-2863	190	26	histopathologic	histopathologic	NOUN
dpc-2863	190	27	features	feature	NOUN
dpc-2863	190	28	.	.	PUNCT
dpc-2863	191	1	j	j	PROPN
dpc-2863	191	2	am	be	AUX
dpc-2863	191	3	acad	acad	ADJ
dpc-2863	191	4	dermatol	dermatol	NOUN
dpc-2863	191	5	.	.	PUNCT
dpc-2863	192	1	2020;83(4):1130	2020;83(4):1130	NUM
dpc-2863	192	2	-	-	PUNCT
dpc-2863	192	3	1143	1143	NUM
dpc-2863	192	4	.	.	PUNCT
dpc-2863	193	1	doi	doi	NOUN
dpc-2863	193	2	:	:	PUNCT
dpc-2863	193	3	10.1016	10.1016	NUM
dpc-2863	193	4	/	/	SYM
dpc-2863	193	5	j.jaad.2020.04.105	j.jaad.2020.04.105	PROPN
dpc-2863	193	6	.	.	PUNCT
dpc-2863	194	1	pmid	pmid	NOUN
dpc-2863	194	2	:	:	PUNCT
dpc-2863	194	3	32360716	32360716	NUM
dpc-2863	194	4	.	.	PUNCT
dpc-2863	195	1	pmcid	pmcid	ADJ
dpc-2863	195	2	:	:	PUNCT
dpc-2863	195	3	pmc7492441	pmc7492441	NOUN
dpc-2863	195	4	.	.	PUNCT
dpc-2863	196	1	18	18	NUM
dpc-2863	196	2	.	.	PUNCT
dpc-2863	196	3	bartosinska	bartosinska	PROPN
dpc-2863	196	4	j	j	PROPN
dpc-2863	196	5	,	,	PUNCT
dpc-2863	196	6	zakrzewska	zakrzewska	PROPN
dpc-2863	196	7	e	e	PROPN
dpc-2863	196	8	,	,	PUNCT
dpc-2863	196	9	raczkiewicz	raczkiewicz	VERB
dpc-2863	196	10	d	d	PROPN
dpc-2863	196	11	,	,	PUNCT
dpc-2863	196	12	et	et	PROPN
dpc-2863	196	13	al	al	PROPN
dpc-2863	196	14	.	.	PROPN
dpc-2863	196	15	suppressed	suppress	VERB
dpc-2863	196	16	programmed	program	VERB
dpc-2863	196	17	death	death	NOUN
dpc-2863	196	18	1	1	NUM
dpc-2863	196	19	expression	expression	NOUN
dpc-2863	196	20	on	on	ADP
dpc-2863	196	21	cd4	cd4	PROPN
dpc-2863	196	22	+	+	PROPN
dpc-2863	196	23	and	and	CCONJ
dpc-2863	196	24	cd8	cd8	PROPN
dpc-2863	196	25	+	+	PROPN
dpc-2863	196	26	t	t	PROPN
dpc-2863	196	27	cells	cell	NOUN
dpc-2863	196	28	in	in	ADP
dpc-2863	196	29	psoriatic	psoriatic	ADJ
dpc-2863	196	30	patients	patient	NOUN
dpc-2863	196	31	.	.	PUNCT
dpc-2863	197	1	mediators	mediator	NOUN
dpc-2863	197	2	inflamm	inflamm	NOUN
dpc-2863	197	3	.	.	PUNCT
dpc-2863	198	1	2017;2017:5385102	2017;2017:5385102	NUM
dpc-2863	198	2	.	.	PUNCT
dpc-2863	199	1	doi	doi	NOUN
dpc-2863	199	2	:	:	PUNCT
dpc-2863	199	3	10.1155/2017/5385102	10.1155/2017/5385102	NUM
dpc-2863	199	4	.	.	PUNCT
dpc-2863	200	1	pmid	pmid	NOUN
dpc-2863	200	2	:	:	PUNCT
dpc-2863	200	3	29180838	29180838	NUM
dpc-2863	200	4	.	.	PUNCT
dpc-2863	201	1	pmcid	pmcid	NOUN
dpc-2863	201	2	:	:	PUNCT
dpc-2863	201	3	pmc5664337	pmc5664337	PROPN
dpc-2863	201	4	.	.	PUNCT
dpc-2863	202	1	19	19	NUM
dpc-2863	202	2	.	.	PUNCT
dpc-2863	202	3	bartosinska	bartosinska	PROPN
dpc-2863	202	4	j	j	PROPN
dpc-2863	202	5	,	,	PUNCT
dpc-2863	202	6	zakrzewska	zakrzewska	PROPN
dpc-2863	202	7	e	e	PROPN
dpc-2863	202	8	,	,	PUNCT
dpc-2863	202	9	purkot	purkot	PROPN
dpc-2863	202	10	j	j	PROPN
dpc-2863	202	11	,	,	PUNCT
dpc-2863	202	12	et	et	PROPN
dpc-2863	202	13	al	al	PROPN
dpc-2863	202	14	.	.	PROPN
dpc-2863	202	15	decreased	decrease	VERB
dpc-2863	202	16	blood	blood	NOUN
dpc-2863	202	17	cd4+pd-1	cd4+pd-1	ADJ
dpc-2863	202	18	+	+	CCONJ
dpc-2863	202	19	and	and	CCONJ
dpc-2863	202	20	cd8+pd-1	cd8+pd-1	PROPN
dpc-2863	202	21	+	+	PROPN
dpc-2863	202	22	t	t	NOUN
dpc-2863	202	23	cells	cell	NOUN
dpc-2863	202	24	in	in	ADP
dpc-2863	202	25	psoriatic	psoriatic	ADJ
dpc-2863	202	26	patients	patient	NOUN
dpc-2863	202	27	with	with	ADP
dpc-2863	202	28	and	and	CCONJ
dpc-2863	202	29	without	without	ADP
dpc-2863	202	30	arthritis	arthritis	NOUN
dpc-2863	202	31	.	.	PUNCT
dpc-2863	203	1	postepy	postepy	ADJ
dpc-2863	203	2	dermatol	dermatol	NOUN
dpc-2863	203	3	alergol	alergol	NOUN
dpc-2863	203	4	.	.	PUNCT
dpc-2863	204	1	2018;35(4):344	2018;35(4):344	NUM
dpc-2863	204	2	-	-	PUNCT
dpc-2863	204	3	350	350	NUM
dpc-2863	204	4	.	.	PUNCT
dpc-2863	205	1	doi	doi	NOUN
dpc-2863	205	2	:	:	PUNCT
dpc-2863	205	3	10.5114	10.5114	NUM
dpc-2863	205	4	/	/	SYM
dpc-2863	205	5	ada.2018.75609	ada.2018.75609	NOUN
dpc-2863	205	6	.	.	PUNCT
dpc-2863	206	1	pmid	pmid	NOUN
dpc-2863	206	2	:	:	PUNCT
dpc-2863	206	3	30206445	30206445	NUM
dpc-2863	206	4	.	.	PUNCT
dpc-2863	207	1	pmcid	pmcid	NOUN
dpc-2863	207	2	:	:	PUNCT
dpc-2863	207	3	pmc6130132	pmc6130132	PROPN
dpc-2863	207	4	.	.	PUNCT
dpc-2863	208	1	20	20	NUM
dpc-2863	208	2	.	.	PUNCT
dpc-2863	208	3	jung	jung	PROPN
dpc-2863	208	4	cj	cj	PROPN
dpc-2863	208	5	,	,	PUNCT
dpc-2863	208	6	yang	yang	PROPN
dpc-2863	208	7	hj	hj	PROPN
dpc-2863	208	8	,	,	PUNCT
dpc-2863	208	9	bang	bang	PROPN
dpc-2863	208	10	sh	sh	PROPN
dpc-2863	208	11	,	,	PUNCT
dpc-2863	209	1	et	et	PROPN
dpc-2863	209	2	al	al	PROPN
dpc-2863	209	3	.	.	PROPN
dpc-2863	209	4	clinicoprognostic	clinicoprognostic	PROPN
dpc-2863	209	5	and	and	CCONJ
dpc-2863	209	6	histopathological	histopathological	ADJ
dpc-2863	209	7	features	feature	NOUN
dpc-2863	209	8	of	of	ADP
dpc-2863	209	9	guttate	guttate	NOUN
dpc-2863	209	10	and	and	CCONJ
dpc-2863	209	11	plaque	plaque	NOUN
dpc-2863	209	12	psoriasis	psoriasis	NOUN
dpc-2863	209	13	based	base	VERB
dpc-2863	209	14	on	on	ADP
dpc-2863	209	15	pd-1	pd-1	ADP
dpc-2863	209	16	j	j	PROPN
dpc-2863	209	17	clin	clin	PROPN
dpc-2863	209	18	med	med	PROPN
dpc-2863	209	19	.	.	PUNCT
dpc-2863	210	1	2021;10(21):5200	2021;10(21):5200	NUM
dpc-2863	210	2	.	.	X
dpc-2863	210	3	doi	doi	NOUN
dpc-2863	210	4	:	:	PUNCT
dpc-2863	210	5	10.3390/	10.3390/	NUM
dpc-2863	210	6	jcm10215200	jcm10215200	X
dpc-2863	210	7	.	.	PUNCT
dpc-2863	211	1	pmid	pmid	NOUN
dpc-2863	211	2	:	:	PUNCT
dpc-2863	211	3	34768720	34768720	NUM
dpc-2863	211	4	.	.	PUNCT
dpc-2863	212	1	pmcid	pmcid	NOUN
dpc-2863	212	2	:	:	PUNCT
dpc-2863	212	3	pmc8584888	pmc8584888	NOUN
dpc-2863	212	4	.	.	PUNCT
dpc-2863	213	1	21	21	NUM
dpc-2863	213	2	.	.	X
dpc-2863	214	1	kim	kim	PROPN
dpc-2863	214	2	ds	ds	PROPN
dpc-2863	214	3	,	,	PUNCT
dpc-2863	214	4	je	je	PROPN
dpc-2863	214	5	jh	jh	PROPN
dpc-2863	214	6	,	,	PUNCT
dpc-2863	214	7	kim	kim	PROPN
dpc-2863	214	8	sh	sh	PROPN
dpc-2863	214	9	,	,	PUNCT
dpc-2863	214	10	et	et	PROPN
dpc-2863	214	11	al	al	PROPN
dpc-2863	214	12	.	.	PROPN
dpc-2863	214	13	programmed	program	VERB
dpc-2863	214	14	death	death	NOUN
dpc-2863	214	15	-	-	PUNCT
dpc-2863	214	16	ligand	ligand	NOUN
dpc-2863	214	17	1	1	NUM
dpc-2863	214	18	,	,	PUNCT
dpc-2863	214	19	2	2	NUM
dpc-2863	214	20	expressions	expression	NOUN
dpc-2863	214	21	are	be	AUX
dpc-2863	214	22	decreased	decrease	VERB
dpc-2863	214	23	in	in	ADP
dpc-2863	214	24	the	the	DET
dpc-2863	214	25	psoriatic	psoriatic	ADJ
dpc-2863	214	26	epidermis	epidermis	NOUN
dpc-2863	214	27	.	.	PUNCT
dpc-2863	215	1	arch	arch	ADJ
dpc-2863	215	2	dermatol	dermatol	NOUN
dpc-2863	215	3	res	re	NOUN
dpc-2863	215	4	.	.	PUNCT
dpc-2863	216	1	2015	2015	NUM
dpc-2863	216	2	aug;307(6):531	aug;307(6):531	NOUN
dpc-2863	216	3	-	-	SYM
dpc-2863	216	4	8	8	NUM
dpc-2863	216	5	.	.	PUNCT
dpc-2863	217	1	doi	doi	NOUN
dpc-2863	217	2	:	:	PUNCT
dpc-2863	217	3	10.1007	10.1007	NUM
dpc-2863	217	4	/	/	SYM
dpc-2863	217	5	s00403	s00403	NOUN
dpc-2863	217	6	-	-	PUNCT
dpc-2863	217	7	0151588	0151588	NUM
dpc-2863	217	8	-	-	SYM
dpc-2863	217	9	5	5	NUM
dpc-2863	217	10	.	.	PUNCT
dpc-2863	218	1	epub	epub	NOUN
dpc-2863	218	2	2015	2015	NUM
dpc-2863	218	3	jul	jul	PROPN
dpc-2863	218	4	2	2	NUM
dpc-2863	218	5	.	.	PUNCT
dpc-2863	219	1	pmid	pmid	NOUN
dpc-2863	219	2	:	:	PUNCT
dpc-2863	219	3	26133691	26133691	NUM
dpc-2863	219	4	.	.	PUNCT
dpc-2863	220	1	22	22	NUM
dpc-2863	220	2	.	.	PUNCT
dpc-2863	221	1	çetinözman	çetinözman	PROPN
dpc-2863	221	2	f	f	PROPN
dpc-2863	221	3	,	,	PUNCT
dpc-2863	221	4	jansen	jansen	PROPN
dpc-2863	221	5	pm	pm	PROPN
dpc-2863	221	6	,	,	PUNCT
dpc-2863	221	7	willemze	willemze	ADJ
dpc-2863	221	8	r.	r.	NOUN
dpc-2863	221	9	expression	expression	NOUN
dpc-2863	221	10	of	of	ADP
dpc-2863	221	11	programmed	program	VERB
dpc-2863	221	12	death-1	death-1	NUM
dpc-2863	221	13	skin	skin	NOUN
dpc-2863	221	14	biopsies	biopsy	NOUN
dpc-2863	221	15	of	of	ADP
dpc-2863	221	16	benign	benign	ADJ
dpc-2863	221	17	inflammatory	inflammatory	ADJ
dpc-2863	221	18	vs.	vs.	ADP
dpc-2863	221	19	lymphomatous	lymphomatous	ADJ
dpc-2863	221	20	erythroderma	erythroderma	NOUN
dpc-2863	221	21	.	.	PUNCT
dpc-2863	222	1	br	br	PROPN
dpc-2863	222	2	j	j	PROPN
dpc-2863	222	3	dermatol	dermatol	NOUN
dpc-2863	222	4	.	.	PUNCT
dpc-2863	223	1	2014;171(3):499	2014;171(3):499	NUM
dpc-2863	223	2	-	-	SYM
dpc-2863	223	3	504	504	NUM
dpc-2863	223	4	.	.	PUNCT
dpc-2863	224	1	doi	doi	NOUN
dpc-2863	224	2	:	:	PUNCT
dpc-2863	224	3	10.1111	10.1111	NUM
dpc-2863	224	4	/	/	SYM
dpc-2863	224	5	bjd.12934	bjd.12934	PROPN
dpc-2863	224	6	.	.	PUNCT
dpc-2863	225	1	pmid	pmid	NOUN
dpc-2863	225	2	:	:	PUNCT
dpc-2863	225	3	24601935	24601935	NUM
dpc-2863	225	4	.	.	PUNCT
dpc-2863	226	1	23	23	NUM
dpc-2863	226	2	.	.	X
dpc-2863	227	1	bommarito	bommarito	PROPN
dpc-2863	227	2	d	d	PROPN
dpc-2863	227	3	,	,	PUNCT
dpc-2863	227	4	hall	hall	NOUN
dpc-2863	227	5	c	c	NOUN
dpc-2863	227	6	,	,	PUNCT
dpc-2863	227	7	taams	taam	NOUN
dpc-2863	227	8	ls	ls	ADJ
dpc-2863	227	9	,	,	PUNCT
dpc-2863	227	10	corrigall	corrigall	PROPN
dpc-2863	227	11	vm	vm	PROPN
dpc-2863	227	12	.	.	PROPN
dpc-2863	227	13	inflammatory	inflammatory	ADJ
dpc-2863	227	14	cytokines	cytokine	NOUN
dpc-2863	227	15	compromise	compromise	VERB
dpc-2863	227	16	programmed	program	VERB
dpc-2863	227	17	cell	cell	NOUN
dpc-2863	227	18	death-1	death-1	PROPN
dpc-2863	227	19	(	(	PUNCT
dpc-2863	227	20	pd-1)-mediated	pd-1)-mediate	VERB
dpc-2863	227	21	t	t	NOUN
dpc-2863	227	22	cell	cell	NOUN
dpc-2863	227	23	suppression	suppression	NOUN
dpc-2863	227	24	in	in	ADP
dpc-2863	227	25	inflammatory	inflammatory	ADJ
dpc-2863	227	26	arthritis	arthritis	NOUN
dpc-2863	227	27	through	through	ADP
dpc-2863	227	28	up	up	ADJ
dpc-2863	227	29	-	-	PUNCT
dpc-2863	227	30	regulation	regulation	NOUN
dpc-2863	227	31	of	of	ADP
dpc-2863	227	32	soluble	soluble	ADJ
dpc-2863	227	33	pd-1	pd-1	NOUN
dpc-2863	227	34	.	.	PUNCT
dpc-2863	228	1	clin	clin	PROPN
dpc-2863	228	2	exp	exp	NOUN
dpc-2863	228	3	immunol	immunol	NOUN
dpc-2863	228	4	.	.	PUNCT
dpc-2863	229	1	2017;188(3):455	2017;188(3):455	NUM
dpc-2863	229	2	-	-	SYM
dpc-2863	229	3	466	466	NUM
dpc-2863	229	4	.	.	PUNCT
dpc-2863	229	5	doi	doi	NOUN
dpc-2863	229	6	:	:	PUNCT
dpc-2863	229	7	10.1111	10.1111	NUM
dpc-2863	229	8	/	/	SYM
dpc-2863	229	9	cei.12949	cei.12949	X
dpc-2863	229	10	.	.	PUNCT
dpc-2863	230	1	pmid	pmid	NOUN
dpc-2863	230	2	:	:	PUNCT
dpc-2863	230	3	28245522	28245522	NUM
dpc-2863	230	4	.	.	PUNCT
dpc-2863	231	1	pmcid	pmcid	NOUN
dpc-2863	231	2	:	:	PUNCT
dpc-2863	231	3	pmc5422858	pmc5422858	NOUN
dpc-2863	231	4	.	.	PUNCT
dpc-2863	232	1	not	not	PART
dpc-2863	232	2	ample	ample	ADJ
dpc-2863	232	3	evidence	evidence	NOUN
dpc-2863	232	4	and	and	CCONJ
dpc-2863	232	5	the	the	DET
dpc-2863	232	6	results	result	NOUN
dpc-2863	232	7	of	of	ADP
dpc-2863	232	8	the	the	DET
dpc-2863	232	9	present	present	ADJ
dpc-2863	232	10	study	study	NOUN
dpc-2863	232	11	are	be	AUX
dpc-2863	232	12	not	not	PART
dpc-2863	232	13	sufficient	sufficient	ADJ
dpc-2863	232	14	for	for	ADP
dpc-2863	232	15	a	a	DET
dpc-2863	232	16	thorough	thorough	ADJ
dpc-2863	232	17	understanding	understanding	NOUN
dpc-2863	232	18	of	of	ADP
dpc-2863	232	19	the	the	DET
dpc-2863	232	20	subject	subject	NOUN
dpc-2863	232	21	matter	matter	NOUN
dpc-2863	232	22	.	.	PUNCT
dpc-2863	233	1	for	for	ADP
dpc-2863	233	2	a	a	DET
dpc-2863	233	3	better	well	ADJ
dpc-2863	233	4	understanding	understanding	NOUN
dpc-2863	233	5	of	of	ADP
dpc-2863	233	6	this	this	DET
dpc-2863	233	7	subject	subject	NOUN
dpc-2863	233	8	,	,	PUNCT
dpc-2863	233	9	it	it	PRON
dpc-2863	233	10	is	be	AUX
dpc-2863	233	11	necessary	necessary	ADJ
dpc-2863	233	12	to	to	PART
dpc-2863	233	13	investigate	investigate	VERB
dpc-2863	233	14	the	the	DET
dpc-2863	233	15	pd-1	pd-1	ADJ
dpc-2863	233	16	and	and	CCONJ
dpc-2863	233	17	pd	pd	PROPN
dpc-2863	233	18	-	-	PUNCT
dpc-2863	233	19	l1	l1	PROPN
dpc-2863	233	20	expressions	expression	NOUN
dpc-2863	233	21	in	in	ADP
dpc-2863	233	22	psoriasis	psoriasis	NOUN
dpc-2863	233	23	patients	patient	NOUN
dpc-2863	233	24	with	with	ADP
dpc-2863	233	25	reference	reference	NOUN
dpc-2863	233	26	to	to	ADP
dpc-2863	233	27	the	the	DET
dpc-2863	233	28	studies	study	NOUN
dpc-2863	233	29	conducted	conduct	VERB
dpc-2863	233	30	with	with	ADP
dpc-2863	233	31	more	more	ADJ
dpc-2863	233	32	patients	patient	NOUN
dpc-2863	233	33	and	and	CCONJ
dpc-2863	233	34	employing	employ	VERB
dpc-2863	233	35	more	more	ADV
dpc-2863	233	36	detailed	detailed	ADJ
dpc-2863	233	37	research	research	NOUN
dpc-2863	233	38	designs	design	NOUN
dpc-2863	233	39	.	.	PUNCT
dpc-2863	234	1	we	we	PRON
dpc-2863	234	2	believe	believe	VERB
dpc-2863	234	3	that	that	SCONJ
dpc-2863	234	4	this	this	PRON
dpc-2863	234	5	may	may	AUX
dpc-2863	234	6	unearth	unearth	VERB
dpc-2863	234	7	new	new	ADJ
dpc-2863	234	8	pathways	pathway	NOUN
dpc-2863	234	9	in	in	ADP
dpc-2863	234	10	the	the	DET
dpc-2863	234	11	pathogenesis	pathogenesis	NOUN
dpc-2863	234	12	of	of	ADP
dpc-2863	234	13	psoriasis	psoriasis	NOUN
dpc-2863	234	14	.	.	PUNCT
dpc-2863	235	1	in	in	ADP
dpc-2863	235	2	the	the	DET
dpc-2863	235	3	future	future	NOUN
dpc-2863	235	4	,	,	PUNCT
dpc-2863	235	5	medications	medication	NOUN
dpc-2863	235	6	modulating	modulate	VERB
dpc-2863	235	7	the	the	DET
dpc-2863	235	8	function	function	NOUN
dpc-2863	235	9	of	of	ADP
dpc-2863	235	10	the	the	DET
dpc-2863	235	11	pd-1	pd-1	NOUN
dpc-2863	235	12	/	/	SYM
dpc-2863	235	13	pd	pd	ADJ
dpc-2863	235	14	-	-	PUNCT
dpc-2863	235	15	l1	l1	PROPN
dpc-2863	235	16	pathway	pathway	NOUN
dpc-2863	235	17	may	may	AUX
dpc-2863	235	18	emerge	emerge	VERB
dpc-2863	235	19	as	as	ADP
dpc-2863	235	20	a	a	DET
dpc-2863	235	21	promising	promising	ADJ
dpc-2863	235	22	option	option	NOUN
dpc-2863	235	23	in	in	ADP
dpc-2863	235	24	the	the	DET
dpc-2863	235	25	treatment	treatment	NOUN
dpc-2863	235	26	of	of	ADP
dpc-2863	235	27	psoriasis	psoriasis	NOUN
dpc-2863	235	28	.	.	PUNCT
dpc-2863	236	1	pd-1	pd-1	ADJ
dpc-2863	236	2	and	and	CCONJ
dpc-2863	236	3	pd	pd	PROPN
dpc-2863	236	4	-	-	PUNCT
dpc-2863	236	5	l1	l1	PROPN
dpc-2863	236	6	expressions	expression	NOUN
dpc-2863	236	7	in	in	ADP
dpc-2863	236	8	the	the	DET
dpc-2863	236	9	immune	immune	ADJ
dpc-2863	236	10	cells	cell	NOUN
dpc-2863	236	11	in	in	ADP
dpc-2863	236	12	the	the	DET
dpc-2863	236	13	psoriatic	psoriatic	ADJ
dpc-2863	236	14	skin	skin	NOUN
dpc-2863	236	15	are	be	AUX
dpc-2863	236	16	significantly	significantly	ADV
dpc-2863	236	17	higher	high	ADJ
dpc-2863	236	18	in	in	ADP
dpc-2863	236	19	comparison	comparison	NOUN
dpc-2863	236	20	to	to	ADP
dpc-2863	236	21	the	the	DET
dpc-2863	236	22	 	 	SPACE
dpc-2863	236	23	healthy	healthy	ADJ
dpc-2863	236	24	controls	control	NOUN
dpc-2863	236	25	.	.	PUNCT
dpc-2863	237	1	increased	increase	VERB
dpc-2863	237	2	immune	immune	ADJ
dpc-2863	237	3	system	system	NOUN
dpc-2863	237	4	activity	activity	NOUN
dpc-2863	237	5	in	in	ADP
dpc-2863	237	6	the	the	DET
dpc-2863	237	7	psoriatic	psoriatic	ADJ
dpc-2863	237	8	lesions	lesion	NOUN
dpc-2863	237	9	may	may	AUX
dpc-2863	237	10	trigger	trigger	VERB
dpc-2863	237	11	pd-1	pd-1	ADJ
dpc-2863	237	12	and	and	CCONJ
dpc-2863	237	13	pd	pd	PROPN
dpc-2863	237	14	-	-	PROPN
dpc-2863	237	15	l1	l1	PROPN
dpc-2863	237	16	expression	expression	NOUN
dpc-2863	237	17	in	in	ADP
dpc-2863	237	18	the	the	DET
dpc-2863	237	19	immune	immune	ADJ
dpc-2863	237	20	cells	cell	NOUN
dpc-2863	237	21	of	of	ADP
dpc-2863	237	22	the	the	DET
dpc-2863	237	23	lesioned	lesione	VERB
dpc-2863	237	24	skin	skin	NOUN
dpc-2863	237	25	.	.	PUNCT
dpc-2863	238	1	references	reference	NOUN
dpc-2863	238	2	1	1	NUM
dpc-2863	238	3	.	.	PUNCT
dpc-2863	238	4	mahil	mahil	PROPN
dpc-2863	238	5	sk	sk	PROPN
dpc-2863	238	6	,	,	PUNCT
dpc-2863	238	7	capon	capon	NOUN
dpc-2863	238	8	f	f	PROPN
dpc-2863	238	9	,	,	PUNCT
dpc-2863	238	10	barker	barker	PROPN
dpc-2863	238	11	jn	jn	PROPN
dpc-2863	238	12	.	.	PROPN
dpc-2863	238	13	update	update	NOUN
dpc-2863	238	14	on	on	ADP
dpc-2863	238	15	psoriasis	psoriasis	NOUN
dpc-2863	238	16	immunopathogenesis	immunopathogenesis	NOUN
dpc-2863	238	17	and	and	CCONJ
dpc-2863	238	18	targeted	target	VERB
dpc-2863	238	19	immunotherapy	immunotherapy	NOUN
dpc-2863	238	20	.	.	PUNCT
dpc-2863	239	1	semin	semin	PROPN
dpc-2863	239	2	immunopathol	immunopathol	PROPN
dpc-2863	239	3	.	.	PUNCT
dpc-2863	240	1	2016;38(1):11	2016;38(1):11	NUM
dpc-2863	240	2	-	-	SYM
dpc-2863	240	3	27	27	NUM
dpc-2863	240	4	.	.	PUNCT
dpc-2863	241	1	doi	doi	NOUN
dpc-2863	241	2	:	:	PUNCT
dpc-2863	241	3	10.1007	10.1007	NUM
dpc-2863	241	4	/	/	SYM
dpc-2863	241	5	s00281	s00281	NOUN
dpc-2863	241	6	-	-	PUNCT
dpc-2863	241	7	015	015	NUM
dpc-2863	241	8	-	-	PUNCT
dpc-2863	241	9	0539	0539	NUM
dpc-2863	241	10	-	-	SYM
dpc-2863	241	11	8	8	NUM
dpc-2863	241	12	.	.	PUNCT
dpc-2863	242	1	pmid	pmid	NOUN
dpc-2863	242	2	:	:	PUNCT
dpc-2863	242	3	26573299	26573299	NUM
dpc-2863	242	4	.	.	PUNCT
dpc-2863	243	1	pmcid	pmcid	ADJ
dpc-2863	243	2	:	:	PUNCT
dpc-2863	243	3	pmc4706579	pmc4706579	NOUN
dpc-2863	243	4	.	.	PUNCT
dpc-2863	244	1	2	2	X
dpc-2863	244	2	.	.	X
dpc-2863	244	3	zamani	zamani	PROPN
dpc-2863	244	4	rm	rm	PROPN
dpc-2863	244	5	,	,	PUNCT
dpc-2863	244	6	aslani	aslani	PROPN
dpc-2863	244	7	s	s	PROPN
dpc-2863	244	8	,	,	PUNCT
dpc-2863	244	9	salmaninejad	salmaninejad	NOUN
dpc-2863	244	10	a	a	NOUN
dpc-2863	244	11	,	,	PUNCT
dpc-2863	244	12	javan	javan	PROPN
dpc-2863	244	13	mr	mr	PROPN
dpc-2863	244	14	,	,	PUNCT
dpc-2863	244	15	rezaei	rezaei	PROPN
dpc-2863	244	16	n.	n.	PROPN
dpc-2863	244	17	pd-1	pd-1	PROPN
dpc-2863	244	18	/	/	SYM
dpc-2863	244	19	pd	pd	NOUN
dpc-2863	244	20	-	-	NOUN
dpc-2863	244	21	l	l	NOUN
dpc-2863	244	22	and	and	CCONJ
dpc-2863	244	23	autoimmunity	autoimmunity	NOUN
dpc-2863	244	24	:	:	PUNCT
dpc-2863	244	25	a	a	DET
dpc-2863	244	26	growing	grow	VERB
dpc-2863	244	27	relationship	relationship	NOUN
dpc-2863	244	28	.	.	PUNCT
dpc-2863	245	1	cell	cell	NOUN
dpc-2863	245	2	immunol	immunol	NOUN
dpc-2863	245	3	.	.	PUNCT
dpc-2863	246	1	2016;310:27	2016;310:27	NUM
dpc-2863	246	2	-	-	SYM
dpc-2863	246	3	41	41	NUM
dpc-2863	246	4	.	.	PUNCT
dpc-2863	247	1	doi	doi	NOUN
dpc-2863	247	2	:	:	PUNCT
dpc-2863	247	3	10.1016	10.1016	NUM
dpc-2863	247	4	/	/	SYM
dpc-2863	247	5	j.cellimm.2016.09.009	j.cellimm.2016.09.009	PROPN
dpc-2863	247	6	.	.	PUNCT
dpc-2863	248	1	pmid	pmid	NOUN
dpc-2863	248	2	:	:	PUNCT
dpc-2863	248	3	27660198	27660198	NUM
dpc-2863	248	4	.	.	PUNCT
dpc-2863	249	1	3	3	X
dpc-2863	249	2	.	.	X
dpc-2863	249	3	keir	keir	PROPN
dpc-2863	249	4	me	me	PROPN
dpc-2863	249	5	,	,	PUNCT
dpc-2863	249	6	liang	liang	PROPN
dpc-2863	249	7	sc	sc	PROPN
dpc-2863	249	8	,	,	PUNCT
dpc-2863	249	9	guleria	guleria	PROPN
dpc-2863	249	10	i	i	PROPN
dpc-2863	249	11	,	,	PUNCT
dpc-2863	249	12	et	et	PROPN
dpc-2863	249	13	al	al	PROPN
dpc-2863	249	14	.	.	PUNCT
dpc-2863	250	1	tissue	tissue	NOUN
dpc-2863	250	2	expression	expression	NOUN
dpc-2863	250	3	of	of	ADP
dpc-2863	250	4	pd	pd	PROPN
dpc-2863	250	5	-	-	PROPN
dpc-2863	250	6	l1	l1	PROPN
dpc-2863	250	7	mediates	mediate	NOUN
dpc-2863	250	8	peripheral	peripheral	ADJ
dpc-2863	250	9	t	t	NOUN
dpc-2863	250	10	cell	cell	NOUN
dpc-2863	250	11	tolerance	tolerance	NOUN
dpc-2863	250	12	.	.	PUNCT
dpc-2863	251	1	j	j	PROPN
dpc-2863	251	2	exp	exp	NOUN
dpc-2863	251	3	med	med	PROPN
dpc-2863	251	4	.	.	PUNCT
dpc-2863	252	1	2006;203(4):883	2006;203(4):883	NUM
dpc-2863	252	2	-	-	SYM
dpc-2863	252	3	895	895	NUM
dpc-2863	252	4	.	.	PUNCT
dpc-2863	252	5	doi	doi	NOUN
dpc-2863	252	6	:	:	PUNCT
dpc-2863	252	7	10.1084	10.1084	NUM
dpc-2863	252	8	/	/	SYM
dpc-2863	252	9	jem.20051776	jem.20051776	NOUN
dpc-2863	252	10	.	.	PUNCT
dpc-2863	253	1	pmid	pmid	NOUN
dpc-2863	253	2	:	:	PUNCT
dpc-2863	253	3	16606670	16606670	NUM
dpc-2863	253	4	.	.	PUNCT
dpc-2863	254	1	pmcid	pmcid	NOUN
dpc-2863	254	2	:	:	PUNCT
dpc-2863	254	3	pmc2118286	pmc2118286	ADJ
dpc-2863	254	4	.	.	PUNCT
dpc-2863	255	1	4	4	X
dpc-2863	255	2	.	.	X
dpc-2863	255	3	hamza	hamza	PROPN
dpc-2863	255	4	a	a	PROPN
dpc-2863	255	5	,	,	PUNCT
dpc-2863	255	6	roberts	roberts	PROPN
dpc-2863	255	7	d	d	PROPN
dpc-2863	255	8	,	,	PUNCT
dpc-2863	255	9	su	su	PROPN
dpc-2863	255	10	s	s	PROPN
dpc-2863	255	11	,	,	PUNCT
dpc-2863	255	12	weber	weber	PROPN
dpc-2863	255	13	rs	rs	PROPN
dpc-2863	255	14	,	,	PUNCT
dpc-2863	255	15	bell	bell	NOUN
dpc-2863	255	16	d	d	PROPN
dpc-2863	255	17	,	,	PUNCT
dpc-2863	255	18	ferrarotto	ferrarotto	PROPN
dpc-2863	255	19	r.	r.	PROPN
dpc-2863	255	20	pd	pd	PROPN
dpc-2863	255	21	-	-	PROPN
dpc-2863	255	22	l1	l1	PROPN
dpc-2863	255	23	expression	expression	NOUN
dpc-2863	255	24	by	by	ADP
dpc-2863	255	25	immunohistochemistry	immunohistochemistry	NOUN
dpc-2863	255	26	in	in	ADP
dpc-2863	255	27	salivary	salivary	ADJ
dpc-2863	255	28	duct	duct	NOUN
dpc-2863	255	29	carcinoma	carcinoma	NOUN
dpc-2863	255	30	.	.	PUNCT
dpc-2863	256	1	ann	ann	PROPN
dpc-2863	256	2	diagn	diagn	PROPN
dpc-2863	256	3	pathol	pathol	NOUN
dpc-2863	256	4	.	.	PUNCT
dpc-2863	257	1	2019;40:49	2019;40:49	NUM
dpc-2863	257	2	-	-	SYM
dpc-2863	257	3	52	52	NUM
dpc-2863	257	4	.	.	PUNCT
dpc-2863	258	1	doi	doi	NOUN
dpc-2863	258	2	:	:	PUNCT
dpc-2863	258	3	10.1016	10.1016	NUM
dpc-2863	258	4	/	/	SYM
dpc-2863	258	5	j.anndiagpath.2019.04.001	j.anndiagpath.2019.04.001	PROPN
dpc-2863	258	6	.	.	PUNCT
dpc-2863	259	1	pmid	pmid	NOUN
dpc-2863	259	2	:	:	PUNCT
dpc-2863	259	3	30978575	30978575	NUM
dpc-2863	259	4	.	.	PUNCT
dpc-2863	260	1	pmcid	pmcid	NOUN
dpc-2863	260	2	:	:	PUNCT
dpc-2863	260	3	pmc6599643	pmc6599643	NOUN
dpc-2863	260	4	.	.	PUNCT
dpc-2863	261	1	5	5	X
dpc-2863	261	2	.	.	X
dpc-2863	261	3	adamczyk	adamczyk	PROPN
dpc-2863	261	4	m	m	PROPN
dpc-2863	261	5	,	,	PUNCT
dpc-2863	261	6	krasowska	krasowska	PROPN
dpc-2863	261	7	d.	d.	NOUN
dpc-2863	261	8	pd1	pd1	PROPN
dpc-2863	261	9	/	/	SYM
dpc-2863	261	10	pd	pd	NOUN
dpc-2863	261	11	-	-	PROPN
dpc-2863	261	12	l1	l1	PROPN
dpc-2863	261	13	pathway	pathway	NOUN
dpc-2863	261	14	in	in	ADP
dpc-2863	261	15	psoriasis	psoriasis	NOUN
dpc-2863	261	16	and	and	CCONJ
dpc-2863	261	17	psoriatic	psoriatic	ADJ
dpc-2863	261	18	arthritis	arthritis	NOUN
dpc-2863	261	19	:	:	PUNCT
dpc-2863	261	20	a	a	DET
dpc-2863	261	21	review	review	NOUN
dpc-2863	261	22	.	.	PUNCT
dpc-2863	262	1	postepy	postepy	ADJ
dpc-2863	262	2	dermatol	dermatol	NOUN
dpc-2863	262	3	alergol	alergol	NOUN
dpc-2863	262	4	.	.	PUNCT
dpc-2863	263	1	2021;38(6):925	2021;38(6):925	NUM
dpc-2863	263	2	-	-	SYM
dpc-2863	263	3	930	930	NUM
dpc-2863	263	4	.	.	PUNCT
dpc-2863	264	1	doi	doi	NOUN
dpc-2863	264	2	:	:	PUNCT
dpc-2863	264	3	10.5114	10.5114	NUM
dpc-2863	264	4	/	/	SYM
dpc-2863	264	5	ada.2021.112274	ada.2021.112274	NUM
dpc-2863	264	6	.	.	PUNCT
dpc-2863	265	1	pmid	pmid	NOUN
dpc-2863	265	2	:	:	PUNCT
dpc-2863	265	3	35125995	35125995	NUM
dpc-2863	265	4	.	.	PUNCT
dpc-2863	266	1	pmcid	pmcid	NOUN
dpc-2863	266	2	:	:	PUNCT
dpc-2863	266	3	pmc8802966	pmc8802966	NOUN
dpc-2863	266	4	.	.	PUNCT
dpc-2863	267	1	6	6	X
dpc-2863	267	2	.	.	X
dpc-2863	267	3	sharpe	sharpe	PROPN
dpc-2863	267	4	ah	ah	PROPN
dpc-2863	267	5	,	,	PUNCT
dpc-2863	267	6	pauken	pauken	ADJ
dpc-2863	267	7	ke	ke	PROPN
dpc-2863	267	8	.	.	PUNCT
dpc-2863	268	1	the	the	DET
dpc-2863	268	2	diverse	diverse	ADJ
dpc-2863	268	3	functions	function	NOUN
dpc-2863	268	4	of	of	ADP
dpc-2863	268	5	the	the	DET
dpc-2863	268	6	pd1	pd1	NOUN
dpc-2863	268	7	inhibitory	inhibitory	ADJ
dpc-2863	268	8	pathwaynat	pathwaynat	NOUN
dpc-2863	268	9	rev	rev	X
dpc-2863	268	10	immunol	immunol	NOUN
dpc-2863	268	11	.	.	PUNCT
dpc-2863	269	1	2018;18(3):153	2018;18(3):153	NUM
dpc-2863	269	2	-	-	PUNCT
dpc-2863	269	3	167	167	NUM
dpc-2863	269	4	.	.	PUNCT
dpc-2863	270	1	doi	doi	NOUN
dpc-2863	270	2	:	:	PUNCT
dpc-2863	270	3	10.1038	10.1038	NUM
dpc-2863	270	4	/	/	SYM
dpc-2863	270	5	nri.2017.108	nri.2017.108	PROPN
dpc-2863	270	6	.	.	PUNCT
dpc-2863	271	1	pmid	pmid	NOUN
dpc-2863	271	2	:	:	PUNCT
dpc-2863	271	3	28990585	28990585	NUM
dpc-2863	271	4	.	.	PUNCT
dpc-2863	272	1	7	7	X
dpc-2863	272	2	.	.	X
dpc-2863	272	3	belum	belum	PROPN
dpc-2863	272	4	vr	vr	PROPN
dpc-2863	272	5	,	,	PUNCT
dpc-2863	272	6	benhuri	benhuri	PROPN
dpc-2863	272	7	b	b	PROPN
dpc-2863	272	8	,	,	PUNCT
dpc-2863	272	9	postov	postov	PROPN
dpc-2863	272	10	ma	ma	PROPN
dpc-2863	272	11	,	,	PUNCT
dpc-2863	272	12	et	et	PROPN
dpc-2863	272	13	al	al	PROPN
dpc-2863	272	14	.	.	PROPN
dpc-2863	272	15	characterisation	characterisation	NOUN
dpc-2863	272	16	and	and	CCONJ
dpc-2863	272	17	management	management	NOUN
dpc-2863	272	18	of	of	ADP
dpc-2863	272	19	dermatologic	dermatologic	ADJ
dpc-2863	272	20	adverse	adverse	ADJ
dpc-2863	272	21	to	to	ADP
dpc-2863	272	22	events	event	NOUN
dpc-2863	272	23	to	to	ADP
dpc-2863	272	24	agents	agent	NOUN
dpc-2863	272	25	targeting	target	VERB
dpc-2863	272	26	the	the	DET
dpc-2863	272	27	pd-1	pd-1	ADJ
dpc-2863	272	28	receptor	receptor	NOUN
dpc-2863	272	29	.	.	PUNCT
dpc-2863	273	1	eur	eur	PROPN
dpc-2863	273	2	j	j	PROPN
dpc-2863	273	3	cancer	cancer	NOUN
dpc-2863	273	4	.	.	PUNCT
dpc-2863	274	1	2016;60:12	2016;60:12	NUM
dpc-2863	274	2	-	-	SYM
dpc-2863	274	3	25	25	NUM
dpc-2863	274	4	.	.	PUNCT
dpc-2863	274	5	doi	doi	NOUN
dpc-2863	274	6	:	:	PUNCT
dpc-2863	274	7	10.1016	10.1016	NUM
dpc-2863	274	8	/	/	SYM
dpc-2863	274	9	j.	j.	PROPN
dpc-2863	274	10	ejca.2016.02.010	ejca.2016.02.010	PROPN
dpc-2863	274	11	.	.	PUNCT
dpc-2863	275	1	pmid	pmid	NOUN
dpc-2863	275	2	:	:	PUNCT
dpc-2863	275	3	27043866	27043866	NUM
dpc-2863	275	4	.	.	PUNCT
dpc-2863	276	1	pmcid	pmcid	NOUN
dpc-2863	276	2	:	:	PUNCT
dpc-2863	276	3	pmc4998047	pmc4998047	ADJ
dpc-2863	276	4	.	.	PUNCT
dpc-2863	277	1	8	8	NUM
dpc-2863	277	2	.	.	PUNCT
dpc-2863	277	3	bonigen	bonigen	PROPN
dpc-2863	277	4	j	j	PROPN
dpc-2863	277	5	,	,	PUNCT
dpc-2863	277	6	raynaud	raynaud	PROPN
dpc-2863	277	7	-	-	PUNCT
dpc-2863	277	8	donzel	donzel	PROPN
dpc-2863	277	9	c	c	PROPN
dpc-2863	277	10	,	,	PUNCT
dpc-2863	277	11	hureaux	hureaux	PROPN
dpc-2863	277	12	j	j	PROPN
dpc-2863	277	13	,	,	PUNCT
dpc-2863	277	14	et	et	PROPN
dpc-2863	277	15	al	al	PROPN
dpc-2863	277	16	.	.	PUNCT
dpc-2863	278	1	anti	anti	ADJ
dpc-2863	278	2	-	-	ADJ
dpc-2863	278	3	pd1	pd1	NOUN
dpc-2863	278	4	-	-	PUNCT
dpc-2863	278	5	induced	induce	VERB
dpc-2863	278	6	psoriasis	psoriasis	NOUN
dpc-2863	278	7	:	:	PUNCT
dpc-2863	278	8	a	a	DET
dpc-2863	278	9	study	study	NOUN
dpc-2863	278	10	of	of	ADP
dpc-2863	278	11	21	21	NUM
dpc-2863	278	12	patients	patient	NOUN
dpc-2863	278	13	.	.	PUNCT
dpc-2863	279	1	j	j	PROPN
dpc-2863	279	2	eur	eur	PROPN
dpc-2863	279	3	acad	acad	PROPN
dpc-2863	279	4	dermatol	dermatol	NOUN
dpc-2863	279	5	venereol	venereol	NOUN
dpc-2863	279	6	.	.	PUNCT
dpc-2863	280	1	2017;31(5):e254	2017;31(5):e254	NUM
dpc-2863	280	2	-	-	PUNCT
dpc-2863	280	3	e257	e257	PROPN
dpc-2863	280	4	.	.	PUNCT
dpc-2863	280	5	doi	doi	NOUN
dpc-2863	280	6	:	:	PUNCT
dpc-2863	280	7	10.1111	10.1111	NUM
dpc-2863	280	8	/	/	SYM
dpc-2863	280	9	jdv.14011	jdv.14011	PROPN
dpc-2863	280	10	.	.	PUNCT
dpc-2863	281	1	pmid	pmid	NOUN
dpc-2863	281	2	:	:	PUNCT
dpc-2863	281	3	27739129	27739129	NUM
dpc-2863	281	4	.	.	PUNCT
dpc-2863	282	1	9	9	X
dpc-2863	282	2	.	.	X
dpc-2863	282	3	sibaud	sibaud	PROPN
dpc-2863	282	4	v	v	PROPN
dpc-2863	282	5	,	,	PUNCT
dpc-2863	282	6	meyer	meyer	PROPN
dpc-2863	282	7	n	n	CCONJ
dpc-2863	282	8	,	,	PUNCT
dpc-2863	282	9	lamant	lamant	PROPN
dpc-2863	282	10	l	l	NOUN
dpc-2863	282	11	,	,	PUNCT
dpc-2863	282	12	vigarios	vigarios	PROPN
dpc-2863	282	13	e	e	NOUN
dpc-2863	282	14	,	,	PUNCT
dpc-2863	282	15	mazieres	mazieres	PROPN
dpc-2863	282	16	j	j	PROPN
dpc-2863	282	17	,	,	PUNCT
dpc-2863	282	18	delord	delord	PROPN
dpc-2863	282	19	jp	jp	NOUN
dpc-2863	282	20	.	.	PUNCT
dpc-2863	283	1	dermatologic	dermatologic	ADJ
dpc-2863	283	2	complications	complication	NOUN
dpc-2863	283	3	of	of	ADP
dpc-2863	283	4	anti	anti	ADJ
dpc-2863	283	5	-	-	ADJ
dpc-2863	283	6	pd-1	pd-1	ADJ
dpc-2863	283	7	/	/	SYM
dpc-2863	283	8	pd	pd	ADJ
dpc-2863	283	9	-	-	PUNCT
dpc-2863	283	10	l1	l1	PROPN
dpc-2863	283	11	immune	immune	ADJ
dpc-2863	283	12	checkpoint	checkpoint	NOUN
dpc-2863	283	13	antibodies	antibodie	VERB
dpc-2863	283	14	.	.	PUNCT
dpc-2863	284	1	curr	curr	PROPN
dpc-2863	284	2	opin	opin	PROPN
dpc-2863	284	3	oncol	oncol	PROPN
dpc-2863	284	4	.	.	PUNCT
dpc-2863	285	1	2016;28(4):254	2016;28(4):254	NUM
dpc-2863	285	2	-	-	SYM
dpc-2863	285	3	263	263	NUM
dpc-2863	285	4	.	.	PUNCT
dpc-2863	286	1	doi	doi	NOUN
dpc-2863	286	2	:	:	PUNCT
dpc-2863	286	3	10.1097	10.1097	NUM
dpc-2863	286	4	/	/	SYM
dpc-2863	286	5	cco.0000000000000290	cco.0000000000000290	NUM
dpc-2863	286	6	.	.	PUNCT
dpc-2863	287	1	pmid	pmid	NOUN
dpc-2863	287	2	:	:	PUNCT
dpc-2863	287	3	27136138	27136138	NUM
dpc-2863	287	4	.	.	PUNCT
dpc-2863	288	1	10	10	NUM
dpc-2863	288	2	.	.	PUNCT
dpc-2863	288	3	peled	pele	VERB
dpc-2863	288	4	m	m	PROPN
dpc-2863	288	5	,	,	PUNCT
dpc-2863	288	6	strazza	strazza	VERB
dpc-2863	288	7	m	m	PRON
dpc-2863	288	8	,	,	PUNCT
dpc-2863	288	9	azoulay	azoulay	NOUN
dpc-2863	288	10	-	-	PUNCT
dpc-2863	288	11	alfaguter	alfaguter	NOUN
dpc-2863	289	1	i	i	PRON
dpc-2863	289	2	,	,	PUNCT
dpc-2863	289	3	mor	mor	PROPN
dpc-2863	289	4	a.	a.	NOUN
dpc-2863	289	5	analysis	analysis	NOUN
dpc-2863	289	6	of	of	ADP
dpc-2863	289	7	programmed	program	VERB
dpc-2863	289	8	death-1	death-1	PROPN
dpc-2863	289	9	in	in	ADP
dpc-2863	289	10	patients	patient	NOUN
dpc-2863	289	11	with	with	ADP
dpc-2863	289	12	psoriatic	psoriatic	ADJ
dpc-2863	289	13	arthritis	arthritis	NOUN
dpc-2863	289	14	.	.	PUNCT
dpc-2863	290	1	inflammation	inflammation	NOUN
dpc-2863	290	2	.	.	PUNCT
dpc-2863	291	1	2015;38(4):1573	2015;38(4):1573	NUM
dpc-2863	291	2	-	-	SYM
dpc-2863	291	3	1579	1579	NUM
dpc-2863	291	4	.	.	PUNCT
dpc-2863	292	1	doi	doi	NOUN
dpc-2863	292	2	:	:	PUNCT
dpc-2863	292	3	10.1007	10.1007	NUM
dpc-2863	292	4	/	/	SYM
dpc-2863	292	5	s10753015	s10753015	NOUN
dpc-2863	292	6	-	-	PUNCT
dpc-2863	292	7	0132	0132	NUM
dpc-2863	292	8	-	-	SYM
dpc-2863	292	9	2	2	NUM
dpc-2863	292	10	.	.	PUNCT
dpc-2863	293	1	pmid	pmid	NOUN
dpc-2863	293	2	:	:	PUNCT
dpc-2863	293	3	25663558	25663558	NUM
dpc-2863	293	4	.	.	PUNCT